ALDEN JOHN FINANCIAL CORP
DEFM14A, 1998-07-31
LIFE INSURANCE
Previous: VANGUARD NEW JERSEY TAX FREE FUND, 485BPOS, 1998-07-31
Next: GOLDMAN SACHS TRUST, 497, 1998-07-31



<PAGE>   1
 
                                  SCHEDULE 14A
 
                                 (RULE 14a-101)
 
                    INFORMATION REQUIRED IN PROXY STATEMENT
 
                            SCHEDULE 14A INFORMATION
          PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
                              EXCHANGE ACT OF 1934
 
     Filed by the Registrant [X]
 
     Filed by a Party other than the Registrant [ ]
 
     Check the appropriate box:
 
     [ ] Preliminary Proxy Statement        [ ] Confidential, for Use of the
                                                Commission Only (as permitted by
                                                Rule 14a-6(e)(2))
 
     [X] Definitive Proxy Statement
 
     [ ] Definitive Additional Materials
 
     [ ] Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
 
                        JOHN ALDEN FINANCIAL CORPORATION
- --------------------------------------------------------------------------------
                (Name of Registrant as Specified in Its Charter)
 
                                 Not Applicable
- --------------------------------------------------------------------------------
    (Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
 
     [ ] No fee required.
 
     [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
         0-11.
 
     (1) Title of each class of securities to which transaction applies:
 
         Common Stock, par value $.01 per share, of John Alden Financial
         Corporation ("Common Stock")
- --------------------------------------------------------------------------------
 
     (2) Aggregate number of securities to which transaction applies:
 
         27,029,522 shares of Common Stock
- --------------------------------------------------------------------------------
 
     (3) Per unit price or other underlying value of transaction computed
         pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
         filing fee is calculated and state how it was determined)(1):
         $22.50 in cash per share of Common Stock
- --------------------------------------------------------------------------------
 
     (4) Proposed maximum aggregate value of transaction:
 
         $608,164,245
- --------------------------------------------------------------------------------
 
     (5) Total fee paid(1):
 
         $121,632.85
- --------------------------------------------------------------------------------
 
     [X] Fee paid previously with preliminary materials.
 
     [ ] Check box if any part of the fee is offset as provided by Exchange Act
         Rule 0-11(a)(2) and identify the filing for which the offsetting fee
         was paid previously. Identify the previous filing by registration
         statement number, or the form or schedule and the date of its filing.
 
     (1) Amount previously paid:
 
- --------------------------------------------------------------------------------
 
     (2) Form, schedule or registration statement no.:
 
- --------------------------------------------------------------------------------
 
     (3) Filing party:
 
- --------------------------------------------------------------------------------
 
     (4) Date filed:
 
- --------------------------------------------------------------------------------
- ---------------
(1) The filing fee assumes the purchase of 27,029,522 shares of Common Stock at
    $22.50 in cash per share. The amount of the filing fee, calculated in
    accordance with Rule 0-11(c)(1) of the Securities Exchange Act of 1934, as
    amended, equals one-fiftieth (1/50) of one percent of the proposed cash
    payments to the holders of Common Stock, for a total of $121,632.85
<PAGE>   2
 
JOHN ALDEN LOGO         JOHN ALDEN FINANCIAL CORPORATION
 
                          7300 CORPORATE CENTER DRIVE
                           MIAMI, FLORIDA 33126-1223
                                 (305) 715-3767
 
July 29, 1998
 
Dear Fellow Stockholder:
 
     You are cordially invited to attend the Special Meeting of Stockholders of
John Alden Financial Corporation, which will be held on Friday, August 28, 1998
at 10:00 a.m., Eastern Time, at the Miami Airport Marriott, 1201 N.W. LeJeune
Road, Miami, Florida 33126.
 
     At the Special Meeting, you will be asked to consider and vote upon a
proposal to approve and adopt an Agreement and Plan of Merger, dated March 9,
1998, among John Alden, Fortis, Inc. and JAFCO Acquisition Corp., a wholly owned
subsidiary of Fortis, Inc. In the merger, among other things, (i) each
outstanding share of Common Stock, par value $.01 per share, of John Alden will
be converted into the right to receive $22.50 in cash, without interest, and
(ii) each outstanding share of 9% Cumulative Preferred Stock, par value $.01 per
share, of John Alden will be redeemed for cash in accordance with its terms as
set forth in John Alden's Certificate of Incorporation.
 
     You should read carefully the accompanying Notice of Special Meeting of
Stockholders and Proxy Statement for details regarding the merger and additional
related information, including the opinion of Credit Suisse First Boston
Corporation, John Alden's financial advisor, as to the fairness of the merger
consideration to John Alden's stockholders from a financial point of view.
 
     Your Board of Directors:
 
     1.  unanimously recommends that you vote "FOR" the approval and adoption of
         the Merger Agreement;
 
     2.  has unanimously determined that the merger is fair to and in the best
         interests of John Alden and its stockholders; and
 
     3.  has unanimously approved and declared advisable the merger, the Merger
         Agreement and the related stock option agreement.
 
     The affirmative vote of the holders of shares representing a majority of
the outstanding voting power of John Alden's Common Stock is necessary to
approve the Merger Agreement. Your vote is important. Please sign, date and mail
your proxy card in the postage prepaid envelope today.
 
     Your prompt consideration of the Merger Agreement and the merger will be
greatly appreciated. On behalf of the Board of Directors, thank you for your
continued support.
 
                                          Sincerely,
 
                                          /s/ Glendon E. Johnson
                                          GLENDON E. JOHNSON
                                          Chairman and Chief Executive Officer
<PAGE>   3
 
JOHN ALDEN LOGO         JOHN ALDEN FINANCIAL CORPORATION
 
                          7300 CORPORATE CENTER DRIVE
                           MIAMI, FLORIDA 33126-1223
                                 (305) 715-3767
 
                            ------------------------
 
                   NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
                         TO BE HELD ON AUGUST 28, 1998
 
                            ------------------------
 
     NOTICE IS HEREBY GIVEN that a Special Meeting of Stockholders (the "Special
Meeting") of John Alden Financial Corporation, a Delaware corporation (the
"Company"), will be held on Friday, August 28, 1998 at 10:00 a.m., Eastern Time,
at the Miami Airport Marriott, 1201 N.W. LeJeune Road, Miami, Florida 33126, for
the following purposes:
 
     1.  To approve and adopt an Agreement and Plan of Merger, dated as of March
         9, 1998 (the "Merger Agreement"), among the Company, Fortis, Inc., a
         Nevada corporation ("Buyer"), and JAFCO Acquisition Corp., a Delaware
         corporation and a wholly owned subsidiary of Buyer ("Merger Sub"), and
         the merger of Merger Sub with and into the Company upon the terms and
         subject to the conditions thereof (the "Merger"). Pursuant to the
         Merger Agreement, the Company will be the surviving corporation
         resulting from the Merger and will become a wholly owned subsidiary of
         Buyer. In the Merger, among other things, (i) each share of Common
         Stock, par value $.01 per share, of the Company ("Common Stock") issued
         and outstanding immediately prior to the effective time of the Merger
         will be converted into the right to receive from Buyer $22.50 in cash,
         without interest, and (ii) each share of 9% Cumulative Preferred Stock,
         par value $.01 per share, of the Company ("9% Preferred Stock") issued
         and outstanding immediately prior to the Merger will be redeemed for
         cash in accordance with its terms as set forth in the Company's
         Certificate of Incorporation. The Merger is more completely described
         in the accompanying Proxy Statement, and a copy of the Merger Agreement
         is attached as Annex A thereto.
 
     2.  To transact such other business as may properly come before the Special
         Meeting or any adjournments or postponements thereof.
 
     Only holders of record of the Company's Common Stock at the close of
business on July 6, 1998, the record date for the Special Meeting, are entitled
to notice of and to vote at the Special Meeting and any adjournments or
postponements thereof. Holders of the Company's 9% Preferred Stock are not
entitled to notice of or to vote at the Special Meeting or any adjournment or
postponement thereof.
 
THE COMPANY'S BOARD OF DIRECTORS:
 
          (a) has unanimously determined that the Merger is fair to and in the
     best interests of the Company and its stockholders;
 
          (b) has unanimously approved and declared advisable the Merger, the
     Merger Agreement and the related stock option agreement and the
     transactions contemplated thereby; and
 
          (c) unanimously recommends that the Company's stockholders vote "FOR"
     approval and adoption of the Merger Agreement.
 
     The affirmative vote of the holders of shares representing a majority of
the outstanding shares of the Company's Common Stock is necessary to approve and
adopt the Merger Agreement and the Merger.
 
     Holders of the Company's Common Stock have the right to dissent from the
Merger and to receive "fair value" for their shares of Common Stock in cash,
provided the proper steps are taken to properly "perfect" statutory dissenters
rights. Statutory dissenters rights are more fully discussed in various sections
of the Proxy Statement, and a copy of the Delaware statute governing statutory
dissenters' rights is included as Annex D to the accompanying Proxy Statement.
Holders of Common Stock considering the exercise of their dissenters'
<PAGE>   4
 
rights should carefully review these materials and information before voting
with respect to the Merger Agreement and the Merger.
 
     Whether or not you plan to attend the Special Meeting, please complete,
sign and date the enclosed proxy card and return it promptly in the enclosed
postage prepaid envelope. PLEASE DO NOT SEND ANY SHARE CERTIFICATES AT THIS
TIME. Your proxy may be revoked at any time before it is voted by any one of the
following methods: (i) signing and returning a later-dated proxy with respect to
the same shares, (ii) filing with the Secretary of the Company at 7300 Corporate
Center Drive, Miami, Florida 33126-1223, a written revocation bearing a later
date, or (iii) attending and voting at the Special Meeting.
 
                                          By order of the Board of Directors,
 
                                          /s/ MICHAEL P. ANDERSEN
                                          MICHAEL P. ANDERSEN
                                          General Counsel and Secretary
 
Miami, Florida
July 29, 1998
<PAGE>   5
 
                        JOHN ALDEN FINANCIAL CORPORATION
                          7300 CORPORATE CENTER DRIVE
                           MIAMI, FLORIDA 33126-1223
 
                            ------------------------
 
                                PROXY STATEMENT
 
                            ------------------------
 
                     FOR A SPECIAL MEETING OF STOCKHOLDERS
                         TO BE HELD ON AUGUST 28, 1998
 
     John Alden Financial Corporation, a Delaware corporation (the "Company"),
is furnishing this Proxy Statement to its stockholders in connection with the
solicitation of proxies by the Board of Directors of the Company (the "Board")
for use at its Special Meeting of Stockholders and at any adjournments or
postponements thereof (the "Special Meeting"). The Special Meeting is being held
on Friday, August 28, 1998 at 10:00 a.m., Eastern Time, at the Miami Airport
Marriott, 1201 N.W. LeJeune Road, Miami, Florida 33126. The purpose of the
Special Meeting is to consider and vote upon a proposal to approve and adopt an
Agreement and Plan of Merger, dated as of March 9, 1998 (the "Merger
Agreement"), among the Company, Fortis, Inc., a Nevada corporation ("Buyer"),
and JAFCO Acquisition Corp., a Delaware corporation and a wholly owned
subsidiary of Buyer ("Merger Sub"), and the merger of Merger Sub with and into
the Company upon the terms and subject to the conditions of the Merger Agreement
(the "Merger"). Pursuant to the Merger Agreement, the Company will be the
surviving corporation in the Merger and will become a wholly owned subsidiary of
Buyer. In addition, (i) each outstanding share of Common Stock, par value $.01
per share, of the Company ("Common Stock") issued and outstanding immediately
prior to the effective time of the Merger will be converted into the right to
receive from Buyer $22.50 in cash, without interest, and (ii) each share of 9%
Cumulative Preferred Stock, par value $.01 per share, of the Company ("9%
Preferred Stock") issued and outstanding immediately prior to the effective time
of the Merger will be redeemed for cash in accordance with its terms as set
forth in the Company's Certificate of Incorporation. Based on 24,538,604 shares
of Common Stock issued and outstanding as of July 6, 1998, holders of Common
Stock are expected to receive approximately $552,118,590 in cash, in the
aggregate, in exchange for all of the issued and outstanding Common Stock upon
consummation of the Merger.
 
     On July 28, 1998, the last sale price per share of Common Stock as reported
on the New York Stock Exchange (under the symbol "JA") was $22 1/16. The Merger
Agreement provides that, until the Merger is consummated, the Company may
continue to declare and pay its regular quarterly dividend on the Common Stock
in an amount not in excess of $0.12 per share per quarter.
 
     This Proxy Statement, the letter to stockholders, the Notice of Special
Meeting and the form of proxy for use at the Special Meeting are first being
mailed to stockholders on or about July 30, 1998. The date of this Proxy
Statement is July 29, 1998.
<PAGE>   6
 
                              THE SPECIAL MEETING
 
SOLICITATION AND REVOCATION OF PROXIES
 
     Any stockholder giving a proxy has the power to revoke it at any time
before its exercise by any one of the following methods: (i) signing and
returning a later-dated proxy, (ii) filing with the Secretary of the Company at
7300 Corporate Center Drive, Miami, Florida 33126-1223, a written revocation
bearing a later date, or (iii) attending and voting at the Special Meeting.
Proxies in the form provided are being solicited by the Board for use at the
Special Meeting.
 
     STOCKHOLDERS SHOULD NOT FORWARD ANY COMMON STOCK CERTIFICATES WITH THEIR
PROXY CARDS. UPON CONSUMMATION OF THE MERGER, COMMON STOCK CERTIFICATES SHOULD
BE DELIVERED IN ACCORDANCE WITH INSTRUCTIONS SET FORTH IN A LETTER OF
TRANSMITTAL WHICH WILL BE SENT TO STOCKHOLDERS BY THE EXCHANGE AGENT. See "THE
MERGER -- Merger Consideration and Exchange of Certificates" below.
 
     The cost of soliciting proxies will be paid by the Company. The Company has
retained Georgeson & Company Inc. at an estimated cost of $50,000 plus
reimbursement of expenses, to assist in its solicitation of proxies from
brokers, nominees, institutions and individuals. The Company also has made
arrangements with brokerage firms, banks, custodians and other fiduciaries to
forward proxy materials to their principals, and the Company will reimburse them
for their reasonable mailing and other expenses.
 
     In addition to solicitation by mail, certain directors, officers and
employees of the Company, who will receive no additional compensation for their
services, may solicit proxies by telephone, telecopy and by personal contacts.
 
     The completion of the enclosed proxy/direction card is considered to
constitute voting instructions furnished to the trustee of the John Alden
Employee Savings Incentive Plan with respect to shares allocated to individual
accounts under that plan. To the extent that account information is the same,
participants in the plan who are also stockholders of record will receive a
single card representing all shares. If a plan participant does not return a
proxy/direction card to the Company, the trustee of the plan will vote such
shares in proportion to shares for which directions have been received, unless
the trustee determines that voting in this manner is not consistent with the
Employee Retirement Income Security Act of 1974, as amended.
 
STOCKHOLDERS ENTITLED TO VOTE AND SHARES OUTSTANDING
 
     Only holders of record of Common Stock at the close of business on July 6,
1998, the record date for the Special Meeting (the "Record Date"), will be
entitled to vote at the Special Meeting. As of that date, there were 24,538,604
shares of Common Stock issued and outstanding, which were held by approximately
560 holders of record. Holders of Common Stock are entitled to one vote for each
share of Common Stock held by them on any matter to be voted on at the Special
Meeting. Holders of 9% Preferred Stock are not entitled to notice of or to vote
at the Special Meeting. As of the Record Date, the directors and executive
officers of the Company and certain of their affiliates may be deemed to be
beneficial owners of approximately 1% of the outstanding Common Stock entitled
to vote and each such person has advised the Company that such person intends to
vote "for" approval and adoption of the Merger Agreement.
 
VOTES NECESSARY FOR QUORUM AND ADOPTION OF PROPOSALS
 
     The Company is incorporated in the state of Delaware. A majority of all
issued and outstanding shares of Common Stock, represented in person or
represented by proxy, constitutes a quorum. The affirmative vote of the holders
of a majority of the shares of Common Stock issued and outstanding and entitled
to vote at the Special Meeting is necessary for approval and adoption of the
Merger Agreement and the Merger. ANY STOCKHOLDER OF THE COMPANY RETURNING A
BLANK EXECUTED PROXY CARD WILL BE DEEMED TO HAVE VOTED "FOR" APPROVAL AND
ADOPTION OF THE MERGER AGREEMENT AND THE MERGER. Abstentions and broker
non-votes will have the same effect as a vote
 
                                        2
<PAGE>   7
 
against the approval and adoption of the Merger Agreement and the Merger. Under
New York Stock Exchange rules, brokers and nominees are precluded from
exercising their voting discretion on the proposal to approve and adopt the
Merger Agreement and the Merger and, for this reason, absent specific
instructions from the beneficial owner of shares, brokers and nominees are not
permitted to vote such shares thereon.
 
     The grant of a proxy will also confer discretionary authority on the
persons named in the proxy as proxy appointees to vote in accordance with their
best judgment on matters incident to the conduct of the Special Meeting,
including (except as stated in the following sentence) postponement or
adjournment for the purpose of soliciting additional votes. However, shares
represented by proxies that have been voted "AGAINST" approval and adoption of
the Merger Agreement and the Merger will not be used to vote "FOR" postponement
or adjournment of the Special Meeting for the purposes of allowing additional
time for soliciting additional votes "FOR" the approval and adoption of the
Merger Agreement and the Merger.
 
     The Company's Board is not currently aware of any business to be brought
before the Special Meeting other than that described herein, including any
business with respect to which the granting of a proxy would confer
discretionary authority to vote.
 
INTERESTS OF CERTAIN PERSONS IN THE MERGER
 
     In considering the recommendation of the Company's Board with respect to
the Merger, the Company's stockholders should be aware that certain members of
the management of the Company and of the Company's Board have interests in the
Merger that are different from, or in addition to, the interests of the
stockholders of the Company generally. The Company's Board was aware of such
interests and considered them, among other matters, in approving the Merger
Agreement and the transactions contemplated thereby. Such interests are
described in this Proxy Statement under the caption "INTEREST OF CERTAIN PERSONS
IN THE MERGER" and include the following:
 
     Employment Agreements.  The Company has had an employment agreement with
Mr. Glendon E. Johnson since 1992. The employment agreement, originally
scheduled to expire on December 31, 1997, was extended and amended on November
5, 1997 (after the Board of Directors of the Company had authorized management
and CSFB to approach potentially interested third parties regarding a possible
business combination with or acquisition of the Company, see "THE
MERGER -- Background of the Merger") and is now scheduled to expire on November
5, 2000. The terms of the amended agreement are substantially similar to those
of the original agreement. The agreement provides for, among other things, an
annual salary and annual cash bonuses. In the event of Mr. Johnson's death or
disability prior to termination of the agreement, or in the event the agreement
is terminated without cause by the Company or with cause by Mr. Johnson, Mr.
Johnson will receive a payment equal to two times his annual compensation. Upon
a change in control of the Company (as defined in the employment agreement), Mr.
Johnson will have the option to terminate the agreement and receive (i) a cash
payment equal to three times his annual compensation, (ii) continued welfare
benefits for 3 years (or such longer period provided by the applicable program),
(iii) a lump sum retirement benefit equal to the excess of the actuarial
equivalent of the benefits Mr. Johnson would have accrued under the Company
retirement plans had he remained employed for a period of three additional years
after the date of termination and the actuarial equivalent of the actual
benefits accrued as of the date of termination, and (iv) a tax gross-up amount
sufficient to cover any excise or similar taxes pursuant to Section 280G of the
Code. The estimated amount payable to Mr. Johnson, if he were to terminate,
would be approximately $6.4 million. The Merger will constitute a change of
control for purposes of the agreement. In addition, in order to preserve the
deductibility of certain amounts by the Company, under Section 162(m) of the
Code, the $1 million executive compensation deduction limit, Mr. Johnson has
entered into a deferred compensation agreement with the Company pursuant to
which amounts payable to Mr. Johnson under the Company's incentive compensation
plans will be deferred for payment in future years, subject to acceleration of
payment in certain events, including a change in control (as defined in the
employment agreement).
 
     Change of Control Employment Agreements.  In addition to Mr. Johnson,
thirteen officers of the Company (including Marvin H. Assofsky, Mark Schoder,
Scott L. Stanton and Lonnie R. Wright) have entered into change of control
employment agreements with the Company, dated November 5, 1997 (after the
 
                                        3
<PAGE>   8
 
Board of Directors of the Company had authorized management and CSFB to approach
potentially interested third parties regarding a possible business combination
with or acquisition of the Company, see "THE MERGER -- Background of the
Merger") ("Change of Control Employment Agreements"). The Change of Control
Employment Agreements generally provide that during the three-year "employment
period" following the consummation of the Merger (a "Change of Control"), the
officer will receive (i) an annual base salary at least equal to 12 times the
highest monthly base salary paid to the officer during the prior twelve-month
period (the "Annual Base Salary"), and (ii) for each fiscal year ending during
the employment period, an annual bonus at least equal to the officer's target
short-term bonus under the Company's Short-Term Incentive Compensation Plan for
1997 (the "1997 Bonus") or, if higher, the officer's greatest target annual
bonus in any subsequent year prior to the Change of Control. Upon a termination
of an officer's employment by the Company (other than for "Cause" or disability)
or by an officer for "Good Reason" (including termination for any reason during
the 30-day period immediately following the first anniversary of the Change of
Control), the Company shall (i) pay the officer a lump sum pro rata bonus, (ii)
pay the officer a lump sum equal to three times the sum of (A) the Annual Base
Salary and (B) the greater of the officer's 1997 target bonus and the bonus
earned with respect to any fiscal year that begins both subsequent to 1997 and
within 3 years prior to the date of termination, (iii) provide the officer with
continued welfare benefits for 3 years (or such longer period provided by the
applicable program), and (iv) pay the officer a lump sum retirement benefit
equal to the excess of the actuarial equivalent of the benefits the officer
would have accrued under the Company retirement plans had he or she remained
employed for a period of three additional years after the date of termination
and the actuarial equivalent of the actual benefits accrued as of the
termination date.
 
     The Change of Control Employment Agreements provide for a gross-up payment
to be made to the officer, if necessary, to eliminate the effects of the
imposition of the excise tax under Section 4999 of the Code on payments made to
the officer and the imposition of income and excise taxes on such gross-up
payment.
 
     In the event that the employment of all of the officers with Change of
Control Employment Agreements were terminated immediately following a Change of
Control (excluding the three officers described below formerly terminated) and
such officers were entitled to payments thereunder, they would receive in the
aggregate approximately $21.6 million (which includes amounts payable to Mr.
Johnson pursuant to the employment agreement described above), of which amount
Messrs. Johnson, Schoder and Stanton would receive approximately $6.4 million,
$2.2 million and $2.2 million, respectively.
 
     The employment of Messrs. Assofsky and Wright and Kerry Clemmons, Senior
Vice President of Human Resources of the Company, each a party to a Change of
Control Agreement, was terminated on January 31, 1998 (87 days following
execution of their Change of Control Agreements), as a result of a reduction in
force due to the sale of various businesses. Upon such terminations, the
foregoing received approximately $1.6 million, in the aggregate, in severance
payments from the Company. These amounts will be offset against the amounts, if
any, up to approximately $1.6 million, $2.2 million and $1.3 million,
respectively, which such persons may become entitled to receive pursuant to the
change of control provisions under their respective Change of Control
Agreements.
 
APPRAISAL RIGHTS
 
     Under the Delaware General Corporation Law (the "DGCL"), record holders of
Common Stock who do not wish to accept the per share purchase price of $22.50,
who follow the procedures set forth in Section 262 of the DGCL (the text of
which is reprinted in its entirety as Annex D to this Proxy Statement), and who
have not voted in favor of the Merger, will be entitled to have their shares of
Common Stock appraised by the Delaware Court of Chancery and to receive payment
for the "fair value" of such shares, exclusive of any element of value arising
from the accomplishment or expectation of the Merger, together with a fair rate
of interest, as determined by such court. Failure to comply with the foregoing
may result in a loss of such stockholder's appraisal rights. Any stockholder of
the Company returning a blank executed proxy card will be deemed to have voted
for approval and adoption of the Merger Agreement and the Merger, thereby
waiving any such appraisal rights. See "THE MERGER AGREEMENT--Appraisal Rights."
 
                                        4
<PAGE>   9
 
                             PARTIES TO THE MERGER
 
THE COMPANY
 
     The Company is an insurance holding company that, through its subsidiaries,
is principally engaged in providing group health insurance to small businesses.
For more than 25 years, the Company has provided comprehensive group health
benefit packages to employers through its small group health insurance products.
The Company sells primarily to groups with fewer than 50 employees, while
concentrating on groups with fewer than 25 employees. The Company offers
traditional group indemnity products and "managed indemnity" products, which
have provider network, utilization review and case management features to
contain costs. The Company is offering these products in 42 states. In addition
to the small group health insurance products, the Company's healthcare business
includes two other related product lines. Through Alden Risk Management
Services, Inc., the Company provides healthcare stop-loss reinsurance products
to a number of organizations that bear a significant portion of their own risk,
including employer groups whose benefit programs are self-funded. Through a
joint venture corporation, the Company also offers health maintenance
organization products in the South Florida market.
 
     The mailing address of the Company's principal executive offices is 7300
Corporate Center Drive, Miami, Florida 33126-1223, and its telephone number is
(305) 715-3767.
 
BUYER
 
     Buyer, Fortis, Inc., is a financial services company that, through its
operating companies and affiliates, provides specialty insurance and investment
products to businesses, associations, financial service organizations and
individuals in the U.S. Buyer owns or manages approximately $12 billion in
assets. Its key operating companies are American Security Group, which provides
credit related insurance services; Fortis Benefits Insurance Company, which
provides long term disability and dental insurance products; United Family Life
Insurance Company, which provides preneed funeral insurance; Fortis Insurance
Company, which provides health insurance products; Fortis Financial Group, which
provides variable life and annuity products and mutual funds; and Fortis Long
Term Care.
 
     Buyer is a part of Fortis, an international financial group operating in
the fields of insurance, banking and investments, with assets in excess of $175
billion. Buyer is jointly owned by Fortis AMEV N.V. of The Netherlands and
Fortis AG S.A. of Belgium. Fortis AG S.A. securities trade on the Antwerp and
the Brussels exchanges; the securities of Fortis AMEV N.V. trade on the
Amsterdam exchange and as ADRs on the NASDAQ "Bulletin Board" in the U.S. The
shares of both parent companies are also listed on the London and Luxembourg
exchanges.
 
     The mailing address of Buyer's principal executive offices is One Chase
Manhattan Plaza, 41st Floor, New York, New York, 10005.
 
MERGER SUB
 
     Merger Sub, an indirect wholly owned subsidiary of Buyer, was formed by
Buyer solely for the purpose of effectuating the Merger and has not conducted
any business other than in connection with the Merger. On April 1, 1998, Buyer
transferred all of the issued and outstanding capital stock of Merger Sub to
another wholly owned subsidiary of Buyer, Interfinancial Inc., so that upon
consummation of the Merger, the Company will become a direct wholly owned
subsidiary of Interfinancial Inc. and an indirect wholly owned subsidiary of
Buyer. Interfinancial Inc. serves as an intermediate holding company for Buyer's
insurance company subsidiaries. Interfinancial Inc. has no operations, and it
has no assets other than the stock of such insurance subsidiaries. The mailing
address of Merger Sub's and Interfinancial Inc.'s principal executive offices is
c/o Fortis, Inc., One Chase Manhattan Plaza, 41st Floor, New York, New York,
10005.
 
                                        5
<PAGE>   10
 
                      SELECTED CONSOLIDATED FINANCIAL DATA
 
     The following historical financial data for the five years ended December
31, 1997 have been derived from the Consolidated Financial Statements of the
Company, as restated, audited by PricewaterhouseCoopers LLP, independent
accountants. The following selected financial data of the Company should be read
in conjunction with Management's Discussion and Analysis of Financial Condition
and Results of Operations and the Company's audited Consolidated Financial
Statements contained in the Company's Annual Report on Form 10-K for the year
ended December 31, 1997 and incorporated by reference herein.
 
     On March 27, 1996, the Board of Directors of the Company authorized the
sale of its Annuity Operations and the Western Diversified Group. As a result of
this action, beginning in 1996, the Company has reported the results of
operations of the Annuity Operations and Western Diversified Group as
discontinued operations. The Consolidated Statements of Income for the years
ended December 31, 1995 and 1994 have been restated to reflect the results of
these operations as discontinued operations. Accordingly, the Statement of
Income Data for the years ended December 31, 1995 and 1994 has also been
restated.
 
     Effective January 1, 1997, the Company adopted Statement of Financial
Accounting Standard No. 128, "Earnings per Share". In accordance with this
statement, per share amounts for each year presented have been restated to
comply with the provisions of the statement.
 
                                        6
<PAGE>   11
 
                            SELECTED FINANCIAL DATA
               JOHN ALDEN FINANCIAL CORPORATION AND SUBSIDIARIES
 
<TABLE>
<CAPTION>
                                                                         ACTUAL
                                             --------------------------------------------------------------
                                              1997(1)      1996(1)      1995(1)        1994         1993
                                             ----------   ----------   ----------   ----------   ----------
                                                    (IN THOUSANDS, EXCEPT PER SHARE AND RATIO DATA)
<S>                                          <C>          <C>          <C>          <C>          <C>
STATEMENT OF INCOME DATA:
  Gross insurance premiums and contract
    charges earned.........................  $1,329,851   $1,730,879   $1,899,466   $1,792,087   $1,661,229
  Net insurance premiums and contract
    charges earned.........................     727,089      917,199    1,016,239      939,913      930,588
  Net investment income....................      67,219       44,559       49,804       38,145      353,869
  Total revenues...........................     844,075    1,005,901    1,118,135    1,071,198    1,406,784
  Gross claims incurred on insurance
    products...............................     979,428    1,311,856    1,428,289    1,226,531    1,039,693
  Net claims incurred on insurance
    products...............................     508,313      664,212      733,023      609,767      555,517
  Interest expense.........................       5,332        6,615        8,413        6,067        6,096
  Total benefits and expenses..............     856,087    1,010,043    1,144,689    1,000,971    1,279,204
  Net (loss) income before cumulative
    effect of change in accounting
    principle:
    Continuing operations..................      (7,791)      (1,711)     (18,900)      48,625           --
    Discontinued operations................      29,679       32,647       25,308       27,690           --
         Total.............................      21,888       30,936        6,408       76,315       80,044
  Net income...............................      21,888       30,936        6,408       75,774       83,126
  Net income applicable to common stock....      20,538       29,586        5,058       74,424       81,776
  Per common share:
    Net (loss) income before cumulative
      effect of change in accounting
      principle:
      Continuing operations................       (0.36)       (0.12)       (0.80)        1.92           --
      Discontinued operations..............        1.17         1.29         1.00         1.12           --
         Total.............................        0.81         1.17         0.20         3.04         3.36
    Net income.............................        0.81         1.17         0.20         3.02         3.49
  Average common shares outstanding........      25,400       25,295       25,328       24,623       23,422
  Cash dividends declared per common
    share..................................  $     0.48   $     0.46   $     0.44   $     0.40   $     0.27
BALANCE SHEET DATA:
  Total invested assets....................  $1,010,542   $5,973,502   $6,118,144   $5,675,743   $4,988,946
  Total assets.............................   1,430,698    7,638,823    7,680,015    6,962,133    6,131,288
  Short-term debt..........................      41,500       25,000       15,063       22,679       30,875
  Long-term debt...........................      35,000       76,500       92,000      102,399       92,754
  Redeemable securities....................      15,286       18,687       19,416       20,181       23,776
  Stockholders' equity.....................     450,910      465,211      477,231      406,724      344,197
  Book value per share.....................  $    18.29   $    18.39   $    19.05   $    16.57   $    14.39
OTHER DATA:
  Group gross medical loss ratio...........        75.4%        76.3%        75.0%        69.7%        64.9%
  Group gross combined ratio...............       103.1%       100.0%       100.2%        94.8%        90.6%
</TABLE>
 
- ---------------
(1) The Company has a 50% ownership interest in an HMO joint venture, NHP
    Holding Company, Inc. ("NHP"). The Company previously accounted for its
    investment in NHP on a consolidated basis. The Company has changed its
    accounting policy to the equity method and restated its financial statements
    as of December 31, 1997 and 1996 and for the years ended December 31, 1997,
    1996 and 1995. This change had no effect on total stockholders' equity or
    net income as previously reported.
 
                                        7
<PAGE>   12
 
                                   THE MERGER
 
     The description of certain matters set forth below, to the extent such
matters are addressed by the Merger Agreement, does not purport to be complete
and is qualified in its entirety by reference to the Merger Agreement, a copy of
which is attached as Annex A to this Proxy Statement and incorporated herein by
reference. Stockholders are advised to read the Merger Agreement in its entirety
prior to voting.
 
BACKGROUND OF THE MERGER
 
     In response to the changing environment in which the Company operates, the
Company has actively taken steps to realign its business and operations to
increase efficiencies and to concentrate on its core businesses. Beginning in
late 1994 and throughout 1995, the Company conducted a comprehensive evaluation
of its operations. As a result of this evaluation, the Company determined that
it needed to focus all of its attention and resources on its healthcare
operations. In addition, on March 27, 1996, the Board of Directors of the
Company authorized the sale of its Asset Accumulation Segment, which included
substantially all of its annuity business (the "Annuity Operations"), and the
Western Diversified Group, the principal subsidiaries of the Company that
marketed credit life and disability and retail service warranty coverage. The
sale of the Annuity Operations occurred on March 31, 1997, and the sale of the
Western Diversified Group occurred on September 30, 1997. During the first
quarter of 1998, the Company also discontinued its marketing of products written
by third party insurers.
 
     In its continuing effort to remain apprised of and to evaluate the various
alternatives available to the Company to enhance and maximize stockholder value,
the Board of Directors requested representatives of Credit Suisse First Boston
Corporation ("CSFB"), a nationally recognized investment banking firm, to attend
a meeting of the Company's Board on March 7, 1997, to discuss generally the
trends in the health insurance industry and the strategic alternatives available
to companies like the Company in that industry and in light of such trends.
Following such discussions, the Board determined to continue to evaluate the
Company's current operations and performance in light thereof.
 
     At a meeting of the Board of Directors of the Company on August 4, 1997,
the Board met again with representatives of CSFB to further discuss trends in
the health insurance industry and to review the strategic alternatives available
to the Company. Following a presentation by CSFB with respect to the foregoing,
the Board approved the engagement of CSFB as the Company's financial advisors to
explore strategic alternatives in order to maximize stockholder value and the
Company engaged CSFB as the Company's financial advisor.
 
     At the following regularly scheduled Board of Directors meeting, held on
September 4, 1997, CSFB presented to the Board the preliminary results of CSFB's
analysis of the strategic alternatives available to the Company, including
continuing to operate on a stand-alone basis and engaging in a strategic
business combination with a third party, either for cash or stock. Following
discussion of the various alternatives, including continuing to operate on a
stand-alone basis and engaging in a strategic business combination with a third
party, with CSFB and certain members of management present at the meeting, and
after considering a number of Company and industry factors described below under
the caption "-- Reasons for the Merger," the Board authorized management and
CSFB to approach potentially interested third parties regarding a possible
business combination with or acquisition of the Company, and to solicit
indications of interest from such parties. The Board determined to pursue a
possible business combination or acquisition of the Company due to a number of
factors, including (i) the need to enhance the number of covered lives and
earned premiums to thereby allow reduction in unit costs, as compared to the
Company's shrinking number of covered lives and earned premiums operating on a
stand-alone basis, (ii) the need to increase market share to thereby increase
pricing leverage with providers, as compared to the Company's shrinking markets
operating on a stand-alone basis, and (iii) the earnings volatility associated
with continuing on a stand-alone basis resulting from volatility in medical
utilization, which leads to a volatile medical loss ratio. Further, the Board
determined that then was the appropriate time to pursue such a possible
transaction in light of a number of factors, including (A) the impact of
insurers divesting their health businesses and (B) the general state of the
health industry.
 
     In mid-September 1997, CSFB began to contact, on behalf of the Company,
parties that CSFB, based on its knowledge and experience, and the Company deemed
would be potentially interested in a possible business
                                        8
<PAGE>   13
 
combination with or acquisition of the Company. Prior to receiving certain
information on the Company and its business, interested persons were requested
to execute confidentiality agreements. CSFB contacted over 20 parties engaged in
the HMO and health insurance industries on behalf of the Company, and the
Company provided detailed information regarding the Company to and engaged in
preliminary discussions with 12 interested parties which signed the
confidentiality agreements. Following further discussions with and management
presentations to interested parties, in November 1997 two interested parties
submitted preliminary indications of interest and were permitted to proceed with
due diligence. CSFB regularly reported to the Board of Directors of the Company
during this period regarding the progress of the discussions with persons
considering a possible business combination with or acquisition of the Company.
However, efforts to effect such a business combination or acquisition of the
Company were hindered as a result of the industry factors described below under
the caption "-Reasons for the Merger," and the Company did not receive any firm
proposals.
 
     Discussions and due diligence with potentially interested parties continued
periodically from December 1997, through February 1998, regarding a possible
business combination with or acquisition of the Company. Based on such
discussions and due diligence, on March 3, 1998, Buyer made a proposal to the
Company regarding a possible cash purchase of the Company. The Company did not
receive any firm proposal from any other party regarding a possible business
combination with or acquisition of the Company. A special meeting of the
Company's Board of Directors was held to discuss Buyer's proposal on March 4,
1998. At the conclusion of the meeting, the Board authorized management to
conduct further discussions with Buyer and to convene a special meeting of the
Board if appropriate. Management thereafter commenced further discussions with
Buyer's management and representatives regarding the specifics of its proposed
transaction.
 
     From March 5 through March 9, 1998, the Company's management, together with
its legal and financial advisors, negotiated with representatives of Buyer on a
non-exclusive basis the terms of a proposed Merger Agreement, including the
purchase price, and an option agreement pursuant to which the Company would
grant to Buyer an option entitling it to purchase up to 19.9% of the issued and
outstanding Common Stock of the Company under certain circumstances (the "Option
Agreement"). Buyer requested that the Company enter into the Option Agreement as
an inducement and a condition to Buyer entering into the Merger Agreement. See
"OPTION AGREEMENT" below. CSFB participated in the negotiation of the financial
terms of the Merger Agreement and the Option Agreement. During this time, Buyer
completed its due diligence review of the Company.
 
     The Board of Directors of the Company held a special meeting to consider
Buyer's proposal on March 8, 1998. At the special meeting, the Company's
management, together with its legal and financial advisors, reviewed for the
Board the strategic investigation they had conducted, the discussions and
contacts with Buyer and all other potentially interested parties to date, and
the financial and legal terms of the proposed transaction with Buyer, including
the proposed purchase price of $22.50 in cash per share of Common Stock (the
"Per Share Purchase Price") compared to Buyer's initial indication of interest
at book value (which the Company believes to have been approximately $19.00 per
share), and the other terms of the proposed Merger Agreement and Option
Agreement. CSFB reviewed the strategic review process initiated in August 1997
to date and presented the financial analysis set forth in "Opinion of the
Company's Financial Advisor." The Company's legal advisors reviewed for the
Board its fiduciary duties in the context of the proposed transaction. Following
such discussions, and following questions by the Board to the Company's
management, its legal advisors and its financial advisors, the Board voted
unanimously to approve the Merger on the terms set forth in, and authorized the
execution of, the Merger Agreement and the Option Agreement, and further
authorized the Company's management to take all steps necessary to consummate
the Merger.
 
     The Company and Buyer executed the Option Agreement and the Merger
Agreement on March 9, 1998, and issued on that date press releases announcing
the Merger Agreement and the proposed Merger.
 
REASONS FOR THE MERGER
 
     In reaching its conclusion that the Merger is in the best interests of the
Company and its stockholders and in approving the Merger, the Merger Agreement
and the Option Agreement and the transactions contem-
 
                                        9
<PAGE>   14
 
plated thereby, the Company's Board of Directors considered and reviewed with
the Company's management, as well as its financial and legal advisors, a number
of factors, including the following:
 
          (i) the detailed financial and valuation analysis prepared by CSFB and
     its oral opinion (the written opinion, dated March 9, 1998, confirming such
     oral opinion is attached as Annex C hereto) that, as of the date of such
     opinion, the consideration to be received by the Company's stockholders in
     the Merger is fair to such stockholders from a financial point of view (see
     "Opinion of CSFB" below);
 
          (ii) the terms of the Merger (including the purchase price), the
     Merger Agreement and the Option Agreement as negotiated (including the
     potential impact of the proposed Merger Agreement and the Option Agreement
     on other parties that might have an interest in a business combination with
     the Company) and the negotiation process;
 
          (iii) the financial condition, businesses and prospects of the
     Company, including information with respect to recent and historical stock
     and earnings performance (including the then current stock price, see "HIGH
     AND LOW PRICES OF STOCK") and management knowledge of the Company and its
     business, and in each case in light of the terms of the Merger (including
     the purchase price), the Merger Agreement and the Option Agreement as
     negotiated;
 
          (iv) the effect on the Company and its stockholders of continuing as a
     stand-alone entity or pursuing a strategic business combination with other
     potential parties, compared to the effect of a sale of the Company to Buyer
     pursuant to the Merger Agreement in light of the factors summarized herein
     regarding the financial condition and prospects of the Company on a
     stand-alone basis and the current economic and financial environment;
 
          (v) industry and economic factors, including consideration of (A) the
     need to enhance the number of covered lives and earned premiums to thereby
     allow reduction in unit costs, as compared to the Company's shrinking
     number of covered lives and earned premiums, (B) the need to increase
     market share to thereby increase pricing leverage with providers, as
     compared to the Company's shrinking markets, (C) the earnings volatility
     associated with continuing on a stand-alone basis resulting from volatility
     in medical utilization, which leads to a volatile medical loss ratio, (D)
     the increasing competition with HMOs and the escalating costs of continued
     government regulation, (E) the likelihood of any other comparable proposal
     in light of CSFB's strategic review process and the state of the health
     industry, (F) the impact of insurers divesting their health businesses, and
     (G) the general state of the health industry;
 
          (vi) the likelihood of the Merger being approved by the appropriate
     regulatory authorities;
 
          (vii) the effects of the sale of the Company to Buyer on the Company's
     other constituencies, including its employees, independent agents and
     policyholders and on the communities in which the Company has major
     offices; and
 
          (viii) the interests of certain members of the management of the
     Company and of the Company's Board in the Merger that are different from,
     or in addition to, the interests of the stockholders of the Company
     generally, as described in this Proxy Statement under the caption
     "INTERESTS OF CERTAIN PERSONS IN THE MERGER." The Company's Board was fully
     aware of these interests when it unanimously approved the Merger Agreement
     and the transactions contemplated thereby and individual directors may have
     considered such interests differently relative to the various other factors
     considered thereby.
 
     The foregoing discussion of the information and factors considered by the
Company is not intended to be exhaustive, but includes the material factors
considered by the Company's Board of Directors. In reaching its determination to
approve and recommend the Merger Agreement and the transactions contemplated
thereby, the Board of Directors did not assign any relative or specific weights
to the foregoing factors, and individual directors may have considered various
factors differently.
 
                                       10
<PAGE>   15
 
RECOMMENDATION OF THE BOARD OF DIRECTORS
 
     For the reasons described above, the Board:
 
          (a) has unanimously determined that the Merger is fair to and in the
     best interests of the Company and its stockholders;
 
          (b) has unanimously approved and declared advisable the Merger, the
     Merger Agreement and the Option Agreement and the transactions contemplated
     thereby; and
 
          (c) unanimously recommends that the Company's stockholders vote "FOR"
     approval and adoption of the Merger Agreement.
 
OPINION OF CSFB
 
     The Company engaged CSFB to act as its exclusive financial advisor in
connection with the Company's review of strategic alternatives, including the
possible sale of the Company. In connection with such engagement, the Company
requested that CSFB evaluate the fairness to the stockholders of the Company
from a financial point of view of the consideration to be received by such
stockholders in connection with the Merger. The Company imposed no limitations
on CSFB with respect to the investigation made, or the procedures followed, by
it in rendering its opinion. On March 8, 1998, CSFB delivered to the Board of
Directors of the Company its oral opinion, to the effect that, as of such date
and based upon and subject to certain matters described to the Board, the
consideration to be received by the Company's stockholders in the Merger is fair
to such stockholders from a financial point of view.
 
     CSFB has delivered its written opinion, dated March 9, 1998, to the Board
of Directors confirming the oral opinion rendered on March 8, 1998 and stating
that, based upon the procedures and subject to the assumptions and
qualifications described in such opinion, the consideration to be received by
the stockholders of the Company in the Merger is fair to such stockholders from
a financial point of view. CSFB has confirmed its earlier oral and written
opinions by delivery of a written opinion dated the date of this Proxy
Statement. In connection with its opinion dated the date of this Proxy
Statement, CSFB updated certain of the analyses performed in connection with its
earlier opinions and reviewed the assumptions on which such analyses were based
and the factors considered in connection therewith.
 
     THE FULL TEXT OF CSFB'S OPINION, DATED THE DATE OF THIS PROXY STATEMENT,
SETTING FORTH THE ASSUMPTIONS MADE, FACTORS CONSIDERED AND LIMITATIONS AS TO THE
REVIEW UNDERTAKEN BY IT, IS ATTACHED TO THIS PROXY STATEMENT AS ANNEX C AND IS
INCORPORATED BY REFERENCE HEREIN. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ
CAREFULLY THE OPINION OF CSFB IN ITS ENTIRETY. ANY DESCRIPTION OR REFERENCE TO
THE CSFB OPINION IS SUBJECT TO, AND QUALIFIED IN ITS ENTIRETY BY REFERENCE TO,
THE FULL TEXT OF SUCH OPINION. THE PREPARATION OF A FAIRNESS OPINION IS A
COMPLEX PROCESS AND IS NOT NECESSARILY SUBJECT TO PARTIAL ANALYSIS OR SUMMARY
DESCRIPTION. CSFB'S OPINION IS DIRECTED TO THE BOARD OF DIRECTORS OF THE COMPANY
AND DOES NOT CONSTITUTE A RECOMMENDATION TO ANY STOCKHOLDER OF THE COMPANY AS TO
WHETHER SUCH STOCKHOLDER SHOULD VOTE TO APPROVE THE MERGER.
 
     In connection with its opinion, CSFB reviewed, among other things: (i) the
Merger Agreement; (ii) the Annual Reports on Form 10-K of the Company for the
three years ended December 31, 1996; (iii) certain interim reports to
stockholders and Quarterly Reports on Form 10-Q; (iv) certain other
communications from the Company to its stockholders; (v) certain internal
financial analyses for the Company prepared by its management; and (vi) such
other financial studies and analyses as CSFB deemed necessary; and, in
connection with its opinion dated the date of this Proxy Statement, reviewed
this Proxy Statement. CSFB also had discussions with members of the senior
management of the Company regarding its past and current business operations,
financial condition and future prospects. In addition, CSFB reviewed the
reported price and trading activity for the Common Stock; compared certain
financial and stock market information for the Company with similar information
for certain other companies engaged in businesses similar to the Company's and
the securities of which are publicly traded; reviewed the financial terms of
certain recent business combination transactions and performed such other
studies and analyses as CSFB considered appropriate. CSFB relied without
independent verification upon the accuracy and completeness of all of the
                                       11
<PAGE>   16
 
financial and other information reviewed by it for purposes of its opinion
(including the information contained in this Proxy Statement). CSFB assumed that
the financial analyses for the Company have been reasonably prepared on a basis
reflecting the best currently available judgments and estimates of the
management of the Company. In addition, CSFB made no independent evaluation or
appraisal of the assets and liabilities of the Company or any of its
subsidiaries, and CSFB was not furnished with any such evaluation or appraisal.
 
     The preparation of a fairness opinion is a complex process involving
various determinations as to the most appropriate and relevant methods of
financial analysis and the application of those methods to the particular
circumstances. In arriving at its opinion, CSFB made qualitative judgments as to
the significance and relevance of each analysis and factor considered by it, and
did not assign any particular weight to the results of any particular analysis.
Accordingly, CSFB believes that its analyses must be considered as a whole and
that selecting portions of its analyses and factors, without considering all
analyses and factors, could create a misleading or incomplete view of the
processes underlying such analyses and its opinion. In its analyses, CSFB made
numerous assumptions with respect to John Alden, industry performance,
regulatory, general business, economic, market and financial conditions and
other matters, many of which are beyond the control of John Alden. No company,
transaction or business used in such analyses as a comparison is identical to
John Alden nor is an evaluation of the results of such analyses entirely
mathematical; rather, such analyses involve complex considerations and judgments
concerning financial and operating characteristics and other factors that could
affect the acquisition, public trading or other values of the companies,
business segments or transactions being analyzed. The analyses were prepared for
the purpose of enabling CSFB to evaluate whether the consideration to be
received by the Company's stockholders is fair to such stockholders from a
financial point of view, and do not purport to be appraisals or to necessarily
reflect the prices at which businesses or securities of the Company actually may
be sold. Analyses based upon forecasts of future results are not necessarily
indicative of actual future results, which may be significantly more or less
favorable than suggested by such analyses. Accordingly, such analyses are
subject to inherent uncertainty.
 
     The following is a summary of the material financial analyses performed by
CSFB in connection with its oral and written opinions dated March 8 and March 9,
1998, respectively. The results of such analyses were presented by CSFB to the
Board of Directors of the Company on March 8, 1998.
 
     Summary.  In deriving a fully diluted equity value per share reference
range for the Company, CSFB performed, as appropriate, a comparable public
company analysis, a comparable acquisitions analysis and a discounted cash flow
analysis. CSFB also reviewed certain additional information including
information relating to the daily trading volume and price performance of the
Common Stock and the current market environment for health insurance companies.
 
     CSFB's valuation was based on a five-year financial forecast prepared by
the Company's management team (the "Management Five-Year Preliminary Forecast")
and on preliminary 1997 financial results for the full year and the fourth
quarter. Based on discussions with the Company's management, CSFB also assumed
that the Company had approximately $175 million of excess capital (the "Excess
Capital") available as a result of the Company's recent sales of its Annuity
Operations and Western Diversified Group. For purposes of its valuation, CSFB
excluded the financial impact of the Excess Capital, discontinued operations and
certain other adjustments from the Company's preliminary 1997 results ("1997E
Core Net Operating Income") and from the Management Five-Year Preliminary
Forecast (the "Adjusted Management Five-Year Preliminary Forecast") and valued
the Excess Capital on a dollar-for-dollar basis. The Company also provided CSFB
with two financial forecast scenarios in order to run sensitivity analyses: a
"Higher Margin Scenario" with a 1% annual improvement in the total group margin
and a "Lower Margin Scenario" with a 1% annual worsening in the total group
margin. These scenarios were also adjusted to exclude the financial impact of
the Excess Capital, discontinued operations and certain other adjustments.
 
     The Management Five-Year Preliminary Forecast included forecasts of Group
Gross Earned Premiums of approximately $874 million in 1998 growing to
approximately $1.2 billion in 2002, Net Operating EPS from continuing operations
(earnings per share being referred to herein as "EPS") of approximately $1.02
per share in 1998 growing to approximately $3.41 per share in 2002, a group
expense ratio of approximately 26.8% in
 
                                       12
<PAGE>   17
 
1998 falling to approximately 23.5% in 2002, and a group medical loss ratio of
approximately 72.5% for each year of such five-year period.
 
     The Company does not publicly disclose internal management forecasts of the
type provided to CSFB in connection with CSFB's analysis of the Merger. Such
forecasts were not prepared with a view toward public disclosure and investors
are cautioned not to rely on such forecasts. These forecasts were not prepared
with a view to compliance with the published guidelines of the Securities and
Exchange Commission (the "SEC") or the guidelines established by the American
Institute of Certified Public Accountants regarding projections and forecasts or
generally accepted accounting principles. The forecasts are included in this
Proxy Statement only because such forecasts were included in the information
submitted to and received by the Company's Board of Directors and CSFB. None of
the Company, the Buyer, CSFB or any other party to whom these forecasts were
provided make any representation that the results indicated by such forecasts
will occur. The prospective financial information included in this Proxy
Statement has been prepared by, and is the responsibility of, the Company's
management. PricewaterhouseCoopers LLP does not express an opinion or any other
form of assurance with respect thereto. The PricewaterhouseCoopers LLP report
incorporated by reference in this Proxy Statement relates to the Company's
historical financial information and it does not extend to the prospective
financial information and should not be read to do so.
 
     Analysis of Buyer's Proposal.  CSFB reviewed Buyer's proposal, calculated
certain aggregate values that were presented and then analyzed these aggregate
values and per share values as a multiple of certain financial information of
the Company. Based on the proposed purchase price per share of $22.50, CSFB
calculated the "Total Equity Purchase Price" for the Company, assuming 26.4
million fully diluted shares outstanding and taking into account net option
proceeds, to be $561.0 million and the "Total Transaction Value" (defined as
Total Equity Purchase Price plus total debt and preferred stock outstanding) to
be $652.8 million. CSFB also calculated the "Net Equity Purchase Price" (defined
as the Total Equity Purchase Price minus Excess Capital) to be $386.0 million.
The Net Equity Purchase Price represented a multiple of 51.5x 1997E Core Net
Operating Income and 1.4x 12/31/97 Core Pro Forma Book Value (defined as
projected year-end 1997 book value excluding Excess Capital and the impact of
Statement of Financial Accounting Standards Number 115 ("SFAS 115") and
including the Company's deferred gain on the sale of its Annuity Operations and
Western Diversified Group). The Net Equity Purchase Price also represented
multiples of 20.7x, 15.8x and 30.2x 1998E Core Net Operating Income, and 16.3x,
12.9x and 22.1x 1999E Core Net Operating Net Income, based on the Adjusted
Management Five-Year Preliminary Forecast, the Higher Margin Scenario, as
adjusted, and the Lower Margin Scenario, as adjusted, respectively. CSFB also
compared the proposed purchase price per share to certain financial information
of the Company and market projections without eliminating the financial impact
of the Excess Capital. In conducting this analysis, CSFB noted that: (i) the
Company's preliminary fourth quarter and full year 1997 results and the
Company's forecast for 1998 and 1999 earnings per share were significantly below
what equity research analysts were expecting for the Company for these same
periods; and, (ii) the Management Five-Year Preliminary Forecast and the
consensus equity research analysts estimates for earnings per share (as reported
by First Call Corporation) for 1998 and 1999 assumed that the Excess Capital was
used to buy back a significant portion of the Common Stock in 1998 thereby
reducing the number of shares outstanding. Based on consensus equity research
analysts estimates of earnings per share (as reported by First Call
Corporation), the proposed purchase price of $22.50 per share represented a
multiple of 16.7x, 11.3x and 8.8x 1997E Operating EPS, 1998E Operating EPS and
1999E Operating EPS, respectively. Furthermore, CSFB analyzed the proposed
purchase price as a multiple of unadjusted preliminary fourth quarter and full
year 1997 results and unadjusted results based on the Management Five-Year
Preliminary Forecast, the Higher Margin Scenario and the Lower Margin Scenario.
Based on this, the proposed purchase price per share represented a multiple of
44.1x 1997E Net Operating EPS and 1.2x 12/31/97 Pro Forma Book Value (defined as
projected year-end 1997 book value including Excess Capital, excluding the
impact of SFAS 115 and including the Company's deferred gain on the sale of its
Annuity Operations and Western Diversified Group). The proposed purchase price
per share also represented multiples of 22.1x, 17.3x and 30.4x 1998E Net
Operating EPS and 17.0x, 13.6x and 22.7x 1999E Net Operating EPS based on the
Management Five-Year Preliminary Forecast, the Higher Margin Scenario, and the
Lower Margin Scenario, respectively.
 
                                       13
<PAGE>   18
 
     Comparable Public Company Analysis.  CSFB reviewed and compared certain
actual and estimated financial, operating and stock market information for the
Company with similar information for selected publicly traded indemnity health
insurers. Such comparable companies included: RightChoice Managed Care, Inc.
("RightChoice"), Trigon HealthCare, Inc. ("Trigon"), WellPoint Health Networks
Inc. ("Wellpoint") and United Wisconsin Services, Inc. ("United Wisconsin")
(collectively, the foregoing being referred to herein as the "Comparable
Companies"). CSFB reviewed the Comparable Companies in terms of various
historical financial measures and in terms of various multiples that certain of
this information represents in comparison to certain other information. In
particular, such analysis indicated that as of March 3, 1998, the market price
of shares of common stock of the Comparable Companies as a multiple of equity
research analysts' consensus estimated earnings (as reported by First Call
Corporation) for 1997, 1998 and 1999, respectively, ranged from 18.4x to 23.9x,
16.3x to 19.2x and 13.3x to 16.5x, respectively. CSFB did not include multiples
of RightChoice in its calculation of such multiple ranges since it believed that
RightChoice's recent financial results would distort the earnings multiple range
of the Comparable Companies as a group. In addition, such analysis indicated
that, as of March 3, 1998, the market price of shares of common stock of the
Comparable Companies as a multiple of book value per share, including
RightChoice, ranged from 1.4x to 3.5x. Based on the Comparable Companies data,
CSFB selected a relevant multiple range of 18.4x to 20.0x 1997 estimated EPS,
16.3x to 18.0x 1998 estimated EPS, 13.3x to 15.0x 1999 estimated EPS and 1.4x to
1.5x book value, and applied these multiples to the appropriate benchmarks for
the Company based on the Company's adjusted 1997 preliminary results and the
Adjusted Management Five-Year Preliminary Forecast to derive an equity value
reference range, before Excess Capital and net options proceeds, of $300.0
million to $375.0 million. Adding the Excess Capital and net options proceeds
resulted in a fully diluted equity value reference range of $507.9 million to
$582.9 million or $19.24 per share to $22.08 per share.
 
     Comparable Acquisitions Analysis.  Using publicly available information,
CSFB analyzed recent acquisitions of businesses similar to the Company (the
"Comparable Acquisitions"), and calculated the price, aggregate transaction
value and implied multiples of selected financial data for such acquisitions.
The Comparable Acquisitions were selected by CSFB because they involved
acquisitions of companies that derive a significant portion of their revenues
from indemnity health insurance. CSFB reviewed 11 selected transactions
involving indemnity health insurance companies since December 1994. In
conducting this analysis, CSFB noted that although in the past 12 months there
have been several indemnity health insurance companies for sale, no significant
indemnity health insurance acquisition has been completed since 1996. In its
analysis, CSFB gave particular emphasis to Humana Inc.'s ("Humana") 1995
acquisition of EMPHESYS Financial Group, Inc. ("EMPHESYS"), a small group health
insurer. The Comparable Acquisitions used in the analysis included: Conseco
Inc.'s acquisition of Pioneer Financial Services, Inc.; WellPoint Health
Networks, Inc.'s acquisition of John Hancock Mutual Life Insurance Company
(Group Benefits Operations); United Wisconsin's acquisition of American Medical
Security Group; WellPoint's acquisition of Blue Cross of California (Commercial
Operations); Columbia/HCA Healthcare Corporation's proposed acquisition of Blue
Cross Blue Shield of Ohio (withdrawn); WellPoint's acquisition of Massachusetts
Mutual Life Insurance Company (Group Life and Health Operations); Humana's
acquisition of EMPHESYS; RightChoice's acquisition of HealthLink; Trigon Blue
Cross Blue Shield's acquisition of MidSouth Insurance Company; United HealthCare
Corporation's acquisition of the MetraHealth Companies, Inc.; and HealthSource,
Inc.'s acquisition of Provident Life & Accident Insurance Company of America
(Group Health Operations). CSFB reviewed the Comparable Acquisitions in terms of
various historical financial measures and in terms of various multiples that
certain of this information represents in comparison to certain other
information. In particular, such analysis indicated that the equity purchase
price of the Comparable Acquisitions as a multiple of latest twelve months
("LTM") net operating income, fiscal year one ("FY1") projected net operating
income, fiscal year two ("FY2") projected net operating income and book value
ranged from 8.0x to 30.1x, 10.7x to 20.1x, 9.3x to 12.1x and 1.0x to 2.4x,
respectively. Based on the Comparable Acquisitions data, CSFB selected a
relevant multiple range of 8.0x to 12.0x LTM net operating income, 10.7x to
13.2x FY1 projected net operating income, 9.3x to 12.1x FY2 projected net
operating income and 1.2x to 2.0x book value, and applied these multiples to the
appropriate benchmarks for the Company based on the Company's adjusted 1997
preliminary results and the Adjusted Management Five-Year Preliminary Forecast
to derive an equity value reference range, before Excess Capital and net options
proceeds, of $300.0 million to $400.0 million. Adding
 
                                       14
<PAGE>   19
 
the Excess Capital and net options proceeds resulted in a fully-diluted equity
value reference range of $507.9 million to $607.9 million or $19.24 per share to
$23.03 per share.
 
     Discounted Cash Flow Analysis.  CSFB performed a discounted cash flow
analysis of the Company based upon financial forecasts provided to CSFB by the
management of the Company. CSFB used the Company's financial results for a
five-year period, and discounted to present value the free cash flows before
financing costs generated in each year and the terminal value in the final
projection year employing discount rates of 11%, 13% and 15% . Terminal values
were estimated by CSFB based on multiples of 8.0x to 12.0x net operating income
and 1.4x to 2.0x book value. The Company's future performance was analyzed using
three sets of assumptions. The base case projections were based on the Adjusted
Management Five-Year Preliminary Forecast. Alternate cases assumed a 1% annual
improvement in the total group margin (the Higher Margin Scenario, as adjusted)
and a 1% annual worsening in the total group margin (the Lower Margin Scenario,
as adjusted). All scenarios were adjusted to exclude the financial impact of the
Excess Capital, discontinued operations and certain other adjustments. CSFB
calculated a range of discounted cash flow values and used those values to
derive an equity value reference range, before Excess Capital and net options
proceeds, of $342.1 million to $442.1 million. Adding the Excess Capital and net
options proceeds resulted in a fully-diluted equity value reference range of
$550.0 million to $650.0 million or $20.83 per share to $24.62 per share.
 
     Additional Information.  CSFB also reviewed among other things, the
following: (i) the daily trading volume and per share daily closing market price
of the Common Stock over the period from March 3, 1997 to March 3, 1998; (ii)
the relative price performance of the Common Stock against the S&P 500 Index, a
Managed Indemnity/PPO Index composed of the Company, RightChoice, Trigon
HealthCare, Inc., WellPoint Health Networks Inc. and United Wisconsin Services,
Inc., and an HMO index composed of Foundation Health Systems, Inc., Humana Inc.,
Oxford Health Plans, Inc., Pacificare Health Systems, Inc. and United HealthCare
Corporation over the period from March 3, 1997 to March 3, 1998; (iii) the price
and volume distribution of trades of the Company's Common Stock over the period
from March 3, 1997 to March 3, 1998 and over the period from September 3, 1997
to March 3, 1998; and (iv) recent market developments for healthcare companies
including a review of recent consolidation activity.
 
     The Company selected CSFB as its financial advisor based on its reputation,
experience and expertise. CSFB is an internationally recognized investment
banking firm that is continually engaged in the valuation of businesses and
their securities in connection with mergers and acquisitions, negotiated
underwriting, competitive bids, secondary distributions of listed and unlisted
securities, private placements and valuations for estate, corporate and other
purposes. CSFB is familiar with the Company, having provided advisory and other
investment banking services to the Company over a period of approximately seven
years, including lead-managing the Company's initial public offering on
September 25, 1992 and two secondary offerings on November 2, 1993, and on
August 18, 1994. In addition, CSFB advised the Company on the sale of its
Annuity Operations to SunAmerica Life Insurance Company which was announced on
December 2, 1996, and closed on March 31, 1997, for which CSFB received a fee of
$3 million. CSFB also advised the Company on the sale of its Western Diversified
Group to Protective Life Insurance Corporation, which was announced on July 11,
1997, and closed on September 30, 1997, for which CSFB received a fee of
$675,000. CSFB received customary fees for the rendering of such services. In
the ordinary course of its securities business, CSFB may actively trade debt
and/or equity securities of the Company for its own account and the accounts of
its customers, and CSFB, therefore, may from time to time hold a long or short
position in such securities.
 
     The Company retained CSFB as its financial advisor with respect to the
evaluation of the Company's strategic alternatives and a potential disposition
of or business combination involving the Company, including Buyer's interest in
acquiring the Company and other matters arising in connection therewith.
Pursuant to a letter agreement dated August 4, 1997 between the Company and CSFB
(the "Engagement Letter"), the Company has agreed to pay CSFB a financial
advisory fee of $100,000 (which is creditable against any transaction fee) and a
transaction fee of 0.825% of the aggregate consideration to be paid to the
Company or its stockholders in connection with the Merger, $1,000,000 of which
was payable upon execution of the Merger Agreement and the balance of which is
payable upon the closing of the Merger. Based on the foregoing, CSFB would have
been entitled only to the $100,000 advisory fee if no transaction had been
entered
                                       15
<PAGE>   20
 
into and the Company had determined to continue to operate on a stand-alone
basis, will be entitled to an aggregate fee of only $1,000,000 if the Merger is
not consummated, and will be entitled to an aggregate fee of approximately
$4,800,000 if the Merger is consummated. The Company has also agreed to
reimburse CSFB for all out-of-pocket expenses, including the fees and expenses
of CSFB legal counsel, if any, and any other advisor retained by CSFB.
 
     Pursuant to a letter agreement dated August 4, 1997 between the Company and
CSFB, the Company has agreed to indemnify CSFB against certain expenses and
liabilities relating to or arising out of its engagement, including liabilities
which might arise under federal securities laws.
 
     Neither the Company nor CSFB believe that the terms of the Engagement
Letter, including the compensation payable to CSFB upon consummation of the
Merger, or the participation of CSFB in the negotiation of the financial terms
of the Merger Agreement and the Option Agreement create any conflict of interest
with respect to CSFB's rendering of its opinions described above.
 
                                       16
<PAGE>   21
 
                              THE MERGER AGREEMENT
 
EFFECTIVE TIME OF THE MERGER
 
     The Merger will become effective at the time (the "Effective Time") that an
executed, acknowledged and filed Certificate of Merger (the "Certificate of
Merger") is accepted for record by the Secretary of State of the State of
Delaware, in accordance with the DGCL (the "Effective Time"). Prior to such
filing, a closing (the "Closing") will be held at the offices of the Company's
counsel, Wachtell, Lipton, Rosen & Katz, or at such other place as the parties
may agree, on the last business day of the month in which all of the conditions
set forth in the Merger Agreement have been satisfied or waived (the "Closing
Date"). The Certificate of Merger will be filed on the Closing Date as soon as
practicable following the Closing. See "Conditions to the Merger" below.
 
TERMS OF THE MERGER
 
     Pursuant to, and subject to the terms and conditions of, the Merger
Agreement, Merger Sub will be merged with and into the Company at the Effective
Time in accordance with the DGCL. The separate corporate existence of Merger Sub
will thereupon cease, and the Company will continue as the surviving corporation
and succeed to and assume all the rights and obligations of Merger Sub in
accordance with the DGCL and the Merger Agreement. Also at the Effective Time,
Interfinancial Inc. will become the sole stockholder of the surviving
corporation, the directors of Merger Sub will become the directors of the
surviving corporation and the officers of the Company will become the officers
of the surviving corporation. From and after the Effective Time, all of the
shares of Common Stock will no longer be outstanding and will be canceled and
retired and cease to exist, and holders of certificates theretofore evidencing
shares of Common Stock will cease to have any rights as stockholders, except as
provided in the Merger Agreement or by law. No transfer of shares of Common
Stock will, after the Effective Time, be made on the stock transfer books of the
Company.
 
MERGER CONSIDERATION AND EXCHANGE OF CERTIFICATES
 
     At the Effective Time, (i) each share of Common Stock (including any
associated rights ("Rights") issued under the Company's Rights Agreement, dated
as of December 16, 1996, as amended March 9, 1998, but excluding shares held by
the Company, Buyer or any of their subsidiaries (which shares will be canceled
and retired at the Effective Time for no consideration) and excluding shares
held by stockholders who perfect their statutory appraisal rights as described
in this Proxy Statement (see "-- Appraisal Rights" below) ("Dissenting Shares"))
issued and outstanding immediately prior to the Effective Time will cease to be
outstanding and will be converted into and exchanged for the right to receive
from Buyer a cash payment in the amount of the Per Share Purchase Price of
$22.50, and (ii) each share of 9% Preferred Stock issued and outstanding
immediately prior to the Effective Time will be redeemed for cash at the
Effective Time in accordance with its terms as set forth in the Company's
Certificate of Incorporation. Promptly after the Effective Time, a bank or trust
company selected by Buyer (the "Exchange Agent") will mail to each former record
holder of Common Stock appropriate transmittal materials and instructions for
use in surrendering such stockholder's Common Stock certificates in exchange for
payment. Upon surrender of a Common Stock certificate to the Exchange Agent,
together with a signed letter of transmittal and any other required documents,
the holder of the Common Stock certificate will be entitled to receive for each
of the shares of Common Stock represented by the certificate the Per Share
Purchase Price, together with all undelivered dividends or distributions in
respect of such shares, without interest thereon, less any withholding of taxes
as may be required by applicable law, and the certificate so surrendered will be
canceled. Until surrendered, certificates formerly evidencing shares of Common
Stock will be deemed for all purposes to evidence only the right to receive the
Per Share Purchase Price. No interest will accrue or be paid on any cash payable
upon the surrender of certificates which immediately prior to the Effective Time
represented outstanding shares of Common Stock.
 
     The Company has given notice to the holders of the Company's 9% Preferred
Stock that the Company has called for the redemption simultaneous with the
consummation of the Merger of all of the outstanding shares of 9% Preferred
Stock at a redemption price per share of $100.00 plus an amount equal to all
accrued
                                       17
<PAGE>   22
 
and unpaid dividends thereon to the redemption date, without interest (for an
aggregate amount payable by the Company of approximately $15.5 million,
calculated as of August 31, 1998, in respect of such redemption). From and after
the redemption date, dividends on the shares of 9% Preferred Stock will cease to
accrue, and such shares will no longer be deemed to be outstanding and will have
the status of authorized but unissued shares of preferred stock, unclassified as
to merits, and all rights of the holders thereof as stockholders of the Company
(except the right to receive from the Company the redemption price) will cease.
 
OPTIONS
 
     Each option granted by the Company to purchase or receive shares of Company
Common Stock under the Company stock plans outstanding at the Effective Time,
whether or not then exercisable or vested (the "Company Options"), will become
fully exercisable and vested. Buyer will pay to each such holder of Company
Options an amount in cash equal to the product of (1) the difference (if
positive) between the Per Share Purchase Price and the price, if any, per share
of Company Common Stock pursuant to which the holder of such Company Option may
purchase the shares of Company Common Stock to which such Company Option relates
(and less any withholding of taxes as may be required by applicable law) and (2)
the number of shares of Company Common Stock subject thereto. At the Effective
Time, each such Company Option shall no longer represent the right to purchase
or receive shares of Company Common Stock, but in lieu thereof shall represent
the right to receive the cash payment referred to above. See "-- Merger
Consideration and Exchange of Certificates" above.
 
REPRESENTATIONS AND WARRANTIES
 
     The Merger Agreement contains certain representations and warranties made
by each of the Company and Buyer that are customary for a transaction of this
type. Each of the Company and Buyer makes similar representations and warranties
with respect to: organization, standing, and qualification; corporate authority
and approval; governmental filing and regulatory compliance; compliance with
laws, orders and permits; litigation; and the accuracy of reports.
 
     The Company makes additional representations and warranties with respect to
capitalization; accuracy of financial and SEC reports; absence of material
adverse changes; employee benefit plans; tax matters; labor relations;
intellectual property; material contracts; real property and environmental
matters; assets; insurance; liabilities; the Investment Company Act;
non-applicability of the Company's rights plan; certain provisions in the
Certificate of Incorporation; non-applicability of anti-takeover laws; and
broker fees.
 
     Buyer makes additional representations and warranties with respect to the
authority of Merger Sub to enter into the Merger.
 
     All of the representations and warranties set forth in the Merger Agreement
will terminate at the Closing.
 
CONDUCT OF THE BUSINESS OF THE COMPANY PRIOR TO THE MERGER
 
     The Company has agreed that, from the date of the Merger Agreement to the
Effective Time, it will, and will cause its subsidiaries to, conduct their
respective operations according to their ordinary course of business consistent
with past practice and, except as contemplated by the Merger Agreement, will not
take certain actions without the prior written consent of Buyer, which actions
include, among others: (i) enter into or engage in the business of selling
products or services materially different from existing products or services or
to engage in any new lines of business without Buyer's prior written approval;
(ii) permit a material change to underwriting, investment or accounting
policies; (iii) authorize any stock splits, combinations, reclassifications, or
dividends (other than the Company's regular quarterly dividends) or amend the
Certificate of Incorporation or Bylaws; (iv) incur any indebtedness for borrowed
money or authorize any capital expenditures other than in amounts not exceeding
$1 million in the aggregate; (v) enter into, adopt, terminate or amend any
bonus, compensation or other employee benefit plan or other arrangement for the
benefit or welfare of any director, officer or employee of Company except for
changes in base compensation in the ordinary course of business consistent with
past practice (which shall not exceed on an annual basis the lesser of 10% or
$5,000 for any individual employee); (vi) the Company will use all reasonable
efforts to ensure that no change
                                       18
<PAGE>   23
 
of control payments are made; (vii) pay or settle any claim except in the usual
course of business for amounts less than $250,000 per claim; (viii) make or
change any tax election except in the usual course of business; (ix) enter into
any contract limiting the ability of the Company to sell its services; (x) enter
into certain new quota share or other reinsurance transactions; (xi) amend or
terminate any material contracts; (xii) make any investments other than publicly
traded bonds, cash equivalents and other investments approved by Buyer; (xiii)
use all commercially reasonable efforts to ensure that there will be no
downgrade in the Company insurance subsidiaries' rating; (xiv) take or omit to
take any action that would cause any conditions precedent to obligations to
consummate the Merger not to be satisfied; and (xv) authorize or enter into a
contract to do any of the foregoing.
 
ACCESS; TECHNOLOGY CONVERSION
 
     The Company has agreed that, from the date of the Merger Agreement until
the Effective Time, it will give Buyer full access to the offices, properties,
books and records of the Company and its subsidiaries, subject to applicable
confidentiality agreements and other contractual restrictions. The Company has
also agreed to give Buyer's representatives an office in Miami to monitor
operations and plans for integration, and to take all commercially reasonable
actions to assure that its computer systems are Year 2000 compliant.
 
NO SOLICITATION
 
     The Company has agreed that it will not, and will not permit or cause any
of its subsidiaries or any of the officers and directors of it or its
subsidiaries to, and will direct its and its subsidiaries' employees and
representatives not to, directly or indirectly, initiate, solicit, encourage or
otherwise facilitate any inquiries or the making of any proposal or offer with
respect to a merger, reorganization, share exchange, consolidation or similar
transaction involving, or any purchase of 15% or more of the assets or any
equity securities of, the Company or any of its subsidiaries (any such proposal
or offer being hereinafter referred to as an "Acquisition Proposal"). The
Company will not, and will not permit or cause any of its subsidiaries or any of
the officers and directors of it or its subsidiaries to and will direct its and
its subsidiaries' employees and representatives not to, directly or indirectly,
engage in any negotiations concerning, or provide any confidential information
or data to, or have any discussions with, any person relating to an Acquisition
Proposal, whether made before or after the date of the Merger Agreement, or
otherwise facilitate any effort or attempt to make or implement an Acquisition
Proposal (including, without limitation, by means of an amendment to the Rights
Agreement); provided, however, that nothing contained in the Merger Agreement
will prevent the Company or its Board of Directors from (i) complying with Rule
14e-2 promulgated under the Securities and Exchange Act of 1934 (the "Exchange
Act") with regard to an Acquisition Proposal, or (ii) at any time after the date
hereof, if the Merger shall not have been approved by the requisite vote of the
Company's stockholders as of such time, (A) providing information in response to
a request therefor by a person who has made an unsolicited bona fide written
Acquisition Proposal if the Board of Directors receives from the person so
requesting such information an executed confidentiality agreement on terms
substantially equivalent to those contained in the confidentiality agreement
between Buyer and Seller; (B) engaging in any negotiations or discussions with
any person who has made an unsolicited bona fide written Acquisition Proposal;
or (C) recommending such an Acquisition Proposal to the stockholders of the
Company, if and only to the extent that, (i) in each such case referred to in
clause (A), (B) or (C) above, the Board of Directors of the Company determines
in good faith after consultation with outside legal counsel that such action is
necessary in order for its directors to comply with their respective fiduciary
duties under applicable law and (ii) in each case referred to in clause (B) or
(C) above, the Board of Directors of the Company determines in good faith (after
consultation with its financial advisor) that such Acquisition Proposal, if
accepted, is reasonably likely to be consummated, taking into account all legal,
financial and regulatory aspects of the proposal and the person making the
proposal and would, if consummated, result in a more favorable transaction than
the transaction contemplated by the Merger Agreement, taking into account, to
the extent relevant, the long-term prospects and interests of the Company and
its stockholders. The Company has agreed to notify Buyer immediately if any such
inquiries, proposals or offers are received by, any such information is
requested from, or any such discussions or negotiations are sought to be
initiated or continued with, any of its or its subsidiaries' directors,
employees or representatives indicating, in connection with such notice, the
name of such person and the material terms and
                                       19
<PAGE>   24
 
conditions of any proposals or offers and thereafter will keep Buyer informed,
on a current basis, on the status and terms of any such proposals or offers and
the status of any such negotiations or discussions.
 
MIAMI PROPERTY
 
     The Company has agreed to give Buyer access to the Company's Miami
properties, and to provide title and survey updates. The Company has also agreed
to use all commercially reasonable means to preserve in force all existing
permits with respect to the Company's Miami properties and to deliver certain
estoppel certificates.
 
INDEMNIFICATION; INSURANCE
 
     Buyer has agreed that from and after the Effective Time it will indemnify
and hold harmless each present and former director and officer of the Company,
determined as of the Effective Time, against claims arising out of matters
existing or occurring at or prior to the Effective Time, to the fullest extent
permitted under applicable Delaware law and by the Company's present Certificate
of Incorporation and bylaws. Buyer also has agreed that, for a period of six
years after the Effective Time, it will maintain in effect, or will cause the
Company to maintain in effect, (i) the Company's existing directors' and
officers' liability insurance policy or (ii) policies having at least the same
coverage and amounts containing terms that are no less advantageous to the
insured parties and that are issued by issuers with claims-paying ratings at
least equal to that of the issuer of the Company's existing policy.
Notwithstanding the foregoing, neither Buyer nor the Company will be obligated
to make premium payments in each year of such six-year period in respect of such
policies exceeding, for the portion related to the Company's directors and
officers, 200% of annual premium payments on the Company's current policy in
effect on the date of the Merger Agreement.
 
CONDITIONS TO THE MERGER
 
     The obligation of Buyer to consummate the Merger is subject to the
following conditions, among others: (i) the truth, as of the Effective Time, of
the representations and warranties of the Company contained in the Merger
Agreement (except where the failure of such representations and warranties to be
true would not have a material adverse effect on the Company); and (ii) the
Company's performance in all material respects of its obligations under the
Merger Agreement. The obligation of the Company to consummate the Merger is
subject to the following conditions, among others: (i) the truth, as of the
Effective Time, of the representations and warranties of Buyer contained in the
Merger Agreement (except where the failure of such representations and
warranties to be true would not adversely affect the ability of Buyer to
consummate the Merger and the transactions contemplated under the Merger
Agreement); (ii) Buyer's performance in all material respects of its obligations
under the Merger Agreement; and (iii) the Exchange Agent having delivered to the
Company a certificate, dated as of the Effective Time, to the effect that Buyer
has deposited with the Exchange Agent sufficient funds to pay the aggregate Per
Share Purchase Price.
 
     In addition, the obligations of Buyer and the Company to consummate the
Merger are subject to the following conditions, among others: (i) the adoption
of the Merger Agreement by the stockholders of the Company; (ii) all other
regulatory consents, approvals or clearances necessary for the consummation of
the Merger shall have been obtained (see "-- Regulatory Approvals" below); and
(iii) no temporary restraining order, preliminary injunction or permanent
injunction or other order issued by any court of competent jurisdiction shall be
in effect prohibiting the consummation of the transactions contemplated under
the Merger Agreement.
 
     If either party waives satisfaction of a material condition to consummation
of the Merger, the Company will appropriately amend and/or supplement this Proxy
Statement and resolicit proxies from the Company's stockholders as may be
required by law.
 
TERMINATION OF THE MERGER AGREEMENT
 
     The Merger Agreement may be terminated and the Merger may be abandoned at
any time prior to the Closing for the following reasons, among others: (i) by
mutual written agreement of the Company and Buyer;
                                       20
<PAGE>   25
 
(ii) by either the Company or Buyer if the Merger shall not have been
consummated on or before September 30, 1998 (provided, that the right to
terminate the Merger Agreement shall not be available to any party whose failure
to fulfill any obligation under the Merger Agreement has been the cause of or
has resulted in the failure of the Merger to occur on or before such date; and
provided further that if all conditions to consummation of the Merger have been
satisfied or waived on or before September 30, 1998, other than obtaining the
required consents from regulatory authorities, such date shall be extended for
up to three additional one-month periods at the request of either Buyer or the
Company); (iii) by either the Company or Buyer if any court or other
governmental body shall have issued an order or taken any other action
permanently restraining, enjoining or otherwise prohibiting the Merger and such
order or other action shall have become final and nonappealable; or (iv) by
either the Company or Buyer, if there has been a material breach by the other
party of any representation, warranty, covenant or agreement that is not cured
or curable by the other party within 20 days.
 
     The Merger may also be terminated by Buyer or by the Company (after having
met certain conditions specified in the Merger Agreement) if the Merger
Agreement shall not have been approved by the Company's stockholders, or if the
Board of Directors of the Company shall have entered into an agreement for a
more favorable Acquisition Proposal with a third party (and, with respect to the
Company's termination rights, Buyer shall not have made a bona fide offer at
least as favorable to the Company within five days of receipt of the Company's
written notification of its intention to enter into an agreement with respect to
such proposal). See "OPTION AGREEMENT."
 
     Other than the consequences any termination may have under the terms of the
Option Agreement as described under the caption "OPTION AGREEMENT," the Company
cannot predict and makes no representation as to the possible adverse
consequences that may affect the Company, the trading price of the Common Stock
or the Company's stockholders if the Merger Agreement is terminated and the
Merger is not consummated.
 
AMENDMENTS AND WAIVERS
 
     Any provision of the Merger Agreement may be amended or waived if, but only
if, such amendment or waiver is explicit and in writing and is signed, in the
case of an amendment, by each party to the Merger Agreement, or in the case of a
waiver, by the party against whom the waiver is to be effective.
 
FEDERAL INCOME TAX CONSEQUENCES
 
     The receipt of cash by a stockholder of the Company in exchange for such
stockholder's shares of Common Stock pursuant to the Merger will constitute a
taxable transaction for federal income tax purposes and may also be a taxable
transaction under state, local, foreign and other tax laws. The federal income
tax consequences to holders of shares of Common Stock who are citizens or
residents of the United States generally will be as follows:
 
          1.  Each holder of shares of Common Stock will recognize a gain or
     loss equal to the difference, if any, between (i) the amount of cash
     received and (ii) the holder's cost or other adjusted tax basis in the
     shares exchanged therefor.
 
          2.  Such gain or loss will be a capital gain or loss (assuming the
     shares of Common Stock are capital assets in the hands of the stockholder).
     Any such capital gain or loss will be long-term if the stockholder's
     holding period for such shares is more than one year as of the Effective
     Time; otherwise, such capital gain or loss will be short-term. The Internal
     Revenue Code of 1986, as amended (the "Code"), limits the deductibility of
     capital losses.
 
          3.  Each stockholder of the Company will, in general, be required to
     provide to the Exchange Agent his or her Social Security number or other
     taxpayer identification number ("TIN"), or in some instances certain other
     information, in order to avoid "backup withholding" at a rate of 31% which
     might otherwise apply under the Code. A stockholder who does not furnish
     the correct TIN may be subject to a penalty imposed by the Internal Revenue
     Service.
 
                                       21
<PAGE>   26
 
     In view of the individual nature of tax consequences, each stockholder of
the Company should consult a tax advisor as to the particular tax consequences
of the Merger to the stockholder, including the effect and applicability of
federal, state and other tax laws.
 
ACCOUNTING TREATMENT
 
     The Merger is intended to qualify as a purchase for accounting and
financial reporting purposes.
 
REGULATORY APPROVALS
 
     State insurance holding company laws and regulations applicable to the
Company generally provide that no person may acquire control of the Company
unless such person has provided certain required information to, and such
acquisition has been approved (or not disapproved) by, the appropriate insurance
regulatory authorities. In accordance with the insurance holding company laws of
Florida, Minnesota and Texas, Buyer, on behalf of itself and certain of its
subsidiaries, has filed an application on Form A for the approval of the Merger
with the respective insurance departments.
 
     The Merger is also subject to review under the HSR Act by the Federal Trade
Commission and the Department of Justice. On April 21, 1998, the Company and
Buyer were notified that early termination of the requisite waiting period under
the HSR Act was granted as of such date.
 
APPRAISAL RIGHTS
 
     Record holders of shares of Common Stock are entitled to appraisal rights
under Section 262 of the DGCL in connection with the Merger. The following
discussion is not a complete statement of the law pertaining to appraisal rights
under the DGCL and is qualified in its entirety by reference to the full text of
Section 262, which is reprinted in its entirety as Annex D to this Proxy
Statement.
 
     Under the DGCL, record holders of Common Stock who do not wish to accept
the Per Share Purchase Price of $22.50, who follow the procedures set forth in
Section 262, and who have not voted in favor of the Merger, will be entitled to
have their shares of Common Stock appraised by the Delaware Court of Chancery
and to receive payment for the "fair value" of such shares, exclusive of any
element of value arising from the accomplishment or expectation of the Merger,
together with a fair rate of interest, as determined by such court.
 
     Pursuant to Section 262, the Company must provide not less than 20 days'
notice of the Special Meeting to all persons who held shares of Common Stock on
the Record Date, and such notice must state that such appraisal rights are
available and include a copy of Section 262. This Proxy Statement constitutes
such notice for purposes of the Special Meeting. Any stockholder of record who
wishes to exercise appraisal rights should review the following discussion and
Annex D carefully because failure to comply timely and properly with the
procedures specified in Section 262 will result in the loss of appraisal rights
under the DGCL.
 
     A holder of Common Stock wishing to exercise appraisal rights must deliver
to the Company, before the vote on the approval and adoption of the Merger
Agreement at the Special Meeting, a written demand for appraisal of such
holder's shares of Common Stock. A proxy or vote against the Merger will not
constitute such a demand. Failure to vote against the Merger will not constitute
a waiver of the holder's appraisal rights, but a vote in favor of the Merger
will constitute such a waiver. In addition, a holder of Common Stock wishing to
exercise appraisal rights must hold of record such Common Stock on the date that
written demand therefor is made and continue to hold such shares of Common Stock
through the Effective Time.
 
     All written demands for appraisal of shares of Common Stock should be
mailed or delivered to John Alden Financial Corporation, 7300 Corporate Center
Drive, Miami, Florida 33126-1223, Attention: Corporate Secretary.
 
     Within 10 days after the Effective Time, the Company must send a notice as
to the effectiveness of the Merger to each person who has satisfied the
appropriate provisions of Section 262. Within 120 days after the Effective Time,
but not thereafter, the Company or any such stockholder who has satisfied the
foregoing
 
                                       22
<PAGE>   27
 
conditions and is otherwise entitled to appraisal rights under Section 262, may
file a petition in the Delaware Court of Chancery demanding a determination of
the fair value of the shares of Common Stock held by such stockholder. Upon the
filing of any such petition by a stockholder, service of a copy of the petition
must be made to the Company. If no such petition is filed, appraisal rights will
be lost for all stockholders who had previously demanded appraisal of their
shares of Common Stock. Stockholders of the Company seeking to exercise
appraisal rights should assume that the Company will not file a petition with
respect to the appraisal of the value of shares of Common Stock and that the
Company will not initiate any negotiations with respect to the "fair value" of
shares of Common Stock. Accordingly, stockholders of the Company who wish to
exercise their appraisal rights should regard it as their obligation to take all
steps necessary to perfect their appraisal rights in the manner described in
Section 262.
 
     Within 120 days after the Effective Time, any record holder of shares of
Common Stock who has complied with the provisions of Section 262 will be
entitled, upon written request, to receive from the Company a statement setting
forth the aggregate number of shares of Common Stock not voted in favor of
approval of the Merger Agreement and with respect to which demands for appraisal
were received by the Company, and the number of holders of such shares of Common
Stock.
 
     If a petition for appraisal is timely filed, after a hearing on such
petition, the Delaware Court of Chancery will determine the holders of shares of
Common Stock entitled to appraisal rights and will appraise the "fair value" of
the shares of Common Stock, exclusive of any element of value arising from the
accomplishment or expectation of the Merger, together with a fair rate of
interest, if any, to be paid upon the amount determined to be the fair value.
Stockholders seeking appraisal should be aware that the fair value of their
shares of Common Stock as determined under Section 262 could be more than, the
same as or less than the value of the Per Share Purchase Price that they would
otherwise receive if they did not seek appraisal.
 
     Any stockholder of the Company who has duly demanded an appraisal in
compliance with Section 262 will not, after the Effective Time, be entitled to
vote such holder's shares of Common Stock for any purpose nor, after the
Effective Time, be entitled to the payment of dividends or other distributions
thereon.
 
     If no petition for an appraisal is filed within the time provided, or if a
stockholder of the Company delivers to the Company a written withdrawal of such
holder's demand for an appraisal and an acceptance of the Per Share Purchase
Price within 60 days after the Effective Time or with the written approval of
the Company thereafter, then the right of such stockholder to an appraisal will
cease and such stockholder shall be entitled to receive the Per Share Purchase
Price multiplied by the number of shares of Common Stock held by such holder,
without interest, as if such stockholder had not demanded appraisal of such
holder's shares of Common Stock.
 
                                OPTION AGREEMENT
 
     The description of the Option Agreement set forth below does not purport to
be complete and is qualified in its entirety by reference to the Option
Agreement, as amended as described below, a copy of which is attached as Annex B
to this Proxy Statement and incorporated herein by reference.
 
     As an inducement and a condition to Buyer entering into the Merger
Agreement, Buyer and the Company entered into the Option Agreement, pursuant to
which the Company granted Buyer an option (the "Option") entitling it to
purchase up to 4,880,108 shares (representing approximately 19.9% of the shares
of Company Common Stock issued and outstanding before giving effect to the
issuance of additional shares of Company Common Stock pursuant to the exercise
of such option) of Company Common Stock under the circumstances described below,
at a cash price per share equal to $22.50, subject to certain anti-dilution
adjustments.
 
     The anti-dilution provisions under the Option Agreement provide that, in
the event of any change in Common Stock by reason of a stock dividend, stock
split, split-up, recapitalization, combination, exchange of shares or similar
transaction, the type and number of shares or securities subject to the Option,
and the purchase price therefor, will be adjusted appropriately, and proper
provision will be made in the agreements governing such transaction, if any, so
that the holder of the Option will receive, upon exercise thereof, the
                                       23
<PAGE>   28
 
number and class of shares or other securities or property that such holder
would have received in respect of Common Stock if the Option had been exercised
immediately prior to such event, or the record date therefor, as applicable.
Further, if any additional shares of Common Stock are issued after March 9, 1998
(the date of the Option Agreement), other than pursuant to an event described in
the foregoing sentence or pursuant to the Option, the number of shares of Common
Stock subject to the Option will be adjusted so that, after such issuance, it,
together with any shares of Common Stock previously issued pursuant thereto,
will not exceed the lesser of (i) 19.9% of the number of shares of Common Stock
then issued and outstanding, without giving effect to any shares subject to or
issued pursuant to the Option and (ii) that minimum number of shares of Common
Stock which when aggregated with any other shares of Common Stock beneficially
owned by Buyer or any affiliate thereof would cause the provisions of any
anti-takeover laws under the DGCL to be applicable to the Merger.
 
     Provided no preliminary or permanent injunction or other order against the
delivery of the shares of the Company Common Stock covered by the Option issued
by any court of competent jurisdiction shall be in effect, Buyer may exercise
the Option, in whole or in part, at any time, from time to time, if, but only
if, a Purchase Event (as defined below) occurs prior to the Option's
termination; provided that Buyer, at the time, is not in material breach of the
Option Agreement or the Merger Agreement. As defined in the Option Agreement,
"Purchase Event" means any of the following events:
 
          1.  without Buyer's prior written consent, the Company authorizing,
     recommending, publicly proposing, or publicly announcing an intention to
     authorize, recommend or propose or enter into an agreement with any third
     party to effect (i) a merger, consolidation, or similar transaction
     involving the Company or any of its subsidiaries, (ii) the disposition, by
     sale, lease, exchange, or otherwise, of 15% or more of the consolidated
     assets of the Company and its subsidiaries, (iii) the issuance, sale, or
     other disposition (including by way of merger, consolidation, share
     exchange, or any similar transaction) of securities representing 15% or
     more of the voting power of the Company or any of its subsidiaries or (iv)
     a Tender Offer or an Exchange Offer (as defined below); or
 
          2.  any person (other than Buyer or any subsidiary of Buyer) acquiring
     beneficial ownership (as such term is defined in Rule 13d-3 promulgated
     under the Exchange Act), or the right to acquire beneficial ownership of,
     or the formation of any "group" (as defined under the Exchange Act), other
     than a group of which Buyer or any Buyer subsidiary is a member, that
     beneficially owns or has the right to acquire beneficial ownership of, 15%
     or more of the outstanding shares of Company Common Stock; or
 
          3.  the stockholders of the Company shall not have approved the Merger
     Agreement at the meeting called for such purpose, or such meeting shall not
     have been held or shall have been cancelled prior to termination of the
     Merger Agreement following a Preliminary Purchase Event (as defined below).
 
     The Option will terminate upon the earliest of the following: (1) the
Effective Time; (2) termination of the Merger Agreement in accordance with the
terms thereof prior to the occurrence of a Purchase Event or a Preliminary
Purchase Event (as defined below) (other than a termination of the Merger
Agreement under certain circumstances involving generally a willful breach by
the Company of a representation or warranty contained in the Merger Agreement or
a breach by the Company of a covenant contained in the Merger Agreement) (a
"Default Termination"); (3) 18 months after a Default Termination; and (4) 18
months after termination of the Merger Agreement following the occurrence of a
Purchase Event or a Preliminary Purchase Event.
 
     As defined in the Option Agreement, "Preliminary Purchase Event" includes
either of the following events: (1) any third party commences, or files a
registration statement under the Securities Act with respect to, a tender offer
or exchange offer to purchase any shares of Company Common Stock such that, upon
consummation of such offer, such person would own or control 15% or more of the
then-outstanding shares of Company Common Stock (a "Tender Offer" or an
"Exchange Offer," respectively); or (2) it shall have been announced that any
person shall have (A) made a bona fide proposal to engage in an Acquisition
Transaction (as such term is defined in the Merger Agreement), (B) commenced a
Tender Offer or an Exchange Offer, or (C) filed an application (or given a
notice) under any federal or state statute seeking consent to an Acquisition
Transaction from a federal or state regulatory agency.
                                       24
<PAGE>   29
 
     Upon the occurrence of a Repurchase Event (as defined in the Option
Agreement) that occurs prior to the exercise or termination of the Option, at
the request of Buyer, delivered within 18 months of the Repurchase Event, the
Company will, subject to regulatory restrictions, be obligated to repurchase the
Option and any shares of Company Common Stock therefor purchased pursuant to the
Option Agreement at a specified price.
 
     At the request of Buyer or any successor holder or holders of the Option
("Holder") at any time commencing upon the first occurrence of a Purchase Event
and ending 18 months immediately thereafter, the Company shall repurchase all,
but not less than all, shares of Company Common Stock purchased by such Holders
pursuant to the Option Agreement whether or not such Holders then have
beneficial ownership of such shares. Such repurchase shall be at an aggregate
price equal to the sum of:
 
          (i) The aggregate purchase price paid by such Holders for any shares
     of Company Common Stock acquired by such Holders pursuant to the Option;
 
          (ii) $15 million; and
 
          (iii) Up to, but not in excess of $2.5 million of Holder's reasonable
     out-of-pocket expenses incurred in connection with the transactions
     contemplated by the Merger Agreement (including, without limitation, legal,
     accounting and investment banking fees and expenses).
 
     At the time of execution of the Option Agreement, the Company would have
been obligated to pay $20 million under clause (ii) above. However, pursuant to
the Settlement (as defined and described under the caption "CERTAIN PENDING
LITIGATION") the Company and Buyer agreed to amend the Option Agreement to
reduce that portion of the repurchase price from $20 million to $15 million. See
"CERTAIN PENDING LITIGATION."
 
     After the occurrence of a Purchase Event, Buyer may assign the Option
Agreement and its rights thereunder in whole or in part.
 
     Upon the occurrence of certain events, the Company has agreed to file with
the SEC and to cause to become effective certain registration statements under
the Securities Act with respect to dispositions by Buyer and its assigns of all
or part of the Option and/or any shares of Company Common Stock into which the
Option is exercisable.
 
                          HIGH AND LOW PRICES OF STOCK
 
     On March 6, 1998, the business day prior to announcement of the Merger
Agreement with Buyer, the high and low sale prices quoted for shares of Common
Stock on the New York Stock Exchange were $23 7/16 and $22 3/8, respectively. On
July 28, 1998, the business day prior to the date of this Proxy Statement
Prospectus, the high and low sale prices quoted for shares of Common Stock on
the New York Stock Exchange were $22 1/8 and $22, respectively.
 
                   INTERESTS OF CERTAIN PERSONS IN THE MERGER
 
     In considering the recommendation of the Company's Board with respect to
the Merger, the Company's stockholders should be aware that certain members of
the management of the Company and of the Company's Board have interests in the
Merger that are different from, or in addition to, the interests of the
stockholders of the Company generally. The Company's Board was aware of such
interests and considered them, among other matters, in approving the Merger
Agreement and the transactions contemplated thereby.
 
     Employment Agreements.  The Company has had an employment agreement with
Mr. Glendon E. Johnson since 1992. The employment agreement, originally
scheduled to expire on December 31, 1997, was extended and amended on November
5, 1997 (after the Board of Directors of the Company had authorized management
and CSFB to approach potentially interested third parties regarding a possible
business combination with or acquisition of the Company, see "THE
MERGER -- Background of the Merger") and is now scheduled to expire on November
5, 2000. The terms of the amended agreement are substantially similar
                                       25
<PAGE>   30
 
to those of the original agreement. The agreement provides for, among other
things, an annual salary and annual cash bonuses. In the event of Mr. Johnson's
death or disability prior to termination of the agreement, or in the event the
agreement is terminated without cause by the Company or with cause by Mr.
Johnson, Mr. Johnson will receive a payment equal to two times his annual
compensation. Upon a change in control of the Company (as defined in the
employment agreement), Mr. Johnson will have the option to terminate the
agreement and receive (i) a cash payment equal to three times his annual
compensation, (ii) continued welfare benefits for 3 years (or such longer period
provided by the applicable program), (iii) a lump sum retirement benefit equal
to the excess of the actuarial equivalent of the benefits Mr. Johnson would have
accrued under the Company retirement plans had he remained employed for a period
of three additional years after the date of termination and the actuarial
equivalent of the actual benefits accrued as of the date of termination, and
(iv) a tax gross-up amount sufficient to cover any excise or similar taxes
pursuant to Section 280G of the Code. The estimated amount payable to Mr.
Johnson, if he were to terminate, would be approximately $6.4 million. The
Merger will constitute a change of control for purposes of the agreement. In
addition, in order to preserve the deductibility of certain amounts by the
Company, under Section 162(m) of the Code, the $1 million executive compensation
deduction limit, Mr. Johnson has entered into a deferred compensation agreement
with the Company pursuant to which amounts payable to Mr. Johnson under the
Company's incentive compensation plans will be deferred for payment in future
years, subject to acceleration of payment in certain events, including a change
in control (as defined in the employment agreement).
 
     Change of Control Employment Agreements.  In addition to Mr. Johnson,
thirteen officers of the Company (including Marvin H. Assofsky, Mark Schoder,
Scott L. Stanton and Lonnie R. Wright) have entered into change of control
employment agreements with the Company, dated November 5, 1997 (after the Board
of Directors of the Company had authorized management and CSFB to approach
potentially interested third parties regarding a possible business combination
with or acquisition of the Company, see "THE MERGER -- Background of the
Merger") ("Change of Control Employment Agreements"). The Change of Control
Employment Agreements generally provide that during the three-year "employment
period" following the consummation of the Merger (a "Change of Control"), the
officer will receive (i) an annual base salary at least equal to 12 times the
highest monthly base salary paid to the officer during the prior twelve-month
period (the "Annual Base Salary"), and (ii) for each fiscal year ending during
the employment period, an annual bonus at least equal to the officer's target
short-term bonus under the Company's Short-Term Incentive Compensation Plan for
1997 (the "1997 Bonus") or, if higher, the officer's greatest target annual
bonus in any subsequent year prior to the Change of Control. Upon a termination
of an officer's employment by the Company (other than for "Cause" or disability)
or by an officer for "Good Reason" (including termination for any reason during
the 30-day period immediately following the first anniversary of the Change of
Control), the Company shall (i) pay the officer a lump sum pro rata bonus, (ii)
pay the officer a lump sum equal to three times the sum of (A) the Annual Base
Salary and (B) the greater of the officer's 1997 target bonus and the bonus
earned with respect to any fiscal year that begins both subsequent to 1997 and
within 3 years prior to the date of termination, (iii) provide the officer with
continued welfare benefits for 3 years (or such longer period provided by the
applicable program), and (iv) pay the officer a lump sum retirement benefit
equal to the excess of the actuarial equivalent of the benefits the officer
would have accrued under the Company retirement plans had he or she remained
employed for a period of three additional years after the date of termination
and the actuarial equivalent of the actual benefits accrued as of the
termination date.
 
     The Change of Control Employment Agreements provide for a gross-up payment
to be made to the officer, if necessary, to eliminate the effects of the
imposition of the excise tax under Section 4999 of the Code on payments made to
the officer and the imposition of income and excise taxes on such gross-up
payment.
 
     In the event that the employment of all of the officers with Change of
Control Employment Agreements were terminated immediately following a Change of
Control (excluding the three officers described below formerly terminated) and
such officers were entitled to payments thereunder, they would receive in the
aggregate approximately $21.6 million (which includes amounts payable to Mr.
Johnson pursuant to the employment agreement described above), of which amount
Messrs. Johnson, Schoder and Stanton would receive approximately $6.4 million,
$2.2 million and $2.2 million, respectively.
 
                                       26
<PAGE>   31
 
     The employment of Messrs. Assofsky and Wright and Kerry Clemmons, Senior
Vice President of Human Resources of the Company, each a party to a Change of
Control Agreement, was terminated on January 31, 1998 (87 days following
execution of their Change of Control Agreements), as a result of a reduction in
force due to the sale of various businesses. Upon such terminations, the
foregoing received approximately $1.6 million, in the aggregate, in severance
payments from the Company. These amounts will be offset against the amounts, if
any, up to approximately $1.6 million, $2.2 million and $1.3 million,
respectively, which such persons may become entitled to receive pursuant to the
change of control provisions under their respective Change of Control
Agreements.
 
     Stock Options and Performance Stock.  Upon consummation of the Merger all
outstanding stock options granted by the Company pursuant to the Company's
employee stock incentive plans ("Company Options"), including Company Options
held by certain officers and directors of the Company, whether or not then
exercisable or vested, will become fully exercisable and vested, and each
Company Option will be cashed out pursuant to the Merger Agreement for an amount
of cash equal to the product of (1) the difference (if positive) between the Per
Share Purchase Price and the price, if any, per share of Company Common Stock
pursuant to which the holder of such Company Option may purchase the shares of
Company Common Stock to which such Company Option relates (and less any
withholding of taxes as may be required by applicable law) and (2) the number of
shares of Company Common Stock subject thereto. Upon consummation of the Merger,
the restrictions and deferral limitations on all outstanding restricted stock
and performance awards granted by the Company pursuant to the Company's employee
stock incentive plans will lapse and such awards shall be fully vested.
 
     Retention Plan.  The Company has adopted a retention bonus plan providing
for the payment of up to approximately $13.6 million, in the aggregate, covering
approximately 750 employees of the Company. The amount and timing of payments
under such plan are contingent upon a number of factors, including continued
employment by the employee with the Company through a date certain, generally
December 31, 1998. Neither Mr. Johnson nor any other officer who is a party to a
Change of Control Employment Agreement is entitled to receive a bonus under such
retention plan.
 
     Indemnification; Insurance.  Buyer has agreed that it will, to the fullest
extent permitted by applicable Delaware law, after the Effective Time indemnify
the present and former directors and officers of the Company from any claim due
to the fact that such person was a director or officer of the Company prior to
the Effective Time. In addition, Buyer has agreed that it or the Company will
maintain directors' and officers' liability insurance for such present and
former directors and officers at the present levels of coverage for six years
from the Effective Time, subject to certain limitations. See "THE MERGER
AGREEMENT -- Indemnification and Insurance."
 
                                       27
<PAGE>   32
 
                        SECURITY OWNERSHIP BY DIRECTORS
                             AND EXECUTIVE OFFICERS
 
     The following chart sets forth, to the knowledge of the Company, certain
information regarding the ownership by the directors, named executive officers
and all directors and executive officers (as a group) of the Company of equity
securities of the Company as of March 16, 1998. As of March 16, 1998, the
Company had 24,526,104 shares of Common Stock issued and outstanding.
 
<TABLE>
<CAPTION>
                                                              AMOUNT AND NATURE OF
                                                                   BENEFICIAL           PERCENT
                                                                  OWNERSHIP(1)        OF CLASS(2)
                                                              --------------------    -----------
<S>                                                           <C>                     <C>
Glendon E. Johnson(4).......................................         961,661(3)           3.8%
Marvin H. Assofsky(4).......................................         197,553                *
Norman E. Crocker(4)........................................           6,820                *
David P. Gardner(4).........................................           9,820                *
Edwin J. Garn(4)............................................           9,820                *
Carl F. Guether(4)..........................................          12,853                *
Linda Jenckes(4)............................................           5,820                *
Lynn G. Merritt(4)..........................................           5,820                *
James L. Moorefield(4)......................................          11,020                *
Mark Schoder................................................          72,774                *
Scott L. Stanton(4).........................................         136,505                *
Lonnie R. Wright(4).........................................          94,340                *
All Directors and executive officers as a group (13
  persons)..................................................       1,595,096(3)           6.2%
</TABLE>
 
- ---------------
 *  Represents holdings of less than one percent
 
(1) Includes shares subject to options that are currently vested and
    exercisable, as follows: Glendon E. Johnson, 876,661; Marvin H. Assofsky,
    69,461; Norman E. Crocker, 5,820; David P. Gardner, 9,820; Edwin J. Garn,
    9,820; Carl F. Geuther, 10,820; Linda Jenckes, 5,820; Lynn G. Merritt,
    5,820; James L. Moorefield, 10,820; Scott L. Stanton, 66,730; Mark Schoder,
    72,774; and Lonnie Wright, 50,253.
 
(2) Percent of class is calculated by assuming, for purposes of both the number
    of shares held by such beneficial owner and the number of shares issued and
    outstanding, that all options to purchase Common Stock held by such
    beneficial owner (and no others) had been exercised.
 
(3) Includes 85,000 shares owned by Glendon E. Johnson, Jr., the son of Glendon
    E. Johnson. Glendon E. Johnson disclaims beneficial ownership of all such
    shares, as to which Glendon E. Johnson, Jr. has sole voting and investment
    power.
 
(4) Director.
 
                                       28
<PAGE>   33
 
                SECURITY OWNERSHIP BY CERTAIN BENEFICIAL OWNERS
 
     To the best of the Company's knowledge, the only beneficial owners of more
than 5% of the outstanding shares of Common Stock of the Company as of December
31, 1997 are set forth below. This table is based on information provided in
Schedule 13Gs last filed with the Securities and Exchange Commission by each of
the parties listed below.
 
<TABLE>
<CAPTION>
                      NAME AND ADDRESS                         NUMBER OF SHARES       PERCENT
                    OF BENEFICIAL OWNER                       BENEFICIALLY OWNED      OF CLASS
                    -------------------                       ------------------      --------
<S>                                                           <C>                     <C>
Heartland Advisors, Inc. ...................................      2,483,000(1)          9.7%
  790 North Milwaukee Street
  Milwaukee, Wisconsin 53202
Legg Mason, Inc. ...........................................      1,807,495(2)          7.1%
  111 South Calvert Street
  Baltimore, Maryland 21202
Sound Shore Management, Inc. ...............................      2,514,200(3)          9.8%
  8 Sound Shore Drive
  Greenwich, Connecticut 06836
</TABLE>
 
- ---------------
(1) Heartland Advisors, Inc. reports in its Schedule 13G that it has sole voting
    power with respect to 2,332,900 shares and sole dispositive power with
    respect to 2,483,000 shares. Heartland Advisors, Inc. reports that the
    shares of Common Stock to which its Schedule 13G relates are held in
    investment advisory accounts of Heartland Advisors, Inc. As a result,
    various persons have the right to receive or the power to direct the receipt
    of dividends from, or the proceeds from the sale of, the securities.
    Heartland Advisors, Inc. further reports that no such account is known to
    have such an interest relating to more than 5% of the class.
 
(2) Legg Mason, Inc. reports in its Schedule 13G that it has sole voting power
    with respect to 1,776,400 shares and sole dispositive power with respect to
    1,807,495 shares. Legg Mason, Inc. reports that such shares are held by Legg
    Mason Total Return Trust, Inc. and Legg Mason Special Investment Trust, Inc.
    with Legg Mason Fund Adviser, Inc. having power to dispose thereof. The
    remainder are held by various clients of Legg Mason Capital Management, Inc.
    and Legg Mason Wood Walker Inc., which have power to dispose thereof.
 
(3) Sound Shore Management, Inc. reports in its Schedule 13G that it has sole
    voting power with respect to 2,342,700 shares and sole dispositive power
    with respect to 2,514,200 shares.
 
                           CERTAIN PENDING LITIGATION
 
     During the period of April 1995 through May 1995, the Company and certain
of its officers and directors were named as defendants in a series of putative
class actions alleging violations of the federal securities laws. The actions,
Christopher W. Aronson, et. al. v. John Alden Financial Corporation, et. al.; In
Re: John Alden Financial Corporation Securities Litigation, all of which were
filed in the United States District Court for the Southern District of Florida
(the "Court"), have been consolidated. In October 1995, the plaintiffs filed a
Consolidated Amended Complaint purportedly on behalf of a class of persons who
purchased the Company's common stock, par value $.01 per share (the "Common
Stock"), during the period of October 27, 1994 through May 3, 1995 seeking
unspecified damages, fees, costs and interest. The first of the original
complaints was filed after the Company revised its previously announced earnings
for the fourth quarter of 1994 to reflect an unanticipated increase in claims
received in 1995 for medical services rendered in 1994. The remainder of the
original complaints were filed after the Company increased reserves during the
first quarter of 1995 to reflect a further increase in such claims. On September
30, 1996, the Court denied the defendants' motion to dismiss the Consolidated
Amended Complaint and the Court certified a class of those persons who purchased
the Company's Common Stock during the period between October 27, 1994 through
May 3, 1995. Discovery in the lawsuit is ongoing. The Company and individual
defendants deny any wrongdoing, believe they have meritorious defenses against
the claims asserted, and intend to vigorously defend the lawsuit.
 
                                       29
<PAGE>   34
 
     The Company and certain of its officers and directors have been named as
defendants in actions entitled Hanf v. Johnson, et al., C.A. No. 16241NC, filed
on March 10, 1998, and Abramsky v. Johnson, et al., C.A. No. 16235NC, filed
March 9, 1998, in the Court of Chancery of the State of Delaware. The plaintiffs
allege that they are owners of the Company's common stock and that they are
bringing the actions as class actions. Plaintiffs challenge the proposed sale of
the Company to Buyer and allege that the Company is not being sold for the
highest price possible. For relief, plaintiffs seek an injunction against
consummation of the proposed transaction with Buyer and an award of damages. The
Company and individual defendants deny any wrongdoing, believe they have
meritorious defenses against the claims asserted, and intend to vigorously
defend the lawsuit. However, the Hanf action has been dismissed and plaintiffs
in the Abramsky action and the Company have entered into a Memorandum of
Understanding, dated July 24, 1998, pursuant to which they have agreed in
principle to settle the Abramsky litigation (the "Settlement"). Pursuant to the
Settlement, the Company agreed to (i) obtain the updated fairness opinion of
CSFB dated the date of this Proxy Statement and attached hereto as Annex B (see
"THE MERGER -- Opinion of CSFB"), (ii) reduce the fixed portion of the
repurchase price under the Option Agreement from $20 million to $15 million (see
"Option Agreement") and (iii) permit plaintiffs' counsel to review and comment
upon a draft of this Proxy Statement. The Settlement is conditioned upon the
parties entering into a final settlement agreement and the subsequent approval
of such agreement by the Court of Chancery of the State of Delaware in New
Castle County.
 
                             PRINCIPAL ACCOUNTANTS
 
     The Company's principal accountants, PricewaterhouseCoopers LLP, will not
be represented at the Special Meeting.
 
                  ANNUAL MEETING AND PROPOSALS OF STOCKHOLDERS
 
     If the Merger is not consummated, the annual meeting of stockholders for
the election of directors and such other business as may be specified in the
notice of such meeting will be held on the earliest practicable date. If an
annual meeting is held, any proposals to be presented by a stockholder at such
annual meeting must have been received by the Company on or prior to December 4,
1997.
 
                                 OTHER MATTERS
 
     Only business within the purposes described in the Notice of Special
Meeting of Stockholders accompanying this Proxy Statement may be conducted at
the Special Meeting.
 
                INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
 
     The following documents filed with the Securities and Exchange Commission
are incorporated into this Proxy Statement by reference:
 
          1. The Company's Annual Report on Form 10-K (Commission File No.
     1-11396) for the year ended December 31, 1997, as amended by Form 10-K/A
     (Commission File No. 1-11396) filed by the Company on April 30, 1998;
 
          2. The Company's Quarterly Report on Form 10-Q (Commission File No.
     1-11396) for the quarter ended March 31, 1998;
 
          3. The Company's Current Reports on Form 8-K (Commission File No.
     1-11396) filed with the Commission on March 19, 1998.
 
     All documents filed pursuant to Section 13(a), 13(c), 14 or 15(d) of the
Exchange Act by the Company after the date hereof but prior to the date of the
Special Meeting shall be deemed to be incorporated by reference into this Proxy
Statement and to be a part of this Proxy Statement from the date of filing of
such document. Any statement contained herein or in a document incorporated or
deemed to be incorporated by
                                       30
<PAGE>   35
 
reference herein shall be deemed to be modified or superseded for purposes of
this Proxy Statement to the extent that a statement contained herein or in any
other subsequently filed document which also is or is deemed to be incorporated
by reference herein modifies or supersedes such statement. Any statement so
modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Proxy Statement.
 
     As used herein, the terms "Proxy Statement" and "herein" mean this Proxy
Statement, including the documents incorporated or deemed to be incorporated
herein by reference, as the same may be amended, supplemented or otherwise
modified from time to time. The Company will provide without charge to any
person to whom this Proxy Statement is delivered, on the written or oral request
of such person, a copy of any or all of its documents incorporated by reference
herein (other than exhibits not specifically incorporated by reference into the
texts of such documents). Requests for such documents should be directed to:
Investor Relations, John Alden Financial Corporation, 7300 Corporate Center
Drive, Miami, Florida, 33126-1223. Telephone requests may be directed to
Investor Relations at (305) 715-3767.
 
                           FORWARD LOOKING STATEMENTS
 
     The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements. This Proxy Statement, the documents
incorporated by reference herein and any other written or oral statements made
by or on behalf of the Company may include forward-looking statements which
reflect the Company's current views with respect to future events and financial
performance. These forward-looking statements are subject to certain
uncertainties and other factors that could cause actual results to differ
materially from such statements. These uncertainties and other factors include,
but are not limited to, uncertainties relating to general economic conditions
and cyclical industry conditions, uncertainties relating to federal and state
government and regulatory policies, volatile and unpredictable developments
(including utilization of medical services), medical inflation, the
uncertainties of the reserving process, the competitive environment in which the
Company operates, the uncertainties inherent in the development and introduction
into the marketplace of the Company's new small group health insurance product,
the ability of the Company to obtain desired contracts and pricing with
providers, the ability to obtain dividend approval from state regulators, the
uncertainties regarding the timing of the assumption of policies coinsured with
SunAmerica, the ability to modify or replace computerized systems to be year
2000 compliant, and the ability of the Company to control costs. Further, the
Company does not publicly disclose internal management forecasts of the type
provided to CSFB in connection with CSFB's analysis of the Merger. Such
forecasts were not prepared with a view toward public disclosure and investors
are cautioned not to rely on such forecasts. Such forecasts were based on
numerous variables and assumptions that are inherently uncertain and may be
beyond the control of management. There can be no certainty as to the timing of
the consummation of the acquisition of the Company as described herein or
obtaining approval from regulators and stockholders for the Merger. The words
"believe", "expect", "anticipate", "project" and similar expressions identify
forward-looking statements. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of their dates. The
Company undertakes no obligation to publicly update or revise any forward-
looking statements, whether as a result of new information, future events or
otherwise.
 
                                       31
<PAGE>   36
 
                                                                         ANNEX A
 
                          AGREEMENT AND PLAN OF MERGER
                                  BY AND AMONG
                       JOHN ALDEN FINANCIAL CORPORATION,
                                  FORTIS, INC.
                                      AND
                            JAFCO ACQUISITION CORP.
 
                           DATED AS OF MARCH 9, 1998
<PAGE>   37
 
                          AGREEMENT AND PLAN OF MERGER
 
     THIS AGREEMENT AND PLAN OF MERGER (this "Agreement") is made and entered
into as of March 9, 1998, by and among JOHN ALDEN FINANCIAL CORPORATION, a
Delaware corporation (the "Company"), FORTIS, INC., a Nevada corporation
("Parent"), and JAFCO ACQUISITION CORP., a Delaware corporation ("Merger Sub")
(the Company and Merger Sub are sometimes referred to herein collectively as the
"Constituent Corporations"). Certain terms used in this Agreement are defined in
Section 10.1 of this Agreement.
 
                                    RECITALS
 
     WHEREAS, the respective boards of directors of each of Parent, Merger Sub
and the Company have determined that the merger of Merger Sub with and into the
Company upon the terms and subject to the conditions set forth in this Agreement
is advisable and have approved the Merger;
 
     WHEREAS, as a condition to, and simultaneous with, execution of this
Agreement, the Company and Parent are entering into a stock option agreement
(the "Stock Option Agreement") in the form attached hereto as Exhibit 1; and
 
     WHEREAS, the Company, Parent and Merger Sub desire to make certain
representations, warranties, covenants and agreements in connection with this
Agreement.
 
     NOW, THEREFORE, in consideration of the premises, and of the
representations, warranties, covenants and agreements contained herein, the
parties hereto agree as follows:
 
                                   ARTICLE 1
 
                        TRANSACTIONS AND TERMS OF MERGER
 
     1.1  MERGER.  Subject to the terms and conditions of this Agreement, at the
Effective Time, Merger Sub shall be merged with and into the Company in
accordance with the provisions of, and having the effects specified in, the DGCL
(the "Merger"). The Company shall be the Surviving Corporation resulting from
the Merger and shall become a wholly owned Subsidiary of Parent and shall
continue to be governed by the Laws of the State of Delaware. The separate
corporate existence of Merger Sub shall cease upon the effectiveness of the
Merger.
 
     1.2  TIME AND PLACE OF CLOSING.  The consummation of the transactions
contemplated hereby (the "Closing") will take place at 9:00 a.m. local time at
the offices of Wachtell, Lipton, Rosen & Katz, 51 West 52nd Street, New York,
New York, or at such other place and time as the Parties shall mutually agree,
on the last business day of the month in which all of the conditions set forth
in Article 8 are satisfied or waived (the "Closing Date").
 
     1.3  EFFECTIVE TIME.  On the Closing Date and as soon as practicable
following the Closing, the Company and Parent will cause a Certificate of Merger
(the "Certificate of Merger") to be executed, acknowledged and filed with the
Secretary of State of the State of Delaware (the "Secretary") as provided in the
DGCL. The Merger shall become effective at the time the Secretary accepts for
record the Certificate of Merger or at such later time agreed by the Parties and
established under the Certificate of Merger (the "Effective Time").
 
     1.4  EXECUTION OF STOCK OPTION AGREEMENT.  Simultaneously with the
execution of this Agreement by the Parties and as a condition thereto, the
Company is executing and delivering to Parent the Stock Option Agreement,
pursuant to which the Company is granting to Parent an option to purchase shares
of the Company Common Stock.
 
                                       A-1
<PAGE>   38
 
                                   ARTICLE 2
 
                                TERMS OF MERGER
 
     2.1  CHARTER.  The Certificate of Incorporation of the Company in effect
immediately prior to the Effective Time shall be the Certificate of
Incorporation of the Surviving Corporation until duly amended or repealed.
 
     2.2  BYLAWS.  The Bylaws of Merger Sub in effect immediately prior to the
Effective Time shall be the Bylaws of the Surviving Corporation until duly
amended or repealed.
 
     2.3  DIRECTORS AND OFFICERS.  The directors of Merger Sub in office
immediately prior to the Effective Time, together with such additional persons
as may thereafter be elected, shall serve as the directors of the Surviving
Corporation from and after the Effective Time in accordance with the Bylaws of
the Surviving Corporation. The officers of the Company in office immediately
prior to the Effective Time, together with such additional persons as may
thereafter be elected, shall serve as the officers of the Surviving Corporation
from and after the Effective Time in accordance with the Bylaws of the Surviving
Corporation.
 
                                   ARTICLE 3
 
                          MANNER OF CONVERTING SHARES
 
     3.1  CONVERSION OF SHARES.  Subject to the provisions of this Article 3, at
the Effective Time, by virtue of the Merger and without any action on the part
of Parent, the Company, Merger Sub or the stockholders of any of the foregoing,
the shares of the Constituent Corporations shall be converted as follows:
 
          (a) Each share of Merger Sub Common Stock issued and outstanding
     immediately prior to the Effective Time shall cease to be outstanding and
     shall be converted into one share of Company Common Stock.
 
          (b) Each share of Company Common Stock (including any associated
     Rights, but excluding shares held by any Company Entity or any Parent
     Entity, and excluding shares held by stockholders who perfect their
     statutory appraisal rights as provided in Section 3.3) issued and
     outstanding immediately prior to the Effective Time shall cease to be
     outstanding and shall be converted into and exchanged for the right to
     receive from Parent a cash payment in the amount of twenty-two dollars and
     fifty cents ($22.50) (the "Per Share Purchase Price").
 
          (c) Each share of Company 9% Preferred Stock issued and outstanding
     immediately prior to the Effective Time shall be redeemed for cash at the
     Effective Time in accordance with the terms of such Company 9% Preferred
     Stock as set forth in the Company's Certificate of Incorporation.
 
          (d) Each share of capital stock of Parent issued and outstanding
     immediately prior to the Effective Time shall remain issued and outstanding
     from and after the Effective Time.
 
     3.2  SHARES HELD BY THE COMPANY OR PARENT.  Each of the shares of Company
Common Stock held by any Company Entity or by any Parent Entity shall be
canceled and retired at the Effective Time and no consideration shall be issued
in exchange therefor.
 
     3.3  DISSENTING STOCKHOLDERS.  Any holder of shares of Company Common Stock
who perfects his appraisal rights in accordance with and as contemplated by
Section 262 of the DGCL shall be entitled to receive the value of such shares in
cash as determined pursuant to such provision of Law; provided, that no such
payment shall be made to any dissenting stockholder unless and until such
dissenting stockholder has complied with the applicable provisions of the DGCL
and surrendered to the Company the certificate or certificates representing the
shares for which payment is being made. In the event that after the Effective
Time a dissenting stockholder of the Company fails to perfect, or effectively
withdraws or loses, his right to appraisal and of payment for his shares, Parent
shall issue and deliver the consideration to which such holder of shares of
Company Common Stock is entitled under this Article 3 (without interest) upon
surrender by such holder of the certificate or certificates representing shares
of Company Common Stock held by him. If
 
                                       A-2
<PAGE>   39
 
and to the extent required by applicable Law, the Company will establish (or
cause to be established) an escrow account with an amount sufficient to satisfy
the maximum aggregate payment that may be required to be paid to dissenting
stockholders. Upon satisfaction of all claims of dissenting stockholders, the
remaining escrowed amount, reduced by payment of the fees and expenses of the
escrow agent, will be returned to the Surviving Corporation.
 
     3.4  CONVERSION OF STOCK OPTIONS; RESTRICTED STOCK.  At the Effective Time,
(i) each option or other Equity Right to purchase or receive shares of Company
Common Stock pursuant to stock options, stock appreciation rights, restricted
stock awards or performance share awards granted by the Company under the
Company Stock Plans and outstanding at the Effective Time, whether or not then
exercisable or vested (collectively, the "Company Options"), shall become fully
exercisable and vested, (ii) each such Company Option shall be canceled and
(iii) in consideration of such cancellation, Parent shall pay to each such
holder of Company Options an amount in cash equal to the product of (1) the
difference (if positive) between the Per Share Purchase Price and the price, if
any, per share of Company Common Stock pursuant to which the holder of such
Company Option may purchase the shares of Company Common Stock to which such
Company Option relates (and less any withholding of Taxes as may be required by
applicable Law) and (2) the number of shares of Company Common Stock subject
thereto. At the Effective Time, each such Company Option shall no longer
represent the right to purchase or receive shares of Company Common Stock, but
in lieu thereof shall represent the right to receive the cash payment referred
to above. At or prior to the Effective Time, the Company shall take all actions
necessary to provide notice of the provisions of this Section 3.4 to all holders
of Company Options and to cause the cancellation of the Company Options in
accordance herewith at the Effective Time.
 
                                   ARTICLE 4
 
                               EXCHANGE OF SHARES
 
     4.1  EXCHANGE PROCEDURES.  Promptly after the Effective Time, Parent and
the Company shall cause the exchange agent selected by Parent (the "Exchange
Agent") to mail to each holder of record of a certificate which represented
shares of Company Common Stock immediately prior to the Effective Time (the
"Certificates") appropriate transmittal materials and instructions (which shall
specify that delivery shall be effected, and risk of loss and title to such
Certificates shall pass, only upon proper delivery of such Certificates to the
Exchange Agent). The Certificates of Company Common Stock so delivered shall be
duly endorsed as the Exchange Agent may require. In the event of a transfer of
ownership of shares of Company Common Stock represented by Certificates that are
not registered in the transfer records of the Company, the consideration
provided in Section 3.1 may be issued to a transferee if the Certificates
representing such shares are delivered to the Exchange Agent, accompanied by all
documents required to evidence such transfer and by evidence satisfactory to the
Exchange Agent that any applicable stock transfer taxes have been paid. If any
Certificate shall have been lost, stolen, mislaid or destroyed, upon receipt of
(a) an affidavit of that fact from the holder claiming such Certificate to be
lost, mislaid, stolen or destroyed, (b) such bond, security or indemnity as
Parent and the Exchange Agent may reasonably require and (c) any other documents
reasonably necessary to evidence and effect the bona fide exchange thereof, the
Exchange Agent shall issue to such holder the consideration into which the
shares represented by such lost, stolen, mislaid or destroyed Certificate shall
have been converted. The Exchange Agent may establish such other reasonable and
customary rules and procedures in connection with its duties as it may deem
appropriate. After the Effective Time, each holder of shares of Company Common
Stock (other than shares to be canceled pursuant to Section 3.2 or as to which
statutory appraisal rights have been perfected, and not withdrawn or lost, as
provided in Section 3.3) issued and outstanding at the Effective Time shall
surrender the Certificates representing such shares to the Exchange Agent and
shall promptly upon surrender thereof receive in exchange therefor the
consideration provided in Section 3.1, together with all undelivered dividends
or distributions in respect of such shares (without interest thereon) pursuant
to Section 4.2, less any withholding of Taxes as may be required by applicable
Law. Parent shall not be obligated to deliver the consideration to which any
former holder of Company Common Stock is entitled as a result of the Merger
until such holder surrenders such holder's Certificates for exchange as provided
in this Section 4.1. Any other provision of this Agreement notwithstand-
                                       A-3
<PAGE>   40
 
ing, neither Parent, the Surviving Corporation nor the Exchange Agent shall be
liable to a holder of Company Common Stock for any amounts paid or property
delivered in good faith to a public official pursuant to any applicable
abandoned property, escheat or similar Law. Adoption of this Agreement by the
stockholders of the Company shall constitute ratification of the appointment of
the Exchange Agent.
 
     4.2  RIGHTS OF FORMER COMPANY STOCKHOLDERS.  At the Effective Time, the
stock transfer books of the Company shall be closed as to holders of Company
Common Stock immediately prior to the Effective Time and no transfer of Company
Common Stock by any such holder shall thereafter be made or recognized. Until
surrendered for exchange in accordance with the provisions of Section 4.1, each
Certificate theretofore representing shares of Company Common Stock (other than
shares to be canceled pursuant to Sections 3.2 and 3.3) shall from and after the
Effective Time represent for all purposes only the right to receive the
consideration provided in Section 3.1 in exchange therefor, subject, however, to
the Surviving Corporation's obligation to pay any dividends or make any other
distributions with a record date prior to the Effective Time which have been
declared or made by the Company in respect of such shares of Company Common
Stock in accordance with the terms of this Agreement and which remain unpaid at
the Effective Time. However, upon surrender of such Certificate, any undelivered
dividends and cash payments payable hereunder (without interest) shall be
delivered and paid with respect to each share represented by such Certificate.
 
                                   ARTICLE 5
 
                 REPRESENTATIONS AND WARRANTIES OF THE COMPANY
 
     Except as set forth in the corresponding sections or subsections of the
Company Disclosure Letter or in any Company Report filed prior to January 1,
1998, the Company hereby represents and warrants to Parent and Merger Sub as
follows:
 
     5.1  ORGANIZATION, GOOD STANDING AND QUALIFICATION.
 
     (a) The Company is a corporation duly organized, validly existing and in
good standing under the Laws of the State of Delaware. Section 5.1(a) of the
Company Disclosure Letter contains a list of all of the Company Subsidiaries.
Each Company Subsidiary is a corporation duly organized, validly existing and in
good standing under the Laws of its respective jurisdiction of organization.
Each Company Entity has all requisite corporate or similar power and authority
to own and operate its Assets and to carry on its business as presently
conducted and is qualified to do business and is in good standing as a foreign
corporation in each jurisdiction where the ownership or operation of its Assets
or conduct of its business requires such qualification, except where the failure
to be so qualified or in good standing, when taken together with all other such
failures, is not reasonably likely to have a Company Material Adverse Effect.
The Company has made available to Parent a complete and correct copy of each
Company Entity's charter and bylaws, each as amended to date. Each Company
Entity's charter and bylaws so delivered are in full force and effect.
 
     (b) The Company conducts its insurance operations through the Subsidiaries
set forth in Section 5.1(b) of the Company Disclosure Letter (collectively, the
"Company Insurance Subsidiaries"). Each of the Company Insurance Subsidiaries is
(i) duly licensed or authorized as an insurance company and, where applicable, a
reinsurer in its jurisdiction of incorporation, (ii) duly licensed or authorized
as an insurance company and, where applicable, a reinsurer in each other
jurisdiction where it is required to be so licensed or authorized, and (iii)
duly authorized in its jurisdiction of incorporation and each other applicable
jurisdiction to write each line of business reported as being written in the
Company SAP Statements, except, in any such case, where the failure to be so
licensed or authorized is not reasonably likely to have a Company Material
Adverse Effect. The Company has made all required filings under applicable
insurance holding company statutes except where the failure to file is not
reasonably likely to have a Company Material Adverse Effect.
 
     5.2  CAPITAL STRUCTURE.
 
     (a) The authorized stock of the Company consists of 75,000,000 shares of
Company Common Stock, of which 24,523,156 shares were outstanding as of the
close of business on March 9, 1998; and 432,000 shares of
 
                                       A-4
<PAGE>   41
 
preferred stock, $.01 par value ("Preferred Stock"), of which (i) 270,000 shares
have been authorized as 9% Cumulative Preferred Stock ("Company 9% Preferred
Stock"), of which 150,000 shares were outstanding as of March 9, 1998, and (ii)
162,000 shares have been authorized as Series B Participating Preferred Stock,
of which no shares were outstanding as of March 9, 1998. All of the outstanding
shares of Company Common Stock and Company 9% Preferred Stock have been duly
authorized and are validly issued, fully paid and nonassessable. The Company has
no commitments to issue or deliver Company Common Stock, except that, as of
March 9, 1998, there were 2,506,366 shares of Company Common Stock subject to
issuance pursuant to the Company Stock Plans. The Company has no commitments to
issue or deliver any shares of preferred stock, except that as of March 9, 1998,
there were 245,231.56 shares of Series A Junior Participating Preferred Stock
subject to issuance pursuant to the Rights Agreement, the terms of which shares
of Series A Junior Participating Preferred Stock are set forth in a designation
that has been approved by the board of directors of the Company as part of the
Rights Agreement but not filed with the Secretary. Section 5.2(a) of the Company
Disclosure Letter contains a correct and complete list of each outstanding
Company Option, including the applicable Company Stock Plan, the holder of such
Company Option, date of grant, exercise price and number of shares subject
thereto.
 
     (b) Each of the outstanding shares of capital stock or other securities of
each of the Company's Subsidiaries is duly authorized, validly issued, fully
paid and nonassessable and owned by the Company or a direct or indirect wholly
owned Subsidiary of the Company, free and clear of any and all Liens.
 
     (c) Except as set forth in this Section 5.2 above, and except with respect
to the Stock Option Agreement and the Rights Agreement, there are no preemptive
or other outstanding Equity Rights with respect to any shares of capital stock
or other securities of the Company or any of its Subsidiaries, and no securities
or obligations evidencing such rights are authorized, issued or outstanding. The
Company does not have outstanding any bonds, debentures, notes or other
obligations the holders of which have the right to vote (or convertible into or
exercisable for securities having the right to vote) with the stockholders of
the Company on any matter.
 
     5.3  CORPORATE AUTHORITY; APPROVAL AND FAIRNESS.
 
     (a) The Company has all requisite corporate power and authority, and has
taken all corporate action necessary in order, to execute, deliver and perform
its obligations under this Agreement and the Stock Option Agreement and to
consummate the transactions contemplated hereby and thereby, subject only to
approval of the Merger by the holders of at least a majority of the outstanding
Company Common Stock (the "Company Requisite Vote") and to the receipt of the
approvals referred to in Section 5.4. This Agreement and the Stock Option
Agreement are the valid and binding agreements of the Company enforceable
against the Company in accordance with their terms, subject to bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and similar laws of
general applicability relating to or affecting creditors' rights and to general
equity principles (the "Bankruptcy and Equity Exception").
 
     (b) The board of directors of the Company at a meeting duly called and
held, has by unanimous vote of those directors present (who constituted all of
the directors then in office), (i) determined that the Agreement and the Stock
Option Agreement, and the Merger and the other transactions contemplated hereby
and thereby, are fair to and in the best interests of the Company and its
stockholders, (ii) authorized, approved and adopted in all respects the
Agreement and the Stock Option Agreement, and the Merger and the other
transactions contemplated hereby and thereby, and (iii) subject to Section 7.2,
resolved to recommend that the holders of the Company Common Stock adopt this
Agreement. The board of directors of the Company has received the opinion of
Credit Suisse First Boston Corporation, dated the date of this Agreement, to the
effect that the consideration to be received in the Merger by the holders of the
Company Common Stock is fair, from a financial point of view, to such holders, a
signed copy of which has been delivered to Parent.
 
     5.4  GOVERNMENTAL FILINGS; NO VIOLATIONS.
 
     (a) Other than the filings, notices and Consents (i) pursuant to Section
1.3, (ii) under the HSR Act and the Exchange Act, (iii) required to be made with
the NYSE, and (iv) the filing of appropriate documents
 
                                       A-5
<PAGE>   42
 
with, and approval of, the respective Commissioners of Insurance or similar
Regulatory Authorities of Bermuda, Florida, Minnesota, Nevada, Ohio and Texas,
and such filings, notices or Consents as may be required under the antitrust
notification insurance Laws of any state in which the Company, Parent or any of
their respective Subsidiaries is domiciled or does business, no notices, reports
or other filings are required to be made by any Company Entity with, nor are any
Consents, registrations or Permits required to be obtained by any Company Entity
from, any Regulatory Authority, in connection with the execution and delivery of
this Agreement and the Stock Option Agreement by the Company and the
consummation by the Company of the Merger and the other transactions
contemplated hereby and thereby, except those that the failure to make or obtain
are not, individually or in the aggregate, reasonably likely to have a Company
Material Adverse Effect or prevent, materially delay or materially impair the
ability of the Company to consummate the transactions contemplated by this
Agreement and the Stock Option Agreement.
 
     (b) The execution, delivery and performance of this Agreement and the Stock
Option Agreement by the Company do not, and the consummation by the Company of
the Merger and the other transactions contemplated hereby and thereby will not,
constitute or result in (i) a Default under the Certificate of Incorporation or
bylaws of the Company or the comparable governing instruments of any of its
Subsidiaries, (ii) a Default under, or the creation of a Lien on the Assets of
the Company or any of its Subsidiaries (with or without notice, lapse of time or
both) pursuant to, any Contract binding upon the Company or any of its
Subsidiaries or (provided, as to consummation, the filings and notices are made,
and approvals are obtained, as referred to in Section 5.4(a)), any Law, Order or
Permit to which the Company or any of its Subsidiaries is subject, or (iii) any
change in the rights or obligations of any party under any of the foregoing
Contracts, except, in the case of clause (ii) or (iii) immediately above, for
any Default, creation of Lien or change that, individually or in the aggregate,
is not reasonably likely to have a Company Material Adverse Effect or prevent,
materially delay or materially impair the ability of the Company to consummate
the transactions contemplated by this Agreement or the Stock Option Agreement.
Section 5.4 of the Company Disclosure Letter sets forth, to the Knowledge of the
Company, a correct and complete list of Contracts of the Company and its
Subsidiaries pursuant to which Consents are or may be required prior to
consummation of the transactions contemplated by this Agreement and the Stock
Option Agreement (whether or not subject to the exception set forth with respect
to clauses (ii) and (iii) immediately above), except those the failure to
obtain, individually or in the aggregate, are not reasonably likely to have a
Company Material Adverse Effect.
 
     5.5  COMPANY REPORTS; FINANCIAL STATEMENTS.
 
     (a) The Company has made available to Parent each registration statement,
report, proxy statement or information statement prepared by it since December
31, 1994, including (i) the Company's Annual Report on Form 10-K for the year
ended December 31, 1996, and (ii) the Company's Quarterly Reports on Form 10-Q
for the periods ended March 31, 1997, June 30, 1997 and September 30, 1997, each
in the form (including exhibits, annexes and any amendments thereto), and filed
with the SEC (collectively, including any such reports filed subsequent to the
date hereof, the "Company Reports"). As of their respective dates, the Company
Reports did not, and any Company Reports filed with the SEC after January 1,
1998 will not, contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the
statements made therein, in light of the circumstances in which they were made,
not misleading. Each of the consolidated balance sheets included in or
incorporated by reference into the Company Reports (including the related notes
and schedules) fairly presents, or will fairly present, the consolidated
financial position of the Company and its Subsidiaries as of its date and each
of the consolidated statements of income, cash flows and changes in stockholders
equity included in or incorporated by reference into the Company Reports
(including any related notes and schedules) fairly presents, or will fairly
present, the results of operations, cash flows and changes in stockholders
equity, as the case may be, of the Company and its Subsidiaries for the periods
set forth therein (subject, in the case of unaudited statements, to notes and
normal year-end audit adjustments that will not be material in amount or
effect), in each case in accordance with GAAP, except as may be noted therein.
 
     (b) The Company has made available to Parent true and complete copies of
the annual and quarterly statements of each of the Company Insurance
Subsidiaries as filed with the applicable insurance Regulatory
 
                                       A-6
<PAGE>   43
 
Authorities for the years ended December 31, 1995, 1996 and 1997, including all
exhibits, interrogatories, notes, schedules and any actuarial opinions,
affirmations or certifications or other supporting documents filed in connection
therewith (collectively, the "Company SAP Statements"). The Company SAP
Statements were prepared in conformity with statutory accounting practices
prescribed or permitted by the applicable insurance Regulatory Authority
consistently applied for the periods covered thereby and present fairly the
statutory financial position of such Company Insurance Subsidiaries as at the
respective dates thereof and the results of operations of such Subsidiaries for
the respective periods then ended. The Company SAP Statements complied in all
material respects with all applicable Laws when filed and, to the Knowledge of
the Company, no material deficiency has been asserted with respect to any
Company SAP Statements by the applicable insurance Regulatory Authority or any
other governmental agency or body. The statutory balance sheets and income
statements included in the Company SAP Statements as of and for the years ended
December 31, 1995 and 1996 have been audited by Price Waterhouse LLP, and the
Company has made available to Parent true and complete copies of all audit
opinions related thereto. The Company has made available to Parent true and
complete copies of all examination reports of insurance departments and any
insurance Regulatory Authorities since January 1, 1994 relating to the Company
Insurance Subsidiaries.
 
     (c) Since January 1, 1993, or the date of organization if later, each
Company Entity has timely filed all reports and statements, together with any
amendments required to be made with respect thereto, that it was required to
file with Regulatory Authorities (except failures to file which are not
reasonably likely to have, individually or in the aggregate, a Company Material
Adverse Effect).
 
     5.6  ABSENCE OF CERTAIN CHANGES.  Since September 30, 1997, the Company and
its Subsidiaries have conducted the businesses of the Company and its
Subsidiaries, taken as a whole, only in, and have not engaged in any material
transaction other than according to, the ordinary and usual course of such
businesses and there has not been (i) any change in the financial condition,
management, Assets, Liabilities, business or results of operations of the
Company and its Subsidiaries which or, to the Knowledge of the Company, any
development or combination of developments which, individually or in the
aggregate, has had or is reasonably likely to have a Company Material Adverse
Effect; (ii) any material damage, destruction or other casualty loss with
respect to any material Asset owned, leased or otherwise used by the Company or
any of its Subsidiaries, whether or not covered by insurance; (iii) any
declaration, setting aside or payment of any dividend or other distribution in
respect of the stock of the Company, except for (A) regular quarterly cash
dividends on the Company Common Stock not in excess of $.12 per share per
quarter, and (B) regular semi-annual cash dividends on the Company 9% Preferred
Stock paid in accordance with the Company's Certificate of Incorporation; (iv)
any material change by the Company in accounting principles, practices or
methods other than those required by GAAP or applicable statutory accounting
principles; (v) any material change in the Company's consolidated reserves for
future policy benefits or other policy claims and benefits; or (vi) any material
change in the accounting, actuarial, investment, reserving, underwriting or
claims administration policies, practices, procedures, methods, assumptions or
principles of any Company Insurance Subsidiary. Since September 30, 1997, there
has not been any increase in the compensation payable or that could become
payable by the Company or any of its Subsidiaries to officers or key employees
or any amendment of any of the Compensation and Benefit Plans other than
increases or amendments in the ordinary course.
 
     5.7  LITIGATION.  There is no Litigation instituted or pending or, to the
Knowledge of the Company, threatened (or unasserted but considered probable of
assertion and which if asserted would have at least a reasonable probability of
an unfavorable outcome) against any Company Entity, or against any director,
officer or Compensation and Benefit Plan, or against any Asset, interest or
right of any of them, nor are there any Orders of any Regulatory Authorities,
other governmental authorities or arbitrators outstanding against any Company
Entity, in each case, except for those that are not, individually or in the
aggregate, reasonably likely to have a Company Material Adverse Effect or
prevent or materially delay or materially impair the ability of the Company to
consummate the transactions contemplated by this Agreement or the Stock Option
Agreement. Section 5.7 of the Company Disclosure Letter contains a summary of
all Litigation pending as of the date of this Agreement to which any Company
Entity is a party and which names a Company Entity as a defendant, co-defendant
or third-party defendant or for which any Company Entity has any potential
Liability.
 
                                       A-7
<PAGE>   44
 
     5.8  EMPLOYEE BENEFITS.
 
     (a) A copy of each bonus, deferred compensation, pension, retirement,
profit-sharing, thrift, savings, employee stock ownership, stock bonus, stock
purchase, restricted stock, stock option, employment, termination, severance,
change of control, compensation, medical, health or other plan, agreement,
policy or arrangement that covers employees, directors, agents, former
employees, former directors or former consultants of any Company Entity (the
"Compensation and Benefit Plans") and any trust agreement or insurance contract
forming a part of such Compensation and Benefit Plans has been made available to
Parent prior to the date hereof. The Compensation and Benefit Plans are listed
in Section 5.8(a) of the Company Disclosure Letter and any "change of control"
or similar provisions therein are specifically identified in Section 5.8(a) of
the Company Disclosure Letter.
 
     (b) All Compensation and Benefit Plans are in substantial compliance with
all applicable Law, including the Code and ERISA. Each Compensation and Benefit
Plan that is an "employee pension benefit plan" within the meaning of Section
(2) of ERISA (a "Pension Plan") and that is intended to be qualified under
Section 401(a) of the Code has received a favorable determination letter from
the IRS with respect to "TRA" (as defined in Section 1 of Rev. Proc. 93-39), and
the Company has no Knowledge of any circumstances reasonably likely to result in
revocation of any such favorable determination letter. There is no pending or,
to the Knowledge of the Company, threatened litigation relating to the
Compensation and Benefit Plans. To the Knowledge of the Company, no Company
Entity has engaged in a transaction with respect to any Compensation and Benefit
Plan that, assuming the taxable period of such transaction expired as of the
date hereof, would subject any Company Entity to a material tax or penalty
imposed by either Section 4975 of the Code or Section 502 of ERISA.
 
     (c) No liability under Subtitle C or D of Title IV of ERISA has been or is
reasonably expected to be incurred by any Company Entity with respect to any
ongoing, frozen or terminated "single-employer plan," within the meaning of
Section 4001(a)(15) of ERISA, currently or formerly maintained by any Company
Entity, or the single-employer plan of any entity which is considered one
employer with the Company under Section 4001 of ERISA or Section 414 of the Code
(an "ERISA Affiliate"). No Company Entity has contributed, or has been obligated
to contribute, to a multiemployer plan as defined in Section 3(37) of ERISA at
any time during the last six years. No notice of a "reportable event," within
the meaning of Section 4043 of ERISA for which the 30-day reporting requirement
has not been waived, has been required to be filed for any Pension Plan or by
any ERISA Affiliate within the 12-month period ending on the date hereof.
 
     (d) All contributions required to be made under the terms of any
Compensation and Benefit Plan as of the date hereof have been timely made or
have been reflected on the most recent consolidated balance sheet filed or
incorporated by reference in the Company Reports prior to the date hereof.
Neither any Pension Plan nor any single-employer plan of an ERISA Affiliate has
an "accumulated funding deficiency" (whether or not waived) within the meaning
of Section 412 of the Code or Section 302 of ERISA. Neither the Company nor its
Subsidiaries has provided, or is required to provide, security to any Pension
Plan or to any single-employer plan of an ERISA Affiliate pursuant to Section
401(a)(29) of the Code.
 
     (e) Under each Pension Plan which is a single-employer plan, as of the date
of the most recent actuarial valuation, the actuarially determined present value
of all "benefit liabilities," within the meaning of Section 4001(a)(16) of ERISA
(as determined on the basis of the actuarial assumptions contained in the
Pension Plan's most recent actuarial valuation), did not exceed the then current
value of the assets of such Pension Plan, and there has been no material change
in the financial condition of such Pension Plan since the date of the most
recent actuarial valuation.
 
     (f) No Company entity has any obligations for retiree health and life
benefits under any Compensation and Benefit Plan, except as specifically
described in Section 5.8(f) of the Company Disclosure Letter. Subject to the
restrictions set forth in Section 7.1 hereof, the Company or its Subsidiaries
may amend or terminate any such plan under the terms of such plan at any time
without incurring any material Liability thereunder.
 
     (g) The consummation of the Merger and the other transactions contemplated
by this Agreement, either alone or in connection with a subsequent termination
of employment, will not (i) entitle any employees of any
 
                                       A-8
<PAGE>   45
 
Company Entity to severance pay, (ii) accelerate the time of payment or vesting
or trigger any payment of compensation or benefits under, increase the amount
payable or trigger any other material obligation pursuant to, any of the
Compensation and Benefit Plans, or (iii) result in any Default under any of the
Compensation and Benefit Plans.
 
     (h) All Compensation and Benefit Plans covering current or former non-U.S.
employees or former employees of the Company and its Subsidiaries comply in all
material respects with applicable Law. No Company Entity has any material
unfunded Liabilities with respect to any Pension Plan that covers such non-U.S.
employees.
 
     (i) No amount that will be received (whether in cash or property or the
vesting of property) as a direct result of the transactions contemplated by this
Agreement by any employee, officer, director, agent or independent contractor of
the Company who is a "disqualified individual" (as such term is defined in
proposed Treasury Regulation Section 1.280G-1) under any employment arrangement
is reasonably likely to be treated as an "excess parachute payment" (as such
term is defined in Section 280G(b)(1) of the Code).
 
     5.9  COMPLIANCE WITH LAWS, ORDERS AND PERMITS.
 
     (a) The business and operations of the Company and the Company Insurance
Subsidiaries have been conducted in compliance in all material respects with all
applicable Laws regulating the business of insurance, including all applicable
orders and directives of insurance Regulatory Authorities and market conduct
recommendations resulting from market conduct examinations of insurance
Regulatory Authorities (collectively, "Insurance Laws"). Notwithstanding the
generality of the foregoing, except where the failure to do so would not,
individually or in the aggregate, be reasonably likely to have a Company
Material Adverse Effect, each Company Insurance Subsidiary and, to the Knowledge
of the Company, its agents have marketed, sold and issued insurance products in
compliance, in all material respects, with Insurance Laws applicable to the
business of such Company Insurance Subsidiary and in the respective
jurisdictions in which such products have been sold, including in compliance
with (i) all applicable prohibitions against "redlining" or withdrawal of
business lines, (ii) all applicable requirements relating to the disclosure of
the nature of insurance products as policies of insurance, and (iii) all
applicable requirements relating to insurance product projections and
illustrations.
 
     (b) There is no pending or, to the Knowledge of the Company, threatened
charge by any insurance Regulatory Authority that any of the Company Insurance
Subsidiaries has violated, nor any pending or, to the Knowledge of the Company,
threatened investigation by any insurance Regulatory Authority with respect to
possible violations of, any applicable Insurance Laws where such violations are,
individually or in the aggregate, reasonably likely to have a Company Material
Adverse Effect. None of the Company Insurance Subsidiaries is subject to any
Order of any insurance Regulatory Authority relating specifically to such
Company Insurance Subsidiary (as opposed to insurance companies generally). The
Company Insurance Subsidiaries have filed all reports required to be filed with
any insurance Regulatory Authority on or before the date hereof as to which the
failure to file such reports is, individually or in the aggregate, reasonably
likely to have a Company Material Adverse Effect.
 
     (c) In addition to Insurance Laws, the business of each Company Entity has
been, and is being, conducted in compliance in all material respects with all
applicable Laws, Orders and Permits, and with such Company Entity's charter and
bylaws or other similar governing documents. No investigation or review by any
Regulatory Authority with respect to any Company Entity is pending or, to the
Knowledge of the Company, threatened, nor, to the Knowledge of the Company, has
any Regulatory Authority indicated an intention to conduct the same, except for
those the outcome of which are not, individually or in the aggregate, reasonably
likely to have a Company Material Adverse Effect or prevent or materially
burden, delay or impair the ability of the Company to consummate the
transactions contemplated by this Agreement. To the Knowledge of the Company, no
material change is required in any Company Entity's processes, properties or
procedures in connection with any applicable Laws, Orders or Permits, and the
Company has not received any written notice or communication of any material
noncompliance with any such Laws, Orders or Permits that has not been cured as
of the date hereof. Each Company Entity has all Permits, Orders, Consents,
trademarks, patents, trade names, copyrights, service marks and franchises
necessary to conduct its business as presently conducted
                                       A-9
<PAGE>   46
 
except those the absence of which are not, individually or in the aggregate,
reasonably likely to have a Company Material Adverse Effect or prevent or
materially burden, delay or impair the ability of the Company to consummate the
Merger and the other transactions contemplated by this Agreement or the Stock
Option Agreement.
 
     (d) Copies of all material written reports, correspondence, notices and
other documents relating to any inspection, audit, monitoring or other form of
review or enforcement action by a Regulatory Authority have been made available
to Parent.
 
     5.10  TAXES.
 
     (a) Each Company Entity has filed, completely and correctly in all material
respects, all Tax Returns that are required by all applicable Laws to be filed
by such Company Entity, and (i) has paid, or made adequate provision for the
payment of, all Taxes which have or may become due and payable pursuant to those
Tax Returns, has paid all estimated Taxes due and (ii) has paid all other
charges, claims and assessments for Taxes received to date other than those
charges, claims and assessments for Taxes being contested in good faith for
which provision has been made in accordance with GAAP on the books of such
Company Entity.
 
     (b) All Taxes which the Company Entities are required by Law to withhold
and collect have been duly withheld and collected, and have been paid over, in a
timely manner, to the proper Taxing Authorities to the extent due and payable.
 
     (c) No Company Entity has executed any currently effective waiver to extend
the applicable statute of limitations in respect of any Tax Liabilities of any
Company Entity for the fiscal years prior to and including the most recent
fiscal year.
 
     (d) No Company Entity has been a member of any consolidated group for
federal income tax purposes other than the consolidated group of which the
Company is the common parent; and no Company Entity is a party to any tax
sharing agreement or arrangement, other than with each other.
 
     (e) No Liens for Taxes exist with respect to any of the Assets of any
Company Entity, except for statutory Liens for Taxes not yet due or payable or
that are being contested in good faith.
 
     (f) All of the income Tax Returns filed by or on behalf of each Company
Entity have been examined by and settled with the IRS or appropriate Taxing
Authority, or the statute of limitations with respect to the relevant Tax
liability expired, for all taxable periods through and including the period
ending on December 31, 1993.
 
     (g) All Taxes due with respect to any completed and settled audit,
examination or deficiency litigation with any Taxing Authority have been, or
prior to the Effective Time will be, paid in full.
 
     (h) There is no audit, examination, deficiency, or refund litigation
pending with respect to any Taxes and during the past three years no Taxing
Authority has given written notice of the commencement of any audit,
examination, deficiency or refund litigation, with respect to any Taxes.
 
     (i) No Company Entity is bound by any currently effective private ruling,
closing agreement or similar agreement with any Taxing Authority relating to a
material amount of Taxes.
 
     (j) The Company is not a "consenting corporation" within the meaning of
Section 341(f) of the Code.
 
     5.11  LABOR MATTERS.  No Company Entity is a party to or otherwise bound by
any collective bargaining agreement, contract or other agreement or
understanding with a labor union or labor organization. No Company Entity is the
subject of any Litigation asserting that any such Company Entity has committed
an unfair labor practice (within the meaning of the National Labor Relations Act
or comparable state law) or seeking to compel any such Company Entity to bargain
with any labor organization as to wages or conditions of employment, nor is any
Company Entity party to any collective bargaining agreement, nor is there any
strike or other labor dispute involving any Company Entity, pending or, to the
Knowledge of the Company, threatened, or, to the Knowledge of the Company, is
there any activity involving any Company Entity's employees seeking to certify a
collective bargaining unit or engaging in any other organization activity.
 
                                      A-10
<PAGE>   47
 
     5.12  INTELLECTUAL PROPERTY.
 
     (a) The Company Entities own, or are licensed or otherwise possess legally
enforceable rights to use, all Intellectual Property that is used in their
businesses as currently conducted, except for any such failures to own, be
licensed or possess that are not, individually or in the aggregate, reasonably
likely to have a Company Material Adverse Effect, and to the Knowledge of the
Company all patents, trademarks, tradenames, service marks and copyrights held
by any Company Entity are valid and subsisting.
 
     (b) Except as are not, individually or in the aggregate, reasonably likely
to have a Company Material Adverse Effect:
 
          (i) The Company is not, nor will it be as a result of the execution
     and delivery of this Agreement or the performance of its obligations
     hereunder, in violation of any licenses, sublicenses and other Contracts as
     to which the Company is a party and pursuant to which the Company is
     authorized to use any third-party patents, trademarks, tradenames, service
     marks, and copyrights ("Third-Party Intellectual Property Rights").
 
          (ii) No claims with respect to (A) the patents, registered and
     material unregistered trademarks and service marks, registered copyrights,
     tradenames, and any applications therefor owned by any Company Entity (the
     "Company Intellectual Property Rights"); (B) any trade secret material to
     the Company; or (C) Third-Party Intellectual Property Rights are currently
     pending or, to the Knowledge of the Company, are threatened by any Person.
 
          (iii) The Company has no Knowledge of any valid grounds for any bona
     fide claims (A) to the effect that the sale, licensing or use of any
     product as now used, sold or licensed or proposed for use, sale or license
     by any Company Entity infringes on any copyright, patent, trademark,
     service mark or trade secret; (B) against the use by any Company Entity of
     any trademarks, trade names, trade secrets, copyrights, patents,
     technology, know-how or computer software programs and applications used in
     the business of any Company Entity as currently conducted or as proposed to
     be conducted; (C) challenging the ownership, validity or effectiveness of
     any of the Company Intellectual Property Rights or other trade secret
     material to the Company; or (D) challenging the license or legally
     enforceable right to use of the Third-Party Intellectual Rights by any
     Company Entity.
 
          (iv) To the Knowledge of the Company, there is no unauthorized use,
     infringement or misappropriation of any of the Company Intellectual
     Property Rights by any third party, including any employee or former
     employee of any Company Entity.
 
     5.13  MATERIAL CONTRACTS.  All of the material Contracts of the Company
Entities that are required to be described in the Company Reports or to be filed
as exhibits thereto (the "Material Contracts") are described in the Company
Reports or filed as exhibits thereto and are in full force and effect. True and
complete copies of all such Material Contracts have been delivered or have been
made available by the Company to Parent. Neither any Company Entity nor any
other party is in Default under any such Material Contract except for such
Defaults as are not, individually or in the aggregate, reasonably likely to have
a Company Material Adverse Effect. No Company Entity is party to any Contract
containing any provision or covenant limiting in any manner the ability of any
Company Entity to (a) sell any products or services of or to any other person,
(b) engage in any line of business, or (c) compete with or to obtain products or
services from any Person or limiting the ability of any Person to provide
products or services to any Company Entity.
 
     5.14  REAL PROPERTY.
 
     (a) Section 5.14(a) of the Company Disclosure Letter contains a list of all
parcels of real property owned by the Company Entities, including the Miami
Property (collectively, the "Owned Real Property"). The Company has good,
marketable and insurable fee simple title to all of the Owned Real Property,
including the Improvements thereon, free and clear of all Liens and other
imperfections of title, except Permitted Title Exceptions. The Company is the
lessor or landlord or the successor lessor or landlord under the Space Leases
free and clear of all Liens except for the Commission Agreements and the
Permitted Title Exceptions and is entitled to receive the rents, issues and
profits from the Space Leases. Without limiting the foregoing, the
 
                                      A-11
<PAGE>   48
 
Space Leases are free and clear of any and all Liens, and the Company has made
no assignment of any of the rights of the Company under any of the Space Leases
or with respect to any of said rents, issues or profits, except as set forth in
the Commission Agreements and the Permitted Title Exceptions, and except as to
any holders of any Liens to be released and canceled at as of the Effective
Time. The Company has delivered to Parent a true and complete copy of the Rent
Roll for the Miami Property, and the Company has no Knowledge that any tenant
listed thereon who currently leases a material portion of the Miami Property has
(i) plans to terminate such tenant's Space Lease, (ii) has commenced a voluntary
case, or had entered against it a petition, for relief under any Law relating to
bankruptcy or insolvency, or (iii) has asserted a right to off-set rent by
reason of the Company's failure to perform its obligations under a Space Lease.
The Miami Property contains not less than 1 million rentable square feet within
the current Improvements thereon.
 
     (b) The Owned Real Property and all Improvements thereon, in all material
respects, conform to and comply with all applicable Laws, including those
relating to zoning, fire, health, building, handicapped persons, sanitation, use
and occupancy. The Company has obtained all material Permits required for the
Owned Real Property, all of which are currently in full force and effect. The
Improvements on the Owned Real Property (i) are properly located within the
boundaries of the Owned Real Property and in accordance with all applicable
set-back restrictions, (ii) are free from all material engineering and
structural defects, (iii) are free from all termites or other wood-destroying
insects, and (iv) do not contain any asbestos or asbestos-containing materials.
No portion of the Improvements located on the Owned Real Property has been
damaged or destroyed by fire or other casualty.
 
     (c) To the Company's Knowledge, no portion of the Owned Real Property is
currently subject to any Condemnation Proceeding and no Condemnation Proceeding
has been commenced or instituted against any portion of the Owned Real Property.
 
     (d) The Acreage (i) contains approximately four acres of vacant land, and
(ii) has all necessary and appropriate zoning designations, ingress and egress,
and utility access, and is otherwise suitable in all material respects, for
commercial development in a manner consistent with the development that exists
on the remainder of the Miami Property.
 
     (e) Section 5.14(e) of the Company Disclosure Letter contains a list of all
parcels of real property leased by any of the Company Entities as lessee
(collectively, the "Leased Real Property"). Each of such leases is in full force
and effect, no Company Entity is in material Default under any material
provisions of such lease, and no lessor has asserted that any Company Entity is
in material Default of any material provision under any such lease.
 
     (f) Each Company Entity has complied in all material respects with all
applicable Environmental Laws; (ii) the properties currently owned or operated
by the Company (including soils, groundwater, surface water, buildings or other
structures) are not contaminated with any Hazardous Substances; (iii) the
properties formerly owned or operated by any Company Entity were not
contaminated with Hazardous Substances during the period of ownership or
operation by such Company Entity; (iv) no Company Entity is subject to Liability
for any Hazardous Substance disposal or contamination on any third party
property; (v) no Company Entity has been associated with any release or threat
of release of any Hazardous Substance; (vi) no Company Entity has received any
notice, demand, letter, claim or request for information alleging that any
Company Entity may be in violation of or liable under any Environmental Law;
(vii) no Company Entity is subject to any Orders or other arrangements with any
Regulatory Authority or is subject to any indemnity or other agreement with any
third party relating to Liability under any Environmental Law or relating to
Hazardous Substances; and (viii) there are no circumstances or conditions
involving any Company Entity that could reasonably be expected to result in any
Liability, investigations or restrictions on the ownership, use or transfer of
any property of the Company pursuant to any Environmental Law, except in each of
clauses (i) through (viii) as are not, individually or in the aggregate,
reasonably likely to have a material adverse effect on the fair market value of
the Owned Real Property.
 
                                      A-12
<PAGE>   49
 
     5.15  OTHER ASSETS.
 
     (a) With respect to all Assets other than the Real Property, the Company
Entities have good and marketable title, free and clear of all Liens, except as
would not be reasonably likely to have, individually or in the aggregate, a
Company Material Adverse Effect. To the Company's Knowledge, all tangible
properties used in the businesses of the Company Entities are in good condition,
reasonable wear and tear excepted, and are usable in the ordinary course of
business consistent with the Company's past practices.
 
     (b) All Assets (other than the Real Property) that are material to the
Company's business on a consolidated basis, and that are held under leases or
subleases by any of the Company Entities, are held under valid Contracts
enforceable in accordance with their respective terms (except as enforceability
may be limited by the Bankruptcy and Equity Exception), and each such Contract
is in full force and effect.
 
     (c) The Company Entities currently maintain insurance similar in amounts,
scope, and coverage to that maintained by other peer organizations. None of the
Company Entities has received written notice from any insurance carrier that (i)
any policy of insurance will be canceled or that coverage thereunder will be
reduced or eliminated, or (ii) premium costs with respect to such policies of
insurance will be substantially increased. There are presently no claims for
amounts exceeding in any individual case $1 million pending under such policies
of insurance and no notices of claims in excess of such amounts have been given
by any Company Entity under such policies.
 
     (d) The Assets (including the Real Property) of the Company Entities
include all Assets required to operate the business of the Company Entities as
presently conducted, except as would not be reasonably likely to have,
individually or in the aggregate, a Company Material Adverse Effect.
 
     5.16  INSURANCE MATTERS.
 
     (a) All policies, binders, slips, certificates, annuity contracts and
participation agreements and other agreements of insurance, whether individual
or group, in effect as of the date hereof (including all applications,
supplements, endorsements, riders and ancillary agreements in connection
therewith) that are issued by the Company Insurance Subsidiaries (the "Company
Insurance Contracts"), and any and all marketing materials, are, to the extent
required under applicable Law, on forms approved by applicable insurance
Regulatory Authorities or which have been filed and not objected to by such
authorities within the period provided for objection, and such forms comply in
all material respects with the Insurance Laws applicable thereto and, as to
premium rates established by any Company Insurance Subsidiary that are required
to be filed with or approved by insurance Regulatory Authorities, the rates have
been so filed or approved, the premiums charged conform thereto in all material
respects, and such premiums comply in all material respects with the Insurance
Laws applicable thereto.
 
     (b) Section 5.16(b) lists all of the reinsurance and coinsurance treaties
or agreements, including retrocessional agreements, to which the Company or any
Company Insurance Subsidiary is a party or under which the Company or any
Company Insurance Subsidiary has any existing rights, obligations or Liabilities
(collectively, the "Reinsurance Contracts"). All of the Reinsurance Contracts
are in full force and effect, and neither the Company nor any Company Insurance
Subsidiary, nor, to the Knowledge of the Company, any other party to a
Reinsurance Contract, is in Default in any material respect as to any provision
thereof. No Reinsurance Contract contains any provision providing that the other
party thereto may terminate such Reinsurance Contract by reason of the
transactions contemplated by this Agreement. Neither the Company nor any Company
Insurance Subsidiary has received any notice to the effect that the financial
condition of any other party to any such Reinsurance Contract is impaired with
the result that a Default thereunder may reasonably be anticipated, whether or
not such Default may be cured by the operation of any offset clause in such
Reinsurance Contract.
 
     (c) Prior to the date hereof, the Company has delivered or made available
to Parent a true and complete copy of any material actuarial reports prepared by
actuaries, independent or otherwise, with respect to any Company Insurance
Subsidiary since December 31, 1994, and all attachments, addenda, supplements
and modifications thereto (the "Company Actuarial Analyses"). The information
and data furnished by the Company or any Company Insurance Subsidiary to its
independent actuaries in connection with the
                                      A-13
<PAGE>   50
 
preparation of the Company Actuarial Analyses were accurate in all material
respects. Furthermore, to the Knowledge of the Company, each Company Actuarial
Analysis was based upon an accurate inventory of policies in force for the
Company Insurance Subsidiaries at the relevant time of preparation, was prepared
using appropriate modeling procedures accurately applied and in conformity with
generally accepted actuarial standards consistently applied, and the projections
contained therein were properly prepared in accordance with the assumptions
stated therein.
 
     (d) None of Standard & Poor's Corporation, Moody's Investors Service, Inc.
or A.M. Best Company has announced that it has under surveillance or review its
rating of the financial strength or claims-paying ability of any Company
Insurance Subsidiary, and the Company has no reason to believe that any rating
presently held by the Company Insurance Subsidiaries is likely to be modified,
qualified, lowered or placed under such surveillance for any reason, including
as a result of the transactions contemplated hereby.
 
     (e) All annuity contracts and life insurance policies issued by each
Company Insurance Subsidiary to an annuity holder domiciled in the United States
satisfy in all material respects all definitional or other requirements for
qualification under the Code section applicable (or intended to be applicable)
to such annuity contracts or life insurance policies, and none of the Company
Insurance Subsidiaries have entered into any Contract or are involved in any
discussions or negotiations and there are no audits, examinations,
investigations or other proceedings with the IRS with respect to the failure of
any life insurance policy under section 7702 or 817(h) of the Code or the
failure of any annuity contract to meet the requirements of section 72(s) of the
Code. There are no "hold harmless" indemnification agreements respecting the tax
qualification or treatment of any product or plan sold, issued, entered into or
administered by the Company Insurance Subsidiaries, and there have been no
claims asserted by any Person under such "hold harmless" indemnification
agreements so set forth.
 
     5.17  LIABILITIES AND RESERVES.
 
     (a) The reserves carried on the Company SAP Statements of each Company
Insurance Subsidiary for future insurance policy benefits, losses, claims and
similar purposes were, as of the respective dates of such Company SAP
Statements, in compliance in all material respects with the requirements for
reserves established by the insurance Regulatory Authority of the state of
domicile of such Company Insurance Subsidiary, were determined in all material
respects in accordance with generally accepted actuarial standards and
principles consistently applied, and were fairly stated in all material respects
in accordance with sound actuarial and statutory accounting principles. Such
reserves were adequate in the aggregate to cover the total amount of all
reasonably anticipated Liabilities of the Company and each Company Insurance
Subsidiary under all outstanding insurance, reinsurance and other applicable
agreements as of the respective dates of such Company SAP Statements. The
admitted assets of each Company Insurance Subsidiary as determined under
applicable Laws are in an amount at least equal to the minimum amounts required
by applicable Laws. In addition, the Company has delivered or made available to
Parent copies of all material work papers used as the basis for establishing the
reserves for the Company and the Company Insurance Subsidiaries at December 31,
1995, December 31, 1996 and September 30, 1997, respectively.
 
     (b) Except for regular periodic assessments in the ordinary course of
business or assessments based on developments which are publicly known within
the insurance industry, to the Knowledge of the Company, no claim or assessment
is pending or threatened against any Company Insurance Subsidiary which is
peculiar or unique to such Company Insurance Subsidiary by any state insurance
guaranty associations in connection with such association's fund relating to
insolvent insurers (or similar state assessment authority) which, if determined
adversely, would, individually or in the aggregate, be reasonably likely to have
a Company Material Adverse Effect.
 
     5.18  INVESTMENT COMPANY.  None of the Company Insurance Subsidiaries
maintains any separate accounts. No Company Entity conducts activities of or is
otherwise deemed under applicable Law to control an "investment advisor" as such
term is defined in Section 2(a)(20) of the Investment Company Act of 1940, as
amended (the "Investment Company Act"), whether or not registered under the
Investment Advisers Act of 1940, as amended. No Company Entity is an "investment
company" as defined under the Investment Company Act, and no Company Entity
sponsors any Person that is such an investment company.
                                      A-14
<PAGE>   51
 
     5.19  RIGHTS PLAN.
 
     (a) Prior to Parent entering into this Agreement and the Stock Option
Agreement, the Company has taken all actions necessary such that, for all
purposes under the Rights Agreement, Parent shall not be deemed an Acquiring
Person (as defined in the Rights Agreement), the Distribution Date (as defined
in the Rights Agreement) shall not be deemed to occur and the rights issuable
pursuant to the Rights Agreement will not separate from the Company Common
Stock, as a result of Parent's entering into this Agreement or the Stock Option
Agreement, or consummating the Merger or the other transactions contemplated
hereby or thereby.
 
     (b) The Company has taken all necessary action with respect to all of the
outstanding Rights so that, as of immediately prior to the Effective Time, (i)
neither the Company nor Parent will have any obligations under the Rights or the
Rights Agreement and (ii) the holders of the Rights will have no rights under
the Rights or the Rights Agreement.
 
     5.20  STATE TAKEOVER STATUTES.  Each Company Entity has taken all necessary
action to exempt the transactions contemplated by this Agreement and the Stock
Option Agreement from, or if necessary to challenge the validity or
applicability of, any applicable "moratorium," "fair price," "business
combination," "control share," or other anti-takeover Laws (collectively,
"Takeover Laws").
 
     5.21  CHARTER PROVISIONS.  Each Company Entity has taken all action so that
the entering into of this Agreement and the Stock Option Agreement, and the
consummation of the Merger and the other transactions contemplated by this
Agreement and the Stock Option Agreement, do not and will not result in the
grant of any rights to any Person under the Certificate of Incorporation, Bylaws
or other governing instruments of any Company Entity or restrict or impair the
ability of Parent or any of its Subsidiaries to vote, or otherwise to exercise
the rights of a stockholder with respect to, shares of any Company Entity that
may be directly or indirectly acquired or controlled by them.
 
     5.22   [INTENTIONALLY OMITTED]
 
     5.23  BROKERS AND FINDERS.  No Company Entity nor any of their officers,
directors or employees has employed any broker or finder or incurred any
liability for any brokerage fees, commissions or finders, fees in connection
with the Merger or the other transactions contemplated in this Agreement, except
that the Company has employed Credit Suisse First Boston Corporation as its
financial advisor, the arrangements with which have been disclosed to Parent
prior to the date hereof.
 
     5.24  STATEMENTS TRUE AND CORRECT.  No statement, certificate, instrument,
or other writing furnished or to be furnished by any Company Entity or any
Affiliate thereof to Parent pursuant to this Agreement or any other document,
agreement, or instrument referred to herein contains or will contain any untrue
statement of material fact or will omit to state a material fact necessary to
make the statements therein, in light of the circumstances under which they were
made, not misleading. None of the information supplied or to be supplied by any
Company Entity or any Affiliate thereof for inclusion in the Proxy Statement to
be mailed to the Company's stockholders in connection with the Stockholders'
Meeting, and any other documents to be filed by a Company Entity or any
Affiliate thereof with the SEC or any other Regulatory Authority in connection
with the transactions contemplated hereby, will, at the respective time such
documents are filed, and with respect to the Proxy Statement, when first mailed
to the stockholders of the Company, be false or misleading with respect to any
material fact, or omit to state any material fact necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading, or, in the case of the Proxy Statement or any amendment thereof
or supplement thereto, at the time of the Stockholders' Meeting, be false or
misleading with respect to any material fact, or omit to state any material fact
necessary to correct any statement in any earlier communication with respect to
the solicitation of any proxy for the Stockholders' Meeting. All documents that
any Company Entity or any Affiliate thereof is responsible for filing with any
Regulatory Authority in connection with the transactions contemplated hereby
will comply as to form in all material respects with the provisions of
applicable Law.
 
                                      A-15
<PAGE>   52
 
                                   ARTICLE 6
 
                    REPRESENTATIONS AND WARRANTIES OF PARENT
 
     Parent hereby represents and warrants to the Company as follows:
 
     6.1  ORGANIZATION, GOOD STANDING AND QUALIFICATION.  Parent is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Nevada. Parent has all requisite corporate or similar power and
authority to own and operate its Assets and to carry on its business as
presently conducted and is qualified to do business and is in good standing as a
foreign corporation in each jurisdiction where the ownership or operation of its
Assets or conduct of its business requires such qualification, except where the
failure to be so qualified or in good standing, when taken together with all
other such failures, is not reasonably likely to have a Parent Material Adverse
Effect. Parent has made available to the Company a complete and correct copy of
Parent's Articles of Incorporation and Bylaws, each as amended to date. Parent's
Articles of Incorporation and Bylaws so delivered are in full force and effect.
 
     6.2  CORPORATE AUTHORITY; APPROVAL.
 
     (a) Parent has all requisite corporate power and authority, and has taken
all corporate action necessary in order, to execute, deliver and perform its
obligations under this Agreement and the Stock Option Agreement and to
consummate the transactions contemplated hereby and thereby, subject only to
receipt of the approvals referred to in Section 6.3. This Agreement and the
Stock Option Agreement are the valid and binding agreements of Parent
enforceable against Parent in accordance with their terms, subject to the
Bankruptcy and Equity Exception.
 
     (b) The board of directors of Parent (i) has declared that the Agreement
and the Stock Option Agreement, and the Merger and the other transactions
contemplated hereby and thereby, are advisable and in the best interests of
Parent, and (ii) has authorized, approved and adopted in all respects the
Agreement and the Stock Option Agreement, and the Merger and the other
transactions contemplated hereby and thereby.
 
6.3  GOVERNMENTAL FILINGS; NO VIOLATIONS.
 
     (a) Other than the filings, notices and Consents (i) pursuant to Section
1.3, (ii) under the HSR Act, and (iii) the filing of appropriate documents with,
and approval of, the respective Commissioners of Insurance or similar Regulatory
Authorities of Bermuda, Florida, Minnesota, Nevada, Ohio and Texas, and such
filings, notices or Consents as may be required under the antitrust notification
insurance laws of any state in which the Company, Parent or any of their
respective Subsidiaries is domiciled or does business, no notices, reports or
other filings are required to be made by any Parent Entity with, nor are any
Consents, registrations or Permits required to be obtained by any Parent Entity
from, any Regulatory Authority, in connection with the execution and delivery of
this Agreement and the Stock Option Agreement by Parent and the consummation by
Parent of the Merger and the other transactions contemplated hereby and thereby,
except those that the failure to make or obtain are not, individually or in the
aggregate, reasonably likely to have a Parent Material Adverse Effect or
prevent, materially delay or materially impair the ability of Parent to
consummate the transactions contemplated by this Agreement and the Stock Option
Agreement.
 
     (b) The execution, delivery and performance of this Agreement and the Stock
Option Agreement by Parent do not, and the consummation by Parent of the Merger
and the other transactions contemplated hereby and thereby will not, constitute
or result in (i) a Default under the Articles of Incorporation or Bylaws of
Parent, (ii) a Default under, or the creation of a Lien on the Assets of Parent
(with or without notice, lapse of time or both) pursuant to, any Contract
binding upon Parent or (provided, as to consummation, the filings and notices
are made, and approvals are obtained, as referred to in Section 6.3(a)), any
Law, Order or Permit to which Parent is subject, or (iii) any change in the
rights or obligations of any party under any of the foregoing Contracts, except,
in the case of clause (ii) or (iii) immediately above, for any Default, creation
of Lien or change that, individually or in the aggregate, is not reasonably
likely to have a Parent Material Adverse Effect or prevent, materially delay or
materially impair the ability of Parent to consummate the transactions
contemplated by this Agreement or the Stock Option Agreement. To the Knowledge
of Parent, there are no
 
                                      A-16
<PAGE>   53
 
Contracts of Parent pursuant to which Consents are or may be required prior to
consummation of the transactions contemplated by this Agreement and the Stock
Option Agreement (whether or not subject to the exception set forth with respect
to clauses (ii) and (iii) immediately above), except those the failure to
obtain, individually or in the aggregate, are not reasonably likely to have a
Parent Material Adverse Effect.
 
     6.4  COMPLIANCE WITH LAWS, ORDERS AND PERMITS.  The business and operations
of Parent have not been, and are not being, conducted in violation of any
applicable Law, Order or Permit, except for violations or possible violations
that are not, individually or in the aggregate, reasonably likely to have a
Parent Material Adverse Effect or prevent or materially burden or materially
impair the ability of Parent to consummate the transactions contemplated by this
Agreement. No investigation or review by any Regulatory Authority with respect
to Parent is pending or, to the Knowledge of Parent, threatened, nor, to the
Knowledge of Parent, has any Regulatory Authority indicated an intention to
conduct the same, except for those the outcome of which are not, individually or
in the aggregate, reasonably likely to have a Parent Material Adverse Effect or
prevent or materially burden or materially impair the ability of Parent to
consummate the transactions contemplated by this Agreement.
 
     6.5  LITIGATION.  There is no Litigation instituted or pending or, to the
Knowledge of Parent, threatened (or unasserted but considered probable of
assertion and which if asserted would have at least a reasonable probability of
an unfavorable outcome) against any Parent Entity, or against any director or
officer of any Parent Entity, or against any Asset, interest or right of any of
them, nor are there any Orders of any Regulatory Authorities, other governmental
authorities or arbitrators outstanding against any Parent Entity, in each case,
except for those that are not, individually or in the aggregate, reasonably
likely to have a Parent Material Adverse Effect or prevent or materially delay
or materially impair the ability of Parent to consummate the transactions
contemplated by this Agreement or by the Stock Option Agreement.
 
     6.6  STATEMENTS TRUE AND CORRECT.  No statement, certificate, instrument or
other writing furnished or to be furnished by any Parent Entity or any Affiliate
thereof to the Company pursuant to this Agreement or any other document,
agreement or instrument referred to herein contains or will contain any untrue
statement of material fact or will omit to state a material fact necessary to
make the statements therein, in light of the circumstances under which they were
made, not misleading. None of the information supplied or to be supplied by any
Parent Entity or any Affiliate thereof for inclusion in the Proxy Statement to
be mailed to the Company's stockholders in connection with the Stockholders'
Meeting, and any other documents to be filed by any Parent Entity or any
Affiliate thereof with any Regulatory Authority in connection with the
transactions contemplated hereby, will, at the respective time such documents
are filed, and with respect to the Proxy Statement, when first mailed to the
stockholders of the Company, be false or misleading with respect to any material
fact, or omit to state any material fact necessary to make the statements
therein, in light of the circumstances under which they were made, not
misleading, or, in the case of the Proxy Statement or any amendment thereof or
supplement thereto, at the time of the Stockholders' Meeting, be false or
misleading with respect to any material fact, or omit to state any material fact
necessary to correct any statement in any earlier communication with respect to
the solicitation of any proxy for the Stockholders' Meeting. All documents that
any Parent Entity or any Affiliate thereof is responsible for filing with any
Regulatory Authority in connection with the transactions contemplated hereby
will comply as to form in all material respects with the provisions of
applicable Law.
 
     6.7  AUTHORITY OF MERGER SUB.  Merger Sub is a corporation duly organized,
validly existing and in good standing under the Laws of the State of Delaware as
a wholly owned Subsidiary of Parent. The authorized capital stock of Merger Sub
consists of 1,000 shares of Merger Sub Common Stock, all of which is validly
issued and outstanding, fully paid and nonassessable and is owned by Parent free
and clear of any Lien. Merger Sub has the corporate power and authority
necessary to execute, deliver and perform its obligations under this Agreement
and to consummate the transactions contemplated hereby. The execution, delivery
and performance of this Agreement and the consummation of the transactions
contemplated hereby, including the Merger, have been duly and validly authorized
by all necessary corporate action in respect thereof on the part of Merger Sub.
This Agreement represents a legal, valid, and binding obligation of Merger Sub,
enforceable against Merger Sub in accordance with its terms (except in all cases
as such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, or similar Laws affecting the enforcement of
                                      A-17
<PAGE>   54
 
creditors' rights generally and except that the availability of the equitable
remedy of specific performance or injunctive relief is subject to the discretion
of the court before which any proceeding may be brought). Parent, as the sole
stockholder of Merger Sub, will vote prior to the Effective Time the shares of
Merger Sub Common Stock in favor of adoption of this Agreement, as and to the
extent required by applicable Law.
 
     6.8  FINANCING.  Parent has, or will have prior to the Closing Date,
sufficient cash, available lines of credit or other sources of immediately
available funds to enable it to make the aggregate cash payments required to be
paid pursuant to Section 3.1(b) and any other amounts to be paid by it
hereunder.
 
                                   ARTICLE 7
 
                                   COVENANTS
 
     7.1  INTERIM OPERATIONS.  The Company covenants and agrees as to itself and
its Subsidiaries that, after the date hereof and prior to the Effective Time
(unless Parent shall otherwise approve in writing, and except as otherwise
expressly contemplated by this Agreement or the Stock Option Agreement or set
forth in Section 7.1 of the Company Disclosure Letter):
 
          (a) The business of all Company Entities shall be conducted in the
     ordinary and usual course (it being understood and agreed that nothing
     contained herein shall permit the Company to enter into or engage in
     (through acquisition, product extension or otherwise) the business of
     selling any products or services materially different from existing
     products or services of the Company Entities or to enter into or engage in
     new lines of business without Parent's prior written approval), and it
     shall be conducted in compliance in all material respects with all
     applicable Laws.
 
          (b) To the extent consistent with (a) above, each Company Entity shall
     use all commercially reasonable efforts to preserve its business
     organization intact and maintain its existing relations and goodwill with
     customers, suppliers, reinsurers, distributors, creditors, lessors,
     employees and business associates, and maintain all Permits necessary for
     the Company Entities to conduct business in the jurisdictions in which they
     currently conduct business.
 
          (c) No Company Entity shall permit a material change in any of its
     underwriting, investment, actuarial, financial reporting or accounting
     practices or policies or in any material assumption underlying an actuarial
     practice or policy, except as may be required by any change in GAAP,
     statutory accounting principles or applicable Law.
 
          (d) The Company shall not (i) issue, sell, pledge, dispose of or
     encumber any capital stock owned by it in any of its Subsidiaries; (ii)
     amend its Certificate of Incorporation or Bylaws or amend, modify or
     terminate the Rights Agreement; (iii) split, combine or reclassify its
     outstanding shares of capital stock; (iv) authorize, declare, set aside or
     pay any dividend payable in cash, stock or property in respect of any
     capital stock other than (A) dividends from its direct or indirect wholly
     owned Subsidiaries, (B) regular quarterly cash dividends on the Company
     Common Stock not to exceed $.12 per share per quarter, and (C) regular
     semi-annual cash dividends required to be paid by the Company on the
     Company 9% Preferred Stock in accordance with the Company's Certificate of
     Incorporation; or (v) repurchase, redeem or otherwise acquire or permit any
     of its Subsidiaries to purchase or otherwise acquire, any shares of its
     stock or any securities convertible into or exchangeable or exercisable for
     any shares of its stock, other than as may be required pursuant to the
     terms of the Company Stock Plans.
 
          (e) No Company Entity shall (i) issue, sell, pledge, dispose of or
     encumber any shares of, or securities convertible into or exchangeable or
     exercisable for, or options, warrants, calls, commitments or rights of any
     kind to acquire, any shares of its capital stock of any class or any other
     property or assets (other than shares of Company Common Stock issuable
     pursuant to Company Options outstanding on the date hereof under any of the
     Company Stock Plans); (ii) other than in the ordinary and usual course of
     business, transfer, lease, license, guarantee, sell, mortgage, pledge,
     dispose of or encumber any other Assets (including capital stock of any of
     Company Subsidiary) or incur or modify any material indebtedness or other
     material Liability; (iii) make or authorize or commit for any capital
     expenditures
 
                                      A-18
<PAGE>   55
 
     other than in amounts not exceeding $1 million in the aggregate; (iv) by
     any means, make any acquisition of, or investment in, assets or stock of
     any other Person or entity, including by way of assumption reinsurance, in
     excess of $100,000 individually or $1 million in the aggregate (other than
     in connection with ordinary course investment activities); or (v) make any
     capital investment in or loan to NHP Holding Company, Inc. or any entity
     controlled by it.
 
          (f) No Company Entity shall terminate, establish, adopt, enter into,
     make any new grants or awards under, amend or otherwise modify, any
     Compensation and Benefit Plans, or increase the salary, wage, bonus or
     other compensation of any employees, except annual base salary (and
     corresponding benefit) increases occurring in the ordinary and usual course
     of business (which shall not exceed on an annual basis the lesser of 10% or
     $5,000 for any individual employee) or as required by applicable Law or
     under existing Contracts.
 
          (g) Each Company Entity shall use all commercially reasonable efforts
     to ensure that no payments are paid or become due under the change of
     control employment agreements listed in Section 5.6 of the Company
     Disclosure Letter.
 
          (h) No Company Entity shall pay, discharge, settle or satisfy any
     claims, Liabilities or obligations (absolute, accrued, asserted or
     unasserted, contingent or otherwise), other than the payment, discharge or
     satisfaction of (A) claims arising under the terms of products, contracts
     or policies issued by the Company Insurance Subsidiaries in the ordinary
     and usual course of business, and (B) such other claims, Liabilities or
     obligations (including Litigation) as shall not exceed $250,000 per claim.
 
          (i) No Company Entity shall make or change any material Tax election,
     settle any material audit, file any material amended Tax Returns or permit
     any insurance policy naming it as a beneficiary or loss-payable payee to be
     canceled or terminated except in the ordinary and usual course of business.
 
          (j) No Company Entity shall enter into any Contract containing any
     provision or covenant limiting in any material respect the ability of any
     Company Entity to (A) sell any products or services of or to any other
     Person, (B) engage in any line of business, or (C) compete with or to
     obtain products or services from any Person or limiting the ability of any
     Person to provide products or services to any Company Entity.
 
          (k) No Company Entity shall enter into any new quota share or other
     reinsurance transaction (A) that does not contain standard cancellation and
     termination provisions, (B) that, except in the ordinary course of
     business, materially increases or reduces the Company Insurance
     Subsidiaries' consolidated ratio of net written premiums to gross written
     premiums, or (C) pursuant to which $5 million or more in gross written
     premiums are ceded by the Company Insurance Subsidiaries to any Person
     other than a Company Entity.
 
          (l) No Company Entity shall enter into, amend or terminate any
     Material Contract (including for this purpose the Amended Shareholders
     Agreement, dated May 23, 1994, by and among JA Services, Inc., Dimension
     Holding Company, Inc. and NHP Holding Company, Inc.).
 
          (m) The Company Entities shall make new investments only in Qualified
     Investments.
 
          (n) The Company shall use all commercially reasonable efforts to
     ensure that there will be no downgrade in any Company Insurance
     Subsidiary's rating relating to its financial strength or claims-paying
     ability as published by A.M. Best Company.
 
          (o) No Company Entity shall take any action or omit to take any action
     that would cause any of the conditions set forth in Sections 8.2(a) or (b)
     not being satisfied (other than by waiver).
 
          (p) No Company Entity shall authorize or enter into a Contract to do
     any of the foregoing.
 
     7.2  ACQUISITION PROPOSALS.  The Company will not, and will not permit or
cause any of its Subsidiaries or any of the officers and directors of it or its
Subsidiaries to, and shall direct its and its Subsidiaries' employees and
Representatives not to, directly or indirectly, initiate, solicit, encourage or
otherwise facilitate any inquiries or the making of any proposal or offer with
respect to a merger, reorganization, share exchange,
                                      A-19
<PAGE>   56
 
consolidation or similar transaction involving, or any purchase of 15% or more
of the Assets or any equity securities of, the Company or any of its
Subsidiaries (any such proposal or offer being hereinafter referred to as an
"Acquisition Proposal"). The Company will not, and will not permit or cause any
of its Subsidiaries or any of the officers and directors of it or its
Subsidiaries to and shall direct its and its Subsidiaries' employees and
Representatives not to, directly or indirectly, engage in any negotiations
concerning, or provide any confidential information or data to, or have any
discussions with, any Person relating to an Acquisition Proposal, whether made
before or after the date of this Agreement, or otherwise facilitate any effort
or attempt to make or implement an Acquisition Proposal (including, without
limitation, by means of an amendment to the Rights Agreement); provided,
however, that nothing contained in this Agreement shall prevent the Company or
its Board of Directors from (i) complying with Rule 14e-2 promulgated under the
Exchange Act with regard to an Acquisition Proposal, or (ii) at any time after
the date hereof, if the Merger shall not have been approved by the Company
Requisite Vote as of such time, (A) providing information in response to a
request therefor by a Person who has made an unsolicited bona fide written
Acquisition Proposal if the Board of Directors receives from the Person so
requesting such information an executed confidentiality agreement on terms
substantially equivalent to those contained in the Parent Confidentiality
Agreement; (B) engaging in any negotiations or discussions with any Person who
has made an unsolicited bona fide written Acquisition Proposal; or (C)
recommending such an Acquisition Proposal to the stockholders of the Company, if
and only to the extent that, (i) in each such case referred to in clause (A),
(B) or (C) above, the Board of Directors of the Company determines in good faith
after consultation with outside legal counsel that such action is necessary in
order for its directors to comply with their respective fiduciary duties under
applicable Law and (ii) in each case referred to in clause (B) or (C) above, the
Board of Directors of the Company determines in good faith (after consultation
with its financial advisor) that such Acquisition Proposal, if accepted, is
reasonably likely to be consummated, taking into account all legal, financial
and regulatory aspects of the proposal and the Person making the proposal and
would, if consummated, result in a more favorable transaction than the
transaction contemplated by this Agreement, taking into account, to the extent
relevant, the long-term prospects and interests of the Company and its
stockholders (any such more favorable Acquisition Proposal being referred to in
this Agreement as a "Superior Proposal"). The Company will immediately cease and
cause to be terminated any existing activities, discussions or negotiations with
any parties conducted heretofore with respect to any of the foregoing. The
Company agrees that it will take the necessary steps to inform promptly the
individuals or entities referred to in the first sentence hereof of the
obligations undertaken in this Section 7.2 and in the Confidentiality Agreement.
The Company will notify Parent immediately if any such inquiries, proposals or
offers are received by, any such information is requested from, or any such
discussions or negotiations are sought to be initiated or continued with, any of
its or its Subsidiaries' directors, employees or Representatives indicating, in
connection with such notice, the name of such Person and the material terms and
conditions of any proposals or offers and thereafter shall keep Parent informed,
on a current basis, on the status and terms of any such proposals or offers and
the status of any such negotiations or discussions. The Company also will
promptly request each Person that has heretofore executed a confidentiality
agreement in connection with its consideration of an Acquisition Proposal to
return or destroy all confidential information heretofore furnished to such
Person by or on behalf of it or any of its Subsidiaries.
 
     7.3  STOCKHOLDERS' MEETING.  The Company will take, in accordance with its
Certificate of Incorporation and Bylaws and the DGCL, all action necessary to
convene a meeting of holders of the Company Common Stock (the "Stockholders'
Meeting") as promptly as practicable, but in no event more than 45 days, after
the definitive Proxy Statement has been filed with the SEC, to consider and vote
upon the adoption of this Agreement. Subject to fiduciary obligations under
applicable Law, the Company's board of directors shall recommend such adoption,
shall not withdraw or modify such recommendation and shall take all lawful
action to solicit such adoption. Without limiting the generality of the
foregoing, in the event that the Company's board of directors withdraws or
modifies its recommendation, the Company nonetheless shall cause the
Stockholders Meeting to be convened and a vote taken with respect to the
adoption of this Agreement.
 
     7.4  FILINGS; OTHER ACTIONS; NOTIFICATION.
 
     (a) In connection with the Stockholders' Meeting, the Company shall prepare
and deliver to Parent within 30 days after the date hereof a draft of the Proxy
Statement. Thereafter, the Company and Parent shall
 
                                      A-20
<PAGE>   57
 
cooperate fully to make such changes to the Proxy Statement as may be
appropriate, file the Proxy Statement with the SEC as soon as practicable, and
respond promptly to any SEC comments. Upon filing the final, definitive Proxy
Statement with the SEC, the Company shall mail such Proxy Statement to its
stockholders.
 
     (b) The Company and Parent shall cooperate with each other and use (and
shall cause their respective Subsidiaries to use) all commercially reasonable
efforts (i) to do or cause to be done all things necessary, proper or advisable
on its part under this Agreement and applicable Laws to consummate and make
effective the Merger and the other transactions contemplated by this Agreement
as soon as practicable, including preparing and filing as promptly as
practicable all documentation to effect all necessary notices, reports and other
filings; and (ii) to obtain as promptly as practicable all Consents and Permits
necessary or advisable to be obtained from any third party or any Regulatory
Authority in connection with, as a result of, or in order to consummate, the
Merger or any of the other transactions contemplated by this Agreement;
provided, however, that nothing in this Section 7.4 shall require, or be
construed to require, Parent, in connection with the receipt of any regulatory
approval or Consent, to proffer to, or agree to (i) sell or hold separate and
agree to sell or to discontinue or to limit, before or after the Effective Time,
any Assets, businesses or interest in any Assets or businesses of Parent, the
Company or any of their respective Affiliates (or to consent to any sale, or
agreement to sell, or discontinuance or limitation by Parent or the Company of
any of its Assets or businesses), or (ii) agree to any conditions relating to,
or changes or restriction in, the operations of any such Asset or businesses
which, in either case, could, in the reasonable judgment of the board of
directors of Parent, materially and adversely impact the economic or business
benefits to Parent of the transactions contemplated by this Agreement. Subject
to applicable Laws relating to the exchange of information, Parent and the
Company shall have the right to review in advance, and to the extent practicable
each will consult the other on, all the information relating to Parent or the
Company, as the case may be, and any of their respective Subsidiaries, that
appear in any filing made with, or written materials submitted to, any third
party or Regulatory Authority in connection with the Merger and the other
transactions contemplated by this Agreement. In exercising the foregoing right,
each of the Company and Parent shall act reasonably and as promptly as
practicable.
 
     (c) The Company and Parent each shall, upon request by the other, furnish
the other with all information concerning itself, its Subsidiaries, directors,
officers and stockholders and such other matters as may be reasonably necessary
or advisable in connection with the Proxy Statement or any other statement,
filing, notice or application made by or on behalf of Parent, the Company or any
of their respective Subsidiaries to any third party or Regulatory Authority in
connection with the Merger and the transactions contemplated by this Agreement.
 
     (d) The Company and Parent each shall keep the other apprised of the status
of matters relating to completion of the transactions contemplated hereby,
including promptly furnishing the other with copies of notices or other
communications received by Parent or the Company, as the case may be, or any of
its Subsidiaries, from any third party or Regulatory Authority with respect to
the Merger and the other transactions contemplated by this Agreement. The
Company and Parent each shall give prompt notice to the other of any change that
is reasonably likely to result in a Company Material Adverse Effect or Parent
Material Adverse Effect, respectively.
 
     7.5  ACCESS; TECHNOLOGY CONVERSIONS.
 
     (a) Upon reasonable notice, and except as may otherwise be required by
applicable Law, all of the Company Entities shall afford Parent's officers,
employees and Representatives access, during normal business hours throughout
the period from the date hereof to the earlier of the termination of this
Agreement or the Effective Time, to the personnel, properties, Contracts, books
and records of the Company Entities and, during such period the Company Entities
shall furnish promptly to Parent all information concerning the Company
Entities' business and financial condition as may reasonably be requested,
provided that no investigation pursuant to this Section shall affect or be
deemed to modify any representation or warranty made by the Company and,
provided, further, that the foregoing shall not require the Company to permit
any inspection, or to disclose any information, that in the reasonable judgment
of the Company would result in the disclosure of any trade secrets of third
parties or violate any of its obligations with respect to confidentiality if
 
                                      A-21
<PAGE>   58
 
the Company shall have used all reasonable efforts to obtain the Consent of such
third party to such inspection or disclosure. All such information shall be
governed by the terms of the Confidentiality Agreement.
 
     (b) From the date hereof through the earlier of termination of this
Agreement or the Effective Time, the Company shall permit Parent to use an
office within the Company's offices at the Miami Property to afford Parent's
internal auditors reasonable access to monitor the operations and financial
activities of the Company Entities. In addition, the Company Entities shall
cooperate with Parent, upon Parent's reasonable request, to develop plans for
the integration of the business of the Company Entities with that of the Parent
Entities.
 
     (c) From the date hereof through the earlier of termination of this
Agreement or the Effective Time, the Company Entities shall promptly take all
commercially reasonable actions as may be necessary to assure that the Company
Entities' computer software systems are able to become Year 2000 compliant on a
timely basis acting in the ordinary course of business. In addition, from the
date hereof through the earlier of termination of this Agreement or the
Effective Time, the Company Entities shall permit Parent's officers, employees
and Representatives to be involved to the extent reasonably requested by Parent,
in the conversion of the Company Entities' computer software systems to systems
that are Year 2000 compliant, and the Company shall use all commercially
reasonable efforts to comply with all reasonable requests of Parent in respect
of the design and implementation of such conversion in anticipation of
consummation of the Merger. Notwithstanding the foregoing, all final decisions
with respect to such conversion design and implementation shall be made by the
appropriate Company Entity. In the event that this Agreement is terminated and
the Merger is not consummated for any reason, neither Party shall have any
Liability to the other with respect to the involvement of Parent's officers,
employees and Representatives in such conversion project.
 
     7.6  MIAMI PROPERTY.  Without limiting the generality of Section 7.1 or
7.5:
 
          (a) Access Rights for Inspections.  From the date hereof until the
     earlier of the Effective Time or the termination of this Agreement, the
     Company shall provide Parent and its employees and Representatives with
     access to the Miami Property at all reasonable times during normal business
     hours (and during evenings, weekends and holidays, provided that Parent has
     a reasonable need for such off-hours access and has given the Company not
     less than 24 hours prior notice of such need for access) to inspect the
     Miami Property and make such studies, audits, tests, appraisals, surveys
     and verifications as Parent reasonably considers necessary with respect to
     the Miami Property, including, investigations of the legal and physical
     status of the Miami Property, tests and assessments with respect to
     environmental matters, soil tests, asbestos analysis, structural review,
     examination of title, preparation of a survey and interviews of tenants.
 
          (b) Title and Survey Update.  At Parent's reasonable request, the
     Company shall cooperate to assist Parent in obtaining, at or prior to the
     Effective Time, a title insurance policy with respect to the Miami
     Property, or an update or endorsement to an existing such title insurance
     policy.
 
          (c) Permits and Zoning.  The Company shall use commercially reasonable
     efforts to preserve in force all existing Permits with respect to the Miami
     Property and to renew all such Permits expiring prior to the Effective Time
     on terms reasonably acceptable to Parent. If any such Permit shall be
     suspended or revoked, the Company shall promptly notify Parent and shall
     diligently take all measures reasonably necessary to cause the
     reinstatement of such Permit without any additional limitation or
     condition. The Company shall not seek or voluntarily allow any amendment to
     any Permit with respect to the Miami Property that would alter the existing
     permissible uses of the Miami Property or any part thereof. Without the
     prior written consent of Parent, the Company shall not apply for, consent
     to or promote any modification of any zoning restrictions or other
     restrictions or regulations of Regulatory Authorities with respect to the
     Miami Property.
 
          (d) Estoppels.  At Parent's request, the Company shall use
     commercially reasonable efforts to obtain and deliver to Parent, at or
     prior to the Effective time, with respect to the Miami Property (i)
     estoppel certificates executed by each party (other than the Company) to a
     Service Contract that is not cancelable upon thirty days after written
     notice from the owner of the Miami Property, which estoppel certificates
     shall in form and substance reasonably approved by Parent, (ii) estoppel
     certificates
 
                                      A-22
<PAGE>   59
 
     executed by each warrantor or guarantor under a Warranty, which estoppel
     certificates shall be in form and substance reasonably approved by Parent,
     and (iii) such other estoppel certificates reasonably requested by Parent,
     in form and substance reasonably approved by Parent, in connection with
     covenants, conditions and restrictions, reciprocal easement agreements
     encumbering the Miami Property.
 
     7.7  PUBLICITY.  The initial press release with respect to the Merger and
the transactions contemplated hereby shall be a joint press release, and
thereafter the Company and Parent each shall consult with each other prior to
issuing any press releases or otherwise making public announcements with respect
to the Merger and the other transactions contemplated by this Agreement, except
as may be required by Law or the rules of the NYSE.
 
     7.8  EMPLOYEE BENEFITS.  From and after the Effective Time, all employees
of the Company Entities (the "Employees") shall be eligible to participate in
Parent's employee benefit plans, programs, policies and arrangements on the same
basis as similarly situated employees of Parent; provided, however, that, in
lieu of Parent's severance pay plan, Parent shall cause the Company's severance
pay plan as described in Section 5.8(a) of the Company Disclosure Letter to
remain in effect with respect to the Employees for the 12 months immediately
following the Effective Time. Parent shall, and shall cause the Company and its
Subsidiaries to, honor, pursuant to their terms, all employee benefit
obligations to current and former directors, officers, consultants and employees
under the Compensation and Benefits Plans, including, without limitation, all
employment, severance and compensation agreements of the Company and its
Subsidiaries. For purposes of all employee benefit plans, programs or
arrangements maintained or contributed to by Parent or any of its Subsidiaries,
in which the Employees shall be eligible to participate, Parent shall cause each
such plan, program or arrangement to treat the prior service with the Company or
its Subsidiaries of each Employee as service rendered to Parent and its
Subsidiaries for purposes of all eligibility periods, vesting and benefit
accruals thereunder (but not for purposes of benefit accruals under any defined
benefit pension plan maintained by Parent or its Subsidiaries (other than the
Company Entities)). No Employee (or eligible spouse or dependent) who elects to
be covered under a Parent medical insurance plan shall be excluded from coverage
under such plan on the basis of a pre-existing condition that was not also
excluded under the Company's or any of its Subsidiaries' medical insurance
plans. To the extent any such Employee has satisfied in whole or in part any
annual deductible or paid any out-of-pocket or co-payment expenses under a
medical insurance plan of the Company or any of its Subsidiaries for a plan
year, such individual shall be credited therefor under the corresponding
provisions of the corresponding plan of Parent and its Subsidiaries in which
such individual participates after the conversion date. Parent agrees that the
consummation of the Merger shall constitute a "Change in Control" of the Company
Entities for all purposes within the meaning of all Compensation and Benefit
Plans.
 
     7.9  EXPENSES.  Except as otherwise provided in Section 9.5, whether or not
the Merger is consummated, all costs and expenses incurred in connection with
this Agreement and the Merger and the other transactions contemplated by this
Agreement shall be paid by the party incurring such expense; provided, however,
that if the Merger is consummated, the Surviving Corporation shall pay all
charges and expenses, including those of the Exchange Agent, in connection with
the transactions contemplated in Article 4.
 
     7.10  INDEMNIFICATION; DIRECTORS' AND OFFICERS' INSURANCE.
 
     (a) From and after the Effective Time, Parent agrees that it will indemnify
and hold harmless each present and former director and officer of the Company
(when acting in such capacity), determined as of the Effective Time (each, an
"Indemnified Party" and, collectively, the "Indemnified Parties"), against any
costs or expenses (including reasonable attorneys' fees), judgments, fines,
losses, claims, damages or liabilities (collectively, "Costs") incurred in
connection with any claim, action, suit, proceeding or investigation, whether
civil, criminal, administrative or investigative, arising out of matters
existing or occurring at or prior to the Effective Time, whether asserted or
claimed prior to, at or after the Effective Time, to the fullest extent that the
Company would have been permitted under Delaware Law and its Certificate of
Incorporation or Bylaws in effect on the date hereof to indemnify such Person
(and Parent shall also advance expenses as incurred to the fullest extent
permitted under applicable Law provided the Person to whom expenses are advanced
provides a written affirmation of his or her good faith belief that the standard
of conduct necessary
 
                                      A-23
<PAGE>   60
 
for indemnification has been met, and an undertaking to repay such advances if
it is ultimately determined that such Person is not entitled to
indemnification).
 
     (b) Any Indemnified Party wishing to claim indemnification under paragraph
(a) of this Section 7.10, upon learning of any such claim, action, suit,
proceeding or investigation, shall promptly notify Parent thereof, but the
failure to so notify shall not relieve Parent of any Liability it may have to
such Indemnified Party if such failure does not materially prejudice Parent as
the indemnifying party. In the event of any such claim, action, suit, proceeding
or investigation (whether arising before or after the Effective Time), (i)
Parent or the Surviving Corporation shall have the right to assume the defense
thereof and Parent shall not be liable to such Indemnified Parties for any legal
expenses of other counsel or any other expenses subsequently incurred by such
Indemnified Parties in connection with the defense thereof, except that if
Parent or the Surviving Corporation elects not to assume such defense, or if
counsel for the Indemnified Parties advises that there are issues that raise
conflicts of interest between Parent or the Surviving Corporation and the
Indemnified Parties, the Indemnified Parties may retain counsel satisfactory to
them, and Parent or the Surviving Corporation shall pay all reasonable fees and
expenses of such counsel for the Indemnified Parties promptly as detailed
statements therefor are received; provided, however, that Parent shall be
obligated pursuant to this paragraph (b) to pay for only one firm of counsel for
all Indemnified Parties in any jurisdiction unless the use of one counsel for
such Indemnified Parties would present such counsel with a conflict of interest,
(ii) the Indemnified Parties will cooperate in the defense of any such matter,
and (iii) Parent shall not be liable for any settlement effected without its
prior written consent, which consent shall not be unreasonably withheld; and
provided, further, that Parent shall not have any obligation hereunder to any
Indemnified Party if and when a court of competent jurisdiction shall ultimately
determine, and such determination shall have become final and non-appealable,
that the indemnification of such Indemnified Party in the manner contemplated
hereby is prohibited by applicable Law.
 
     (c) Parent shall, or shall cause the Surviving Corporation to, maintain in
effect for a period of six years after the Effective Time the Company's existing
directors' and officers' liability insurance policy (provided that Parent may
substitute therefor (i) policies of at least the same coverage and amounts,
containing terms and conditions that are no less advantageous, which policies
are issued by an issuer with a claims-paying rating at least equal to that of
the issuer of the existing policies of the Company, or (ii) with the consent of
the Company given prior to the Effective Time, any other policy with respect to
claims arising from facts or events that occurred at or prior to the Effective
Time and covering persons who are currently covered by such insurance (and the
Company shall cooperate prior to the Effective Time in these efforts); provided,
that neither Parent nor the Surviving Corporation shall be obligated to make
premium payments in each year of such six-year period in respect of such policy
(or coverage replacing such policy) exceeding, for the portion related to the
Company's directors and officers, 200% of the annual premium payments on the
Company's current policy in effect as of the date of this Agreement (the
"Maximum D&O Premium"). If the amount of the premiums necessary to maintain or
procure such insurance coverage exceeds the Maximum D&O Premium, Parent shall
use all commercially reasonable efforts to maintain the most advantageous
policies of directors' and officers' liability insurance obtainable for a
premium equal to the Maximum D&O Premium.
 
     (d) The provisions of this Section are intended to be for the benefit of,
and shall be enforceable by, each of the Indemnified Parties, their heirs and
their legal representatives.
 
     7.11  OTHER ACTIONS BY THE COMPANY AND PARENT.
 
     (a) If any Takeover Statute is or may become applicable to the Merger or
the other transactions contemplated by this Agreement or the Stock Option
Agreement, each of Parent and the Company and its board of directors shall grant
such approvals and take such actions as are necessary so that such transactions
may be consummated as promptly as practicable on the terms contemplated by this
Agreement or the Stock Option Agreement, as the case may be, or by the Merger
and otherwise act to eliminate or minimize the effects of such statute or
regulation on such transactions.
 
     (b) Subject to Section 7.2, the Company shall use its reasonable efforts to
exercise its rights under all confidentiality, lock-up, standstill and similar
agreements entered into with Persons that were considering an Acquisition
Proposal with respect to the Company, to preserve the confidentiality of the
information relating
                                      A-24
<PAGE>   61
 
to the Company Entities provided to such Persons and their Affiliates and
Representatives and to ensure compliance with the terms of this Agreement.
 
                                   ARTICLE 8
 
               CONDITIONS PRECEDENT TO OBLIGATIONS TO CONSUMMATE
 
     8.1  CONDITIONS TO OBLIGATIONS OF EACH PARTY.  The respective obligations
of each Party to consummate the Merger are subject to the satisfaction of the
following conditions, unless waived by both Parties pursuant to Section 10.5:
 
          (a) Stockholder Approval.  The stockholders of the Company shall have
     adopted this Agreement, and the consummation of the transactions
     contemplated hereby, including the Merger, as and to the extent required by
     Law, by the provisions of any governing instruments, or by the rules of the
     NYSE.
 
          (b) Regulatory Approvals.  All Consents of, filings and registrations
     with, and notifications to, all Regulatory Authorities required for
     consummation of the Merger shall have been obtained or made and shall be in
     full force and effect and all waiting periods required by Law shall have
     expired.
 
          (c) Legal Proceedings.  No court or governmental or regulatory
     authority of competent jurisdiction shall have enacted, issued,
     promulgated, enforced or entered any Law or Order (whether temporary,
     preliminary or permanent) or taken any other action which prohibits,
     restricts or makes illegal consummation of the transactions contemplated by
     this Agreement.
 
     8.2  CONDITIONS TO OBLIGATIONS OF PARENT.  The obligations of Parent to
consummate the Merger are subject to the satisfaction of the following
conditions, unless waived by Parent pursuant to Section 10.5(a):
 
          (a) Representations and Warranties.  For purposes of this Section
     8.2(a), the accuracy of the representations and warranties of the Company
     set forth in this Agreement shall be assessed as of the date of this
     Agreement and as of the Effective Time with the same effect as though all
     such representations and warranties had been made on and as of the
     Effective Time (provided that representations and warranties that are
     confined to a specified date shall speak only as of such date). The
     representations and warranties set forth in Section 5.2 shall be true and
     correct (except for inaccuracies which are de minimis in amount). The
     representations and warranties set forth in Sections 5.3, 5.4, 5.14, 5.19,
     5.20 and 5.21 shall be true and correct in all material respects. There
     shall not exist inaccuracies in the representations and warranties of the
     Company set forth in this Agreement (including the representations and
     warranties set forth in Sections 5.2, 5.3, 5.4, 5.14, 5.19, 5.20 and 5.21)
     such that the aggregate effect of such inaccuracies has, or is reasonably
     likely to have, a Company Material Adverse Effect; provided that, for
     purposes of this sentence only, those representations and warranties which
     are qualified by references to "material" or "Material Adverse Effect" of
     any Person shall be deemed not to include such qualifications.
 
          (b) Performance of Agreements and Covenants.  The Company shall have
     performed in all material respects all of its agreements and covenants
     hereunder required to be performed by it on or prior to the Effective Time.
 
          (c) Certificates.  The Company shall have delivered to Parent (i) a
     certificate, dated as of the Effective Time and signed on its behalf by its
     chief executive officer and its chief financial officer, to the effect that
     the conditions set forth in Section 8.1 as relates to the Company and in
     Section 8.2(a) and 8.2(b) have been satisfied, and (ii) certified copies of
     resolutions duly adopted by the Company's board of directors and
     stockholders evidencing the taking of all corporate action necessary to
     authorize the execution, delivery and performance of this Agreement, and
     the consummation of the transactions contemplated hereby, all in such
     reasonable detail as Parent and its counsel shall request.
 
          (d) Rights Agreement.  No Distribution Date (as defined in the Rights
     Agreement) shall have occurred, and the Rights shall not have become
     non-redeemable or exercisable upon consummation of the Merger.
 
                                      A-25
<PAGE>   62
 
     8.3  CONDITIONS TO OBLIGATIONS OF THE COMPANY.  The obligations of the
Company to consummate the Merger are subject to the satisfaction of the
following conditions, unless waived by the Company pursuant to Section 10.5(b):
 
          (a) Representations and Warranties.  For purposes of this Section
     8.3(a), the accuracy of the representations and warranties of Parent set
     forth in this Agreement shall be assessed as of the date of this Agreement
     and as of the Effective Time with the same effect as though all such
     representations and warranties had been made on and as of the Effective
     Time (provided that representations and warranties which are confined to a
     specified date shall speak only as of such date). The representations and
     warranties set forth in Sections 6.2 and 6.7 shall be true and correct in
     all material respects. There shall not exist inaccuracies in the
     representations and warranties of the Company set forth in this Agreement
     (including the representations and warranties set forth in Sections 6.2 and
     6.7) such that the aggregate effect of such inaccuracies has, or is
     reasonably likely to have, a Parent Material Adverse Effect; provided that,
     for purposes of this sentence only, those representations and warranties
     which are qualified by references to "material" or "Material Adverse
     Effect" of any Person shall be deemed not to include such qualifications.
 
          (b) Performance of Agreements and Covenants.  Parent shall have
     performed in all material respects all of its agreements and covenants
     hereunder required to be performed by it on or prior to the Effective Time.
 
          (c) Certificates.  Parent shall have delivered to the Company (i) a
     certificate, dated as of the Effective Time and signed on its behalf by its
     chief executive officer and its chief financial officer, to the effect that
     the conditions set forth in Section 8.1 as relates to Parent and in Section
     8.3(a) and 8.3(b) have been satisfied, and (ii) certified copies of
     resolutions duly adopted by Parent's board of directors and Merger Sub's
     board of directors and sole stockholder evidencing the taking of all
     corporate action necessary to authorize the execution, delivery and
     performance of this Agreement, and the consummation of the transactions
     contemplated hereby, all in such reasonable detail as the Company and its
     counsel shall request.
 
          (d) Exchange Agent Certification.  The Exchange Agent shall have
     delivered to the Company a certificate, dated as of the Effective Time, to
     the effect that Parent has deposited with the Exchange Agent sufficient
     funds to pay the aggregate cash payments required to be paid pursuant to
     Section 3.1(b).
 
                                   ARTICLE 9
 
                                  TERMINATION
 
     9.1  TERMINATION BY MUTUAL CONSENT.  This Agreement may be terminated and
the Merger may be abandoned at any time prior to the Effective Time, whether
before or after the adoption hereof by stockholders of the Company referred to
in Section 8.1(a), by mutual written consent of the Company and Parent by action
of their respective boards of directors.
 
     9.2  TERMINATION BY EITHER PARENT OR THE COMPANY.  This Agreement may be
terminated and the Merger may be abandoned (a) by action of the board of
directors of either Parent or the Company if the Merger shall not have been
consummated by September 30, 1998, whether such date is before or after the date
of adoption hereof by the stockholders of the Company (provided, however, that
if all conditions to Closing have been satisfied or waived on or before
September 30, 1998, other than obtaining the required Consents from Regulatory
Authorities, such date shall be extended past September 30, 1998 for up to three
additional one-month periods at the request of either Parent or the Company)
(the "Termination Date"), or (b) by action of the board of directors of either
Parent or the Company if any Order permanently restraining, enjoining or
otherwise prohibiting consummation of the Merger shall become final and
non-appealable (whether before or after the adoption hereof by the stockholders
of the Company); provided, that the right to terminate this Agreement or request
an extension pursuant to clause (a) above shall not be available to any Party
that has breached in any material respect its obligations under this Agreement
in any manner that shall
 
                                      A-26
<PAGE>   63
 
have proximately contributed to the occurrence of the failure of the Merger to
be consummated on or before the Termination Date.
 
     9.3  TERMINATION BY THE COMPANY.  This Agreement may be terminated and the
Merger may be abandoned at any time prior to the Effective Time, by action of
the board of directors of the Company:
 
          (a) If (i) the Company is not in material breach of any of its
     agreements or covenants under this Agreement, (ii) the Merger shall not
     have been approved by the Company Requisite Vote, (iii) the board of
     directors of the Company authorizes the Company, subject to complying with
     the terms of this Agreement, to enter into a binding written agreement
     concerning a transaction that constitutes a Superior Proposal and the
     Company notifies Parent in writing that it intends to enter into such an
     agreement, attaching the most current version of such agreement to such
     notice, (iv) Parent does not make, within five business days after receipt
     of the Company's written notification of its intention to enter into a
     binding agreement for a Superior Proposal, a bona fide offer that the board
     of directors of the Company determines, in good faith after consultation
     with its financial advisors, is at least as favorable as the Superior
     Proposal, taking into account, to the extent relevant, the long term
     prospects and interests of the Company and its stockholders, and (v) the
     Company has paid Parent any amounts then due to Parent pursuant to the
     Stock Option Agreement; or
 
          (b) If there has been a material breach by Parent of any
     representation, warranty, covenant or agreement contained in this Agreement
     that, together with all such breaches, would prevent any of the conditions
     set forth in Article 8 from being satisfied (other than by waiver) prior to
     the Termination Date and that is not curable or, if curable, is not cured
     within 20 days after written notice of such breach is given by the Company
     to Parent; or
 
          (c) If the Company Requisite Vote shall not have been obtained at a
     meeting duly convened therefor or at any adjournment or postponement
     thereof and the Company has paid Parent any amounts then due to Parent
     pursuant to the Stock Option Agreement.
 
     9.4  TERMINATION BY PARENT.  This Agreement may be terminated and the
Merger may be abandoned at any time prior to the Effective Time, whether before
or after the adoption hereof by the stockholders of the Company referred to in
Section 8.1(a), by action of the board of directors of Parent (a) if the Company
Requisite Vote shall not have been obtained at a meeting duly convened therefor
or at any adjournment or postponement thereof, (b) if the Company enters into a
binding agreement for a Superior Proposal, (c) if there has been a material
breach by the Company of any representation, warranty, covenant or agreement
contained in this Agreement that, together with all such breaches, would prevent
any of the conditions set forth in Article 8 from being satisfied (other than by
waiver) prior to the Termination Date and that is not curable or, if curable, is
not cured within 20 days after written notice of such breach is given by Parent
to the Company, or (d) if the Company shall not have delivered to Parent, on or
before March 31, 1998, a copy of an unqualified opinion of Price Waterhouse LLP
with respect to the Company's consolidated GAAP financial statements for the
year ended December 31, 1997, provided that in such event Parent must terminate
this Agreement pursuant to this Section 9.4(d) prior to the close of business on
the later of April 3, 1998 or 3 business days following the date of delivery to
Parent of such consolidated financial statements with an opinion of such
accountant thereon.
 
     9.5.  EFFECT OF TERMINATION AND ABANDONMENT.  In the event of termination
of this Agreement and the abandonment of the Merger pursuant to this Article 9,
this Agreement (other than as set forth in Section 7.9) shall become void and of
no effect with no Liability on the part of any Party hereto (or of any of its
directors, officers, employees, agents, legal and financial advisors or other
representatives); provided, however, except as otherwise provided herein, no
such termination shall relieve any Party hereto of any Liability resulting from
any willful breach of this Agreement.
 
                                      A-27
<PAGE>   64
 
                                   ARTICLE 10
 
                                 MISCELLANEOUS
 
10.1  DEFINITIONS.
 
     (a) Except as otherwise provided herein, the capitalized terms set forth
below shall have the following meanings:
 
     "AFFILIATE" of a Person means any other Person directly, or indirectly
through one or more intermediaries, controlling, controlled by or under common
control with such Person.
 
     "AGREEMENT" means this Agreement and Plan of Merger, including the Exhibits
(other than the Stock Option Agreement) delivered pursuant hereto and
incorporated herein by reference.
 
     "ASSETS" of a Person means all of the assets, properties, businesses and
rights of such Person of every kind, nature, character and description, whether
real, personal or mixed, tangible or intangible, accrued or contingent, or
otherwise relating to or utilized in such Person's business, directly or
indirectly, in whole or in part, whether or not carried on the books and records
of such Person, and whether or not owned in the name of such Person or any
Affiliate of such Person and wherever located.
 
     "CODE" means the Internal Revenue Code of 1986, as amended, and the rules
and regulations promulgated thereunder.
 
     "COMMISSIONS" means all leasing commissions, referral fees, payments and
obligations to make payments to agents, leasing agents, leasing brokers or other
parties with respect to the Space Leases, whether such agreements are contained
in a Space Lease or in any separate commission agreement.
 
     "COMMISSION AGREEMENTS" means all obligations to pay Commissions, whether
such agreements are contained in a Space Lease or in any separate commission
agreement, together with all amendments thereto or modifications thereof, and
all correspondence, notices, files and other records pertaining to Commissions.
 
     "COMPANY" means John Alden Financial Corporation, a Delaware corporation.
 
     "COMPANY COMMON STOCK" means the $.01 par value common stock of the
Company.
 
     "COMPANY DISCLOSURE LETTER" means the written information entitled "John
Alden Financial Corporation Disclosure Letter" delivered prior to the date of
this Agreement to Parent describing in reasonable detail the matters contained
therein and, with respect to each disclosure made therein, specifically
referencing each Section of this Agreement under which such disclosure is being
made.
 
     "COMPANY ENTITIES" means, collectively, the Company and all Company
Subsidiaries.
 
     "COMPANY MATERIAL ADVERSE EFFECT" means an event, change or occurrence
which, individually or together with any other event, change or occurrence, has
a material adverse impact on (i) the financial condition, business or results of
operations of the Company and its Subsidiaries, taken as a whole, or (ii) the
ability of the Company to perform its obligations under this Agreement or to
consummate the Merger or the other transactions contemplated by this Agreement.
 
     "COMPANY STOCK PLANS" means the existing stock option and other stock-based
compensation plans of the Company designated as follows: 1992 JAFCO Long-Term
Incentive Plan; 1997 JAFCO Long-Term Incentive Plan; North Star Marketing
Long-Term Incentive Plan; Non-employee Directors Stock Option Plan; Amended and
Restated Management Stockholders Agreement, dated February 17, 1993, as amended
July 24, 1994; and Employee Stock Purchase Plan.
 
     "COMPANY SUBSIDIARIES" means the Subsidiaries of the Company, which shall
include all such Subsidiaries as of the date hereof and any corporation or other
organization acquired as a Subsidiary of the Company in the future and held as a
Subsidiary by the Company at the Effective Time.
 
                                      A-28
<PAGE>   65
 
     "CONDEMNATION PROCEEDING" means any proceeding in condemnation, eminent
domain or any written request for a conveyance in lieu thereof, or any notice
that such proceedings have been or will be commenced against any portion of the
Owned Real Property.
 
     "CONFIDENTIALITY AGREEMENT" means that certain Confidentiality Agreement,
dated September 15, 1997, between the Company and Parent.
 
     "CONSENT" means any consent, approval, authorization, clearance, exemption,
waiver, or similar affirmation by any Person pursuant to any Contract, Law,
Order, or Permit.
 
     "CONSTITUENT CORPORATIONS" means, collectively, the Company and Merger Sub.
 
     "CONTRACT" means any written or oral agreement, arrangement, authorization,
commitment, contract, indenture, instrument, lease, obligation, plan, practice,
restriction, understanding, or undertaking of any kind or character, or other
document, in each case, that is binding on any Person or its capital stock,
Assets or business.
 
     "DEFAULT" means (i) any breach or violation of, default under,
contravention of, or conflict with, any Contract, Law, Order or Permit, (ii) any
occurrence of any event that with the passage of time or the giving of notice or
both would constitute a breach or violation of, default under, contravention of
or conflict with, any Contract, Law, Order or Permit, or (iii) any occurrence of
any event that with or without the passage of time or the giving of notice would
give rise to a right of any Person to exercise any remedy or obtain any relief
under, terminate or revoke, suspend, cancel or modify or change the current
terms of, or renegotiate, or to accelerate the maturity or performance of, or to
increase or impose any Liability under, any Contract, Law, Order or Permit.
 
     "DGCL" means the Delaware General Corporation Law.
 
     "ENVIRONMENTAL LAWS" means all Laws relating to pollution or protection of
human health or the environment (including ambient air, surface water, ground
water, land surface, or subsurface strata) and which are administered,
interpreted, or enforced by the United States Environmental Protection Agency
and state and local agencies with jurisdiction over, and including common law in
respect of, pollution or protection of the environment, including the
Comprehensive Environmental Response Compensation and Liability Act, as amended,
42 U.S.C. 9601 et seq. ("CERCLA"), the Resource Conservation and Recovery Act,
as amended, 42 U.S.C. 6901 et seq. ("RCRA"), and other Laws relating to
emissions, discharges, releases, or threatened releases of any Hazardous
Material, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport, or handling of any Hazardous
Material.
 
     "EQUITY RIGHTS" means all arrangements, calls, commitments, Contracts,
options, rights to subscribe to, scrip, understandings, warrants, or other
binding obligations of any character whatsoever relating to the issuance of, or
securities or rights convertible into or exchangeable for, shares of the capital
stock of a Person or by which a Person is or may be bound to issue additional
shares of its capital stock or other Equity Rights.
 
     "ERISA" means the Employee Retirement Income Security Act of 1974, as
amended.
 
     "EXCHANGE ACT" means the Securities Exchange Act of 1934, as amended.
 
     "EXHIBITS" 1 and 2, inclusive, means the Exhibits so marked, copies of
which are attached to this Agreement. Such Exhibits are hereby incorporated by
reference herein and made a part hereof, and may be referred to in this
Agreement and any other related instrument or document without being attached
hereto.
 
     "GAAP" means United States generally accepted accounting principles,
consistently applied during the periods involved.
 
     "HAZARDOUS MATERIAL" means (i) any hazardous substance, hazardous material,
hazardous waste, regulated substance, or toxic substance (as those terms are
defined by any applicable Environmental Laws) and (ii) any chemicals,
pollutants, contaminants, petroleum, petroleum products, or oil (and
specifically shall include asbestos requiring abatement, removal, or
encapsulation pursuant to the requirements of governmental
 
                                      A-29
<PAGE>   66
 
authorities and any polychlorinated biphenyls), in each case other than common
cleaning and office products in reasonable amounts.
 
     "HSR ACT" means Section 7A of the Clayton Act, as added by Title II of the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules
and regulations promulgated thereunder.
 
     "IMPROVEMENTS" means the buildings, structures (surface and subsurface) and
other improvements and fixtures now or hereafter situated on or attached to any
parcel of the Owned Real Property.
 
     "IRS" means the Internal Revenue Service.
 
     "KNOWLEDGE" with respect to the Company means those facts that are known or
should reasonably have been known after due inquiry by the chairman, president,
chief financial officer, chief accounting officer, chief actuary, chief
operating officer, general counsel, any assistant or deputy general counsel, or
any senior, executive or other vice president of any Company Entity; and with
respect to Parent means those facts that are known or should reasonably have
been known after due inquiry by the chairman, president, chief financial
officer, general counsel, corporate counsel or any executive vice president of
Parent.
 
     "LAW" means any code, law (including common law), ordinance, regulation,
reporting or licensing requirement, rule, or statute of any Regulatory Authority
applicable to a Person or its Assets, Liabilities or business.
 
     "LIABILITY" means any direct or indirect, primary or secondary, liability,
indebtedness, obligation, penalty, cost or expense (including costs of
investigation, collection and defense), claim, deficiency, guaranty or
endorsement of or by any Person (other than endorsements of notes, bills,
checks, and drafts presented for collection or deposit in the ordinary course of
business) of any type, whether accrued, absolute or contingent, liquidated or
unliquidated, matured or unmatured, or otherwise.
 
     "LIEN" means any conditional sale agreement, default of title, easement,
encroachment, encumbrance, hypothecation, infringement, lien, mortgage, pledge,
reservation, restriction, security interest, title retention or other security
arrangement, or any adverse right or interest, charge, or claim of any nature
whatsoever of, on, or with respect to any property or property interest, other
than (i) Liens for current property Taxes not yet due and payable and (ii) Liens
which do not materially impair the use of or title to the Assets subject to such
Lien.
 
     "LITIGATION" means any action, arbitration, cause of action, claim,
complaint, criminal prosecution, governmental or other examination or
investigation, hearing, administrative or other proceeding of a Regulatory
Authority relating to or affecting a Party, its business, its Assets (including
Contracts related to it), or the transactions contemplated by this Agreement and
the Stock Option Agreement .
 
     "MERGER SUB" means JAFCO Acquisition Corp., a Delaware corporation.
 
     "MERGER SUB COMMON STOCK" means the $.01 par value common stock of Merger
Sub.
 
     "MIAMI PROPERTY" means that parcel of real property known as Airport
Corporate Center in Miami, Florida, containing 11 buildings, including one
building presently used by the Company as its corporate headquarters and ten
buildings that are leased by the Company to third parties, and including
approximately four acres (the "Acreage") of contiguous undeveloped land located
in Lot B-1 of the West Replat.
 
     "NYSE" means the New York Stock Exchange, Inc.
 
     "ORDER" means any administrative decision or award, decree, injunction,
judgment, order, quasi-judicial decision or award, ruling, or writ of any
Regulatory Authority.
 
     "PARENT" means Fortis, Inc., a Nevada corporation.
 
     "PARENT ENTITIES" means, collectively, Parent and all Parent Subsidiaries.
 
     "PARENT MATERIAL ADVERSE EFFECT" means an event, change or occurrence
which, individually or together with any other event, change or occurrence, has
a material adverse impact on the ability of Parent to perform
 
                                      A-30
<PAGE>   67
 
its obligations under this Agreement or to consummate the Merger or the other
transactions contemplated by this Agreement.
 
     "PARENT SUBSIDIARIES" means the Subsidiaries of Parent, which shall include
all such Subsidiaries as of the date hereof and any corporation or other
organization acquired as a Subsidiary of Parent in the future and held as a
Subsidiary by Parent at the Effective Time.
 
     "PARTY" means either the Company or Parent, and "PARTIES" shall mean both
the Company and Parent.
 
     "PERMIT" means any federal, state, local, and foreign governmental
approval, authorization, certificate, easement, filing, franchise, license,
notice, permit, or right to which any Person is a party or that is or may be
binding upon or inure to the benefit of any Person or its securities, Assets or
business.
 
     "PERMITTED TITLE EXCEPTIONS" means:
 
          (i) the Space Leases and any new leases entered into between the date
     hereof and the Effective Time in accordance with the terms of this
     Agreement;
 
          (ii) all real estate Taxes not yet due and payable as of the Effective
     Time;
 
          (iii) local, state and federal (if applicable) zoning and building
     Laws, provided that neither the Improvements nor the existing use of the
     Owned Real Property violates any of such Laws or results in any unpermitted
     "non-conforming" use thereunder; and
 
          (iv) any existing utility easements serving only the Owned Real
     Property and no other land.
 
     "PERSON" means a natural person or any legal, commercial or governmental
entity, such as, but not limited to, a corporation, general partnership, joint
venture, limited partnership, limited liability company, trust, business
association, group acting in concert, or any person acting in a representative
capacity.
 
     "PROXY STATEMENT" means the proxy statement used by the Company to solicit
the approval of its stockholders of the transactions contemplated by this
Agreement.
 
     "QUALIFIED INVESTMENTS" means (i) publicly traded corporate bonds with a
rating of A or better from a rating agency generally accepted by the insurance
industry, (ii) U.S. government securities, (iii) cash equivalents, and (iv)
other investments approved specifically or as a category by Parent in writing
from time to time.
 
     "REAL PROPERTY" means, collectively, the Owned Real Property and the Leased
Real Property.
 
     "REGULATORY AUTHORITIES" means, collectively, the SEC, the NYSE, the
Federal Trade Commission, the United States Department of Justice, the Minnesota
Department of Commerce, the Texas Department of Insurance, the Florida
Department of Insurance, the Nevada Department of Insurance, the Ohio Department
of Insurance, and all other federal, state, county, local or other judicial,
legislative, governmental or regulatory agencies, authorities (including
self-regulatory authorities), instrumentalities, courts, commissions, boards or
bodies having jurisdiction over the Parties and their respective Subsidiaries.
 
     "RENT ROLL" means the rent roll for the Miami Property as of a date not
more than 30 days prior to the date hereof, which shall show (a) the names of
all Space Tenants and a description of their respective Space Leases, (b) the
portion of the Improvements and total number of square feet covered by each
Space Lease (including any options to expand), (c) the date of the Space Lease
and the commencement date and expiration date (including option periods) of each
Space Lease, (d) the current monthly rental payable under each Space Lease and
other charges payable by such Space Tenant (including base rent and any
percentage rent and operating expense reimbursement), (e) the base year (and, if
applicable, the amount of expenses incurred during such base year) used for
calculating each Space Tenant's operating expense reimbursement under such Space
Tenant's Space Lease, (f) the amount of all tenant deposits with respect to each
Space Lease, less amounts previously applied or returned to such tenant, if any,
(g) whether such tenant is entitled to any assigned storage or parking space,
(h) whether any rents or other charges are in arrears and the period to which
such arrearages relate (including the Company's current "delinquency report"),
(i) any incentives, concessions, abatements, due and unpaid allowances or
inducements granted to such tenant, (j) the amounts
                                      A-31
<PAGE>   68
 
of any due and unpaid Commission with respect to such Space Lease, if any, and
(k) whether the Space Lease is subject to cancellation or termination by the
tenant thereunder and the circumstances which would give rise to such
termination or cancellation (or a reference to the Space Lease provision giving
rise to such right).
 
     "REPRESENTATIVE" means any investment banker, financial advisor, attorney,
accountant, consultant, or other representative engaged by a Person.
 
     "RIGHTS" means the preferred stock purchase rights issued pursuant to the
Rights Agreement.
 
     "RIGHTS AGREEMENT" means that certain Rights Agreement, dated December 16,
1996, as amended March 9, 1998, between the Company and ChaseMellon Shareholder
Services, L.L.C., as Rights Agent.
 
     "SEC" means the Securities and Exchange Commission.
 
     "SERVICE CONTRACTS" means all service, maintenance, and other Contracts
respecting leasing, management, maintenance or operation of the Miami Property
or the Improvements thereon, including all leases by which equipment is leased
to the Company and is used or usable in connection with any present or future
occupation or operation of the Miami Property.
 
     "SPACE LEASES" means all leases, subleases, rental agreements and other
occupancy agreements, whether oral or written and whether or not of record, for
the use or occupancy of any portion of the Miami Property, together with all
amendments to, modifications of, renewals and extensions of said leases,
subleases, rental agreements and other occupancy agreements, all guaranties with
respect thereto, all work letter agreements, improvement agreements and other
agreements with tenants of the Miami Property, all Default letters or notices,
estoppel letters, rental adjustment notices, escalation notices and other
correspondence in regard thereto, and all credit reports and accounting records
in regard thereto.
 
     "SUBSIDIARIES" means all those corporations, associations, or other
business entities of which the entity in question either (i) owns or controls
50% or more of the outstanding equity securities either directly or through an
unbroken chain of entities as to each of which 50% or more of the outstanding
equity securities is owned directly or indirectly by its parent (provided, there
shall not be included any such entity the equity securities of which are owned
or controlled in a fiduciary capacity), (ii) in the case of partnerships, serves
as a general partner, (iii) in the case of a limited liability company, serves
as a managing member, or (iv) otherwise has the ability to elect a majority of
the directors, trustees or managing members thereof.
 
     "SURVIVING CORPORATION" means the Company as the surviving corporation
resulting from the Merger.
 
     "TAX RETURN" means any report, return, information return, or other
information required to be supplied to a taxing authority in connection with
Taxes, including any return of an affiliated or combined or unitary group that
includes any Company Entity.
 
     "TAX" or "TAXES" means any federal, state, county, local, or foreign taxes,
charges, fees, levies, imposts, duties, or other assessments, including income
(net, gross or other, including recapture of any tax items such as investment
tax credits), gross receipts, excise, employment, sales, use, transfer, premium,
gains, license, payroll, franchise, severance, stamp, occupation, environmental,
federal highway use, commercial rent, customs duties, capital stock, paid-up
capital, profits, withholding, Social Security, single business and
unemployment, disability, real property, personal property, registration, ad
valorem, value added, alternative or add-on minimum, estimated, or other tax of
any kind whatsoever, imposes or required to be withheld by the United States or
any state, county, local or foreign government or subdivision or agency thereof,
including any interest, penalties, and additions imposed thereon or with respect
thereto.
 
     "TAXING AUTHORITY" means any authority responsible for the imposition,
collection or administration of any Tax.
 
     "WARRANTIES" means each and every now existing and outstanding bond and
warranty concerning the Miami Property or the Improvements located thereon,
including any and all bonds and warranties in conjunction with any construction,
maintenance or operation Contracts.
 
                                      A-32
<PAGE>   69
 
     (b) The terms set forth below shall have the meanings ascribed thereto in
the referenced sections:
 
<TABLE>
<CAPTION>
                       TERM                            SECTION
                       ----                            -------
<S>                                                    <C>
Acquisition Proposal...............................     7.2
Alternative Transaction Notice.....................     9.3 (a)
Bankruptcy and Equity Exception....................     5.3 (a)
Certificate of Merger..............................     1.3
Certificates.......................................     4.1
Closing............................................     1.2
Closing Date.......................................     1.2
Company Actuarial Analyses.........................     5.16(c)
Compensation and Benefit Plans.....................     5.8 (a)
Company Insurance Contracts........................     5.16(a)
Company Insurance Subsidiaries.....................     5.1 (b)
Company Intellectual Property Rights...............     5.12(b)(ii)
Company 9% Preferred Stock.........................     5.2 (a)
Company Options....................................     3.4
Company SAP Statements.............................     5.5 (b)
Company Reports....................................     5.5 (a)
Company Requisite Vote.............................     5.3 (a)
Compensation and Benefit Plans.....................     5.8 (a)
Costs..............................................     7.9 (a)
Effective Time.....................................     1.3
ERISA Affiliate....................................     5.8 (c)
Exchange Agent.....................................     4.1
Expenses...........................................     9.5 (c)
Indemnified Parties................................     7.9 (a)
Insurance Laws.....................................     5.9 (a)
Investment Company Act.............................     5.18
Leased Real Property...............................     5.14(e)
Material Contracts.................................     5.13
Maximum D&O Premium................................     7.9 (c)
Merger.............................................     1.1
Option Settlement Payment..........................     3.4
Owned Real Property................................     5.14(a)
Pension Plan.......................................     5.8 (b)
Per Share Purchase Price...........................     3.1 (b)
Preferred Stock....................................     5.2 (a)
Reinsurance Contracts..............................     5.16(b)
Secretary..........................................     1.3
Stock Option Agreement.............................     1.4
Stockholders' Meeting..............................     7.3
Superior Proposal..................................     7.2
Takeover Laws......................................     5.20
Termination Date...................................     9.2
Third Party Intellectual Property Rights...........     5.12(b)(i)
</TABLE>
 
     (c) Any singular term in this Agreement shall be deemed to include the
plural, and any plural term the singular. Whenever the words "include,"
"includes" or "including" are used in this Agreement, they shall be deemed
followed by the words "without limitation."
                                      A-33
<PAGE>   70
 
     10.2  NON-SURVIVAL OF REPRESENTATIONS AND COVENANTS.  The respective
representations, warranties, obligations, covenants and agreements of the
Parties shall not survive the Effective Time except Articles 1, 2, 3, 4 and 10
and Sections 7.7, 7.8, 7.9 and 7.10.
 
     10.3  ENTIRE AGREEMENT.  Except as otherwise expressly provided herein,
this Agreement (including the documents and instruments referred to herein)
constitutes the entire agreement between the Parties with respect to the
transactions contemplated hereunder and supersedes all prior arrangements or
understandings with respect thereto, written or oral (except, as to Section 7.5,
for the Confidentiality Agreement). Other than Section 7.10 which shall be
enforceable by the parties intended to receive the benefits thereof, nothing in
this Agreement expressed or implied, is intended to confer upon any Person,
other than the Parties or their respective successors, any rights, remedies,
obligations, or liabilities under or by reason of this Agreement.
 
     10.4  AMENDMENTS.  To the extent permitted by Law, this Agreement may be
amended by a subsequent writing signed by each of the Parties upon the approval
of each of the Parties, whether before or after the Company's stockholders have
adopted this Agreement; provided, that after any such adoption hereof by the
holders of Company Common Stock, there shall be made no amendment that, pursuant
to Section 251 of the DGCL, requires further approval by such stockholders
without the further approval of such stockholders.
 
     10.5  WAIVERS.
 
     (a) Prior to or at the Effective Time, Parent, acting through its board of
directors, chief executive officer or other authorized officer, shall have the
right to waive any Default in the performance of any term of this Agreement by
the Company, to waive or extend the time for the compliance or fulfillment by
the Company of any and all of its obligations under this Agreement, and to waive
any or all of the conditions precedent to the obligations of Parent under this
Agreement, except any condition which, if not satisfied, would result in the
violation of any Law. No such waiver shall be effective unless in writing signed
by a duly authorized officer of Parent.
 
     (b) Prior to or at the Effective Time, the Company, acting through its
board of directors, chief executive officer or other authorized officer, shall
have the right to waive any Default in the performance of any term of this
Agreement by Parent, to waive or extend the time for the compliance or
fulfillment by Parent of any and all of its obligations under this Agreement,
and to waive any or all of the conditions precedent to the obligations of the
Company under this Agreement, except any condition which, if not satisfied,
would result in the violation of any Law. No such waiver shall be effective
unless in writing signed by a duly authorized officer of the Company.
 
     (c) The failure of any Party at any time or times to require performance of
any provision hereof shall in no manner affect the right of such Party at a
later time to enforce the same or any other provision of this Agreement. No
waiver of any condition or of the breach of any term contained in this Agreement
in one or more instances shall be deemed to be or construed as a further or
continuing waiver of such condition or breach or a waiver of any other condition
or of the breach of any other term of this Agreement.
 
     10.6  ASSIGNMENT.  Except as expressly contemplated hereby, neither this
Agreement nor any of the rights, interests or obligations hereunder shall be
assigned by any Party hereto (whether by operation of Law or otherwise) without
the prior written consent of the other Party; provided, however, that Parent may
transfer the Merger Sub Common Stock to any wholly owned Parent Subsidiary prior
to the Effective Time, so that upon the Merger the Company will become a wholly
owned Subsidiary of such Parent Subsidiary, without the need to obtain any
consent of the Company. Subject to the preceding sentence, this Agreement will
be binding upon, inure to the benefit of and be enforceable by the Parties and
their respective successors and assigns.
 
     10.7  NOTICES.  All notices or other communications which are required or
permitted hereunder shall be in writing and sufficient if delivered by hand, by
facsimile transmission, by certified mail, postage pre-paid, or
 
                                      A-34
<PAGE>   71
 
by courier or overnight carrier, to each person at the address set forth below
(or at such other address as may be provided hereunder), and shall be deemed to
have been delivered as of the date so delivered:
 
                  If to the Company:
 
                  John Alden Financial Corporation
                  7300 Corporate Center Drive
                  Miami, Florida 33126-1223
                  Telephone Number: (305) 715-2000
                  Telecopy Number: (305) 715-1342
                  Attention: General Counsel
 
                  Copy (which shall not constitute notice) to Counsel:
 
                  Wachtell, Lipton, Rosen & Katz
                  51 West 52nd Street
                  New York, New York 10019-6150
                  Telephone Number: (212) 403-1000
                  Telecopy Number: (212) 403-2000
                  Attention: Howard A. Mergelkamp III
                  If to Parent:
 
                  Fortis, Inc.
                  One Chase Manhattan Plaza
                  New York, New York 10005
                  Telephone Number: (212) 859-7000
                  Telecopy Number: (212-859-7034)
                  Attention: Jerome Atkinson, General Counsel
 
                  Copy (which shall not constitute notice) to Counsel:
 
                  Alston & Bird LLP
                  1201 West Peachtree Street
                  Atlanta, Georgia 30309-3424
                  Telephone Number: (404) 881-7446
                  Telecopy Number: (404) 881-7777
                  Attention: B. Harvey Hill, Jr.
 
     10.8  GOVERNING LAW.  This Agreement shall be governed by and construed in
accordance with the Laws of the State of Delaware, without regard to any
applicable conflicts of Laws.
 
     10.9  COUNTERPARTS.  This Agreement may be executed in two or more
counterparts, each of which shall be deemed to be an original, but all of which
together shall constitute one and the same instrument.
 
     10.10  CAPTIONS; ARTICLES AND SECTIONS.  The captions contained in this
Agreement are for reference purposes only and are not part of this Agreement.
Unless otherwise indicated, all references to particular Articles or Sections
shall mean and refer to the referenced Articles and Sections of this Agreement.
 
     10.11  INTERPRETATIONS.  Neither this Agreement nor any uncertainty or
ambiguity herein shall be construed or resolved against any Party, whether under
any rule of construction or otherwise. No Party to this Agreement shall be
considered the draftsman. The Parties acknowledge and agree that this Agreement
has been reviewed, negotiated, and accepted by all Parties and their attorneys
and shall be construed and interpreted according to the ordinary meaning of the
words used so as fairly to accomplish the purposes and intentions of all Parties
hereto. Whenever the words "include," "includes" or "including" are used in this
Agreement, they shall be deemed to be followed by the words "without
limitation."
 
                                      A-35
<PAGE>   72
 
     10.12  ENFORCEMENT OF AGREEMENT.  The Parties hereto agree that irreparable
damage would occur in the event that any of the provisions of this Agreement was
not performed in accordance with its specific terms or was otherwise breached.
It is accordingly agreed that the Parties shall be entitled to an injunction or
injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions hereof in any court of the United States or any state
having jurisdiction, this being in addition to any other remedy to which they
are entitled at Law or in equity.
 
     10.13  SEVERABILITY.  Any term or provision of this Agreement which is
invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be
ineffective to the extent of such invalidity or unenforceability without
rendering invalid or unenforceable the remaining terms and provisions of this
Agreement or affecting the validity or enforceability of any of the terms or
provisions of this Agreement in any other jurisdiction. If any provision of this
Agreement is so broad as to be unenforceable, the provision shall be interpreted
to be only so broad as is enforceable.
 
     IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be
executed on its behalf by its duly authorized officers as of the day and year
first above written.
 
                                          JOHN ALDEN FINANCIAL CORPORATION
 
                                          By: /s/ GLENDON E. JOHNSON
                                            ------------------------------------
                                            Name: Glendon E. Johnson
                                            Title: Chairman and Chief Executive
                                              Officer
 
                                          FORTIS, INC.
 
                                          By: /s/ J. KERRY CLAYTON
                                            ------------------------------------
                                            Name: J. Kerry Clayton
                                            Title: Executive Vice President
 
                                          JAFCO ACQUISITION CORP.
 
                                          By: /s/ J. KERRY CLAYTON
                                            ------------------------------------
                                            Name: J. Kerry Clayton
                                            Title: President
 
                                      A-36
<PAGE>   73
 
                                                                         ANNEX B
 
                             STOCK OPTION AGREEMENT
 
     THIS STOCK OPTION AGREEMENT (this "Agreement") is made and entered into as
of March 9, 1998, and amended as of July 28, 1998, by and between John Alden
Financial Corporation, a Delaware corporation ("Issuer"), and Fortis, Inc., a
Nevada corporation ("Grantee").
 
     WHEREAS, Grantee and Issuer have entered into that certain Agreement and
Plan of Merger, dated as of March 9, 1998 (the "Merger Agreement"), providing
for, among other things, the merger of JAFCO Acquisition Corp., a Delaware
corporation ("Merger Sub") with and into Issuer, with Issuer being the surviving
entity and becoming a wholly owned subsidiary of Grantee; and
 
     WHEREAS, as a condition and inducement to Grantee's execution of the Merger
Agreement, Grantee has required that Issuer agree, and Issuer has agreed, to
grant Grantee the Option (as defined below);
 
     NOW, THEREFORE, in consideration of the respective representations,
warranties, covenants and agreements set forth herein and in the Merger
Agreement, and intending to be legally bound hereby, Issuer and Grantee agree as
follows:
 
     1.  DEFINED TERMS.  Capitalized terms which are used but not defined herein
shall have the meanings ascribed to such terms in the Merger Agreement.
 
     2.  GRANT OF OPTION.  Subject to the terms and conditions set forth herein,
Issuer hereby grants to Grantee an irrevocable option (the "Option") to purchase
up to four million eight hundred eighty thousand one hundred and eight
(4,880,108) shares (as adjusted as set forth herein, the "Option Shares," which
shall include the Option Shares before and after any transfer of such Option
Shares) of common stock, $.01 par value per share ("Issuer Common Stock"), of
Issuer at a purchase price per Option Share (subject to adjustment as set forth
herein, the "Purchase Price") equal to twenty two dollars and fifty cents
($22.50); provided, however, that in no event shall the number of shares of
Issuer Common Stock for which this Option is exercisable exceed the lesser of
(i) 19.9% of the Issuer's issued and outstanding shares of Issuer Common Stock
without giving effect to any shares subject to or issued pursuant to the Option
and (ii) that minimum number of shares of Issuer Common Stock which when
aggregated with any other shares of Issuer Common Stock beneficially owned by
Grantee or any Affiliate thereof would cause the provisions of any Takeover Laws
of the DGCL to be applicable to the Merger. Each Option Share to be issued upon
exercise of the Option shall be accompanied by and be deemed to represent a
Right under the Rights Agreement.
 
     3.  EXERCISE OF OPTION.
 
     (a) Provided that (i) Grantee or Holder (as hereinafter defined), as
applicable, shall not be in material breach of its agreements or covenants
contained in this Agreement or the Merger Agreement, and (ii) no preliminary or
permanent injunction or other order against the delivery of shares covered by
the Option issued by any court of competent jurisdiction in the United States
shall be in effect, Holder may exercise the Option, in whole or in part, at any
time and from time to time following the occurrence of a Purchase Event and
prior to the termination of the Option. The Option shall terminate and be of no
further force and effect upon the earliest to occur of (A) the Effective Time,
(B) termination of the Merger Agreement in accordance with the terms thereof
prior to the occurrence of a Purchase Event or a Preliminary Purchase Event
(other than a termination of the Merger Agreement by Grantee pursuant to Section
9.4(c) thereof, but with respect to a termination for material breach of a
representation or warranty by Issuer, only if such termination was a result of a
willful breach by Issuer (a "Default Termination")), (C) 18 months after a
Default Termination, and (D) 18 months after any termination of the Merger
Agreement following the occurrence of a Purchase Event or a Preliminary Purchase
Event. Any purchase of shares upon exercise of the Option shall be subject to
compliance with applicable law, including, without limitation, all applicable
Insurance Laws. The term "Holder" shall mean the holder or holders of the Option
from time to time, and which initially is the Grantee. The rights set forth in
Section 8 shall terminate when the right to exercise the Option terminates
(other than as a result of a complete exercise of the Option) as set forth
herein.
 
                                       B-1
<PAGE>   74
 
     (b) As used herein, a "Purchase Event" means any of the following events
subsequent to the date of this Agreement:
 
          (i) without Grantee's prior written consent, Issuer shall have
     authorized, recommended, publicly proposed or publicly announced an
     intention to authorize, recommend or propose, or entered into an agreement
     with any person (other than Grantee or any Subsidiary of Grantee) to effect
     an Acquisition Transaction (as defined below). As used herein, the term
     Acquisition Transaction shall mean (A) a merger, consolidation or similar
     transaction involving Issuer or any of its Subsidiaries (other than
     transactions solely between Issuer's Subsidiaries), (B) the disposition, by
     sale, lease, exchange or otherwise, of Assets of Issuer or any of its
     Subsidiaries representing in either case 15% or more of the consolidated
     assets of Issuer and its Subsidiaries, (C) the issuance, sale or other
     disposition of (including by way of merger, consolidation, share exchange
     or any similar transaction) securities representing 15% or more of the
     voting power of Issuer or any of its Subsidiaries, or (D) a Tender Offer or
     an Exchange Offer (as such terms are defined below) (any of the foregoing,
     an "Acquisition Transaction");
 
          (ii) any person (other than Grantee or any Subsidiary of Grantee)
     shall have acquired beneficial ownership (as such term is defined in Rule
     13d-3 promulgated under the Securities Exchange Act of 1934, as amended
     (the "Exchange Act")), of or the right to acquire beneficial ownership of,
     or any "group" (as such term is defined under the Exchange Act), other than
     a group of which Grantee or any of its Subsidiaries is a member, shall have
     been formed which beneficially owns or has the right to acquire beneficial
     ownership of, 15% or more of the then-outstanding shares of Issuer Common
     Stock; or
 
          (iii) the holders of Issuer Common Stock shall not have approved the
     Merger Agreement at the meeting called for such purpose, or such meeting
     shall not have been held or shall have been canceled prior to termination
     of the Merger Agreement following a Preliminary Purchase Event.
 
     (c) As used herein, a "Preliminary Purchase Event" means any of the
following events:
 
          (i) any person (other than Grantee or any Subsidiary of Grantee) shall
     have commenced (as such term is defined in Rule 14d-2 under the Exchange
     Act), or shall have filed a registration statement under the Securities Act
     of 1933, as amended (the "Securities Act") with respect to, a tender offer
     or exchange offer to purchase any shares of Issuer Common Stock such that,
     upon consummation of such offer, such person would own or control 15% or
     more of the then-outstanding shares of Issuer Common Stock (such an offer
     being referred to herein as a "Tender Offer" or an "Exchange Offer,"
     respectively); or
 
          (ii) it shall have been publicly announced that any person (other than
     Grantee or any Subsidiary of Grantee) shall have (A) made a bona fide
     proposal to engage in an Acquisition Transaction, (B) commenced a Tender
     Offer or filed a registration statement under the Securities Act with
     respect to an Exchange Offer, or (C) filed an application (or given a
     notice), whether in draft or final form, under any federal or state statute
     or regulation seeking the Consent to an Acquisition Transaction from any
     federal or state governmental or regulatory authority or agency.
 
As used in this Agreement, "person" shall have the meaning specified in Sections
3(a)(9) and 13(d)(3) of the Exchange Act.
 
     (d) In the event Holder wishes to exercise the Option, it shall send to
Issuer a written notice (the date of which being herein referred to as the
"Notice Date") specifying (i) the total number of Option Shares it intends to
purchase pursuant to such exercise and (ii) a place and date not earlier than
three business days nor later than 30 business days from the Notice Date for the
closing (the "Closing") of such purchase (the "Closing Date"). If prior Consent
of any governmental or regulatory agency or authority is required in connection
with such purchase, Issuer shall cooperate with Holder in the filing of the
required notice or application for such Consent and the obtaining of such
Consent and the Closing shall occur immediately following receipt of such
Consents (and expiration of any mandatory waiting periods).
 
     4.  PAYMENT AND DELIVERY OF CERTIFICATES.
 
     (a) On each Closing Date, Holder shall (i) pay to Issuer, in immediately
available funds by wire transfer to a bank account designated by Issuer, an
amount equal to the Purchase Price multiplied by the number of
                                       B-2
<PAGE>   75
 
Option Shares to be purchased on such Closing Date, and (ii) present and
surrender this Agreement to the Issuer at the address of the Issuer specified in
Section 12(f) hereof.
 
     (b) At each Closing, simultaneously with the delivery of immediately
available funds and surrender of this Agreement as provided in Section 4(a), (i)
Issuer shall deliver to Holder (A) a certificate or certificates representing
the Option Shares to be purchased at such Closing, which Option Shares shall be
free and clear of all liens, claims, charges and encumbrances of any kind
whatsoever and subject to no preemptive rights, and (B) if the Option is
exercised in part only, an executed new agreement with the same terms as this
Agreement evidencing the right to purchase the balance of the shares of Issuer
Common Stock purchasable hereunder, and (ii) Holder shall deliver to Issuer a
letter agreeing that Holder shall not offer to sell or otherwise dispose of such
Option Shares in violation of applicable federal and state law or of the
provisions of this Agreement.
 
     (c) In addition to any other legend that is required by applicable law,
certificates for the Option Shares delivered at each Closing shall be endorsed
with a restrictive legend which shall read substantially as follows:
 
          THE TRANSFER OF THE STOCK REPRESENTED BY THIS CERTIFICATE IS
     SUBJECT TO RESTRICTIONS ARISING UNDER THE SECURITIES ACT OF 1933, AS
     AMENDED, AND PURSUANT TO THE TERMS OF A STOCK OPTION AGREEMENT DATED
     AS OF MARCH 9, 1998. A COPY OF SUCH AGREEMENT WILL BE PROVIDED TO THE
     HOLDER HEREOF WITHOUT CHARGE UPON RECEIPT BY THE ISSUER OF A WRITTEN
     REQUEST THEREFOR.
 
     It is understood and agreed that: (i) the references in the above legend to
resale restrictions of the Securities Act shall be removed by delivery of
substitute certificate(s) without such reference if Holder shall have delivered
to Issuer a copy of a letter from the staff of the SEC, or an opinion of counsel
in form and substance reasonably satisfactory to Issuer and its counsel, to the
effect that such legend is not required for purposes of the Securities Act; (ii)
the references in the above legend to the provisions of this Agreement shall be
removed by delivery of substitute certificate(s) without such reference if the
shares have been sold or transferred in compliance with the provisions of this
Agreement and under circumstances that do not require the retention of such
reference; and (iii) the legend shall be removed in its entirety if the
conditions in the preceding clauses (i) and (ii) are both satisfied.
 
     5.  REPRESENTATIONS AND WARRANTIES OF ISSUER.  Issuer hereby represents and
warrants to Grantee as follows:
 
     (a) Issuer has all requisite corporate power and authority to enter into
this Agreement and, subject to any approvals referred to herein, to consummate
the transactions contemplated hereby. The execution and delivery of this
Agreement and the consummation of the transactions contemplated hereby have been
duly authorized by all necessary corporate action on the part of Issuer. This
Agreement has been duly executed and delivered by Issuer.
 
     (b) Issuer has taken all necessary corporate action to authorize and
reserve and to permit it to issue, and, at all times from the date hereof until
the obligation to deliver Issuer Common Stock upon the exercise of the Option
terminates, will have reserved for issuance, upon exercise of the Option, the
number of shares of Issuer Common Stock necessary for Holder to exercise the
Option, and Issuer will take all necessary corporate action to authorize and
reserve for issuance all additional shares of Issuer Common Stock or other
securities which may be issued pursuant to Section 7 upon exercise of the
Option. The shares of Issuer Common Stock to be issued upon due exercise of the
Option, including all additional shares of Issuer Common Stock or other
securities which may be issuable pursuant to Section 7, upon issuance pursuant
hereto, shall be duly and validly issued, fully paid, and nonassessable, and
shall be delivered free and clear of all liens, claims, charges, and
encumbrances of any kind or nature whatsoever, including any preemptive rights
of any stockholder of Issuer.
 
     6.  REPRESENTATIONS AND WARRANTIES OF GRANTEE.  Grantee hereby represents
and warrants to Issuer that:
 
     (a) Grantee has all requisite corporate power and authority to enter into
this Agreement and, subject to any approvals or consents referred to herein, to
consummate the transactions contemplated hereby. The
 
                                       B-3
<PAGE>   76
 
execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby have been duly authorized by all necessary
corporate action on the part of Grantee. This Agreement has been duly executed
and delivered by Grantee.
 
     (b) This Option is not being, and any Option Shares or other securities
acquired by Grantee upon exercise of the Option will not be, acquired with a
view to the public distribution thereof and will not be transferred or otherwise
disposed of except in a transaction registered or exempt from registration under
all applicable federal, state and local securities laws (the "Securities Laws").
 
     7.  ADJUSTMENT UPON CHANGES IN CAPITALIZATION, ETC.
 
     (a) In the event of any change in Issuer Common Stock by reason of a stock
dividend, stock split, split-up, recapitalization, combination, exchange of
shares or similar transaction, the type and number of shares or securities
subject to the Option, and the Purchase Price therefor, shall be adjusted
appropriately, and proper provision shall be made in the agreements governing
such transaction, if any, so that Holder shall receive, upon exercise of the
Option, the number and class of shares or other securities or property that
Holder would have received in respect of Issuer Common Stock if the Option had
been exercised immediately prior to such event, or the record date therefor, as
applicable. If any additional shares of Issuer Common Stock are issued after the
date of this Agreement (other than pursuant to an event described in the first
sentence of this Section 7(a) or pursuant to this Option), the number of shares
of Issuer Common Stock subject to the Option shall be adjusted so that, after
such issuance, it, together with any shares of Issuer Common Stock previously
issued pursuant hereto, shall not exceed the lesser of (i) 19.9% of the number
of shares of Issuer Common Stock then issued and outstanding, without giving
effect to any shares subject to or issued pursuant to the Option and (ii) that
minimum number of shares of Issuer Common Stock which when aggregated with any
other shares of Issuer Common Stock beneficially owned by Grantee or any
Affiliate thereof would cause the provisions of any Takeover Laws of the DGCL to
be applicable to the Merger.
 
     (b) In the event that Issuer shall enter in an agreement: (i) to
consolidate with or merge into any person, other than Grantee or one of its
Subsidiaries, and shall not be the continuing or surviving corporation of such
consolidation or merger; (ii) to permit any person, other than Grantee or one of
its Subsidiaries, to merge into Issuer and Issuer shall be the continuing or
surviving corporation, but, in connection with such merger, the then outstanding
shares of Issuer Common Stock shall be changed into or exchanged for stock or
other securities of Issuer or any other person or cash or any other property or
the outstanding shares of Issuer Common Stock immediately prior to such merger
shall after such merger represent less than 50% of the outstanding shares and
share equivalents of the merged company; or (iii) to sell or otherwise transfer
all or substantially all of its Assets to any person, other than Grantee or one
of its Subsidiaries, then, and in each such case, the agreement governing such
transaction shall make proper provisions so that the Option shall, upon the
consummation of any such transaction and upon the terms and conditions set forth
herein, be converted into, or exchanged for, an option (the "Substitute
Option"), at the election of Grantee, of either (x) the Acquiring Corporation
(as defined below) or (y) any person that controls the Acquiring Corporation (in
each case, such person being referred to as the "Substitute Option Issuer").
 
     (c) The Substitute Option shall have the same terms as the Option, provided
that, if the terms of the Substitute Option cannot, for legal reasons, be the
same as the Option, such terms shall be as similar as possible and in no event
less advantageous to Grantee. The Substitute Option Issuer shall also enter into
an agreement with the then-holder or holders of the Substitute Option in
substantially the same form as this Agreement, which shall be applicable to the
Substitute Option.
 
     (d) The Substitute Option shall be exercisable for such number of shares of
the Substitute Common Stock (as hereinafter defined) as is equal to the Assigned
Value (as hereinafter defined) multiplied by the number of shares of the Issuer
Common Stock for which the Option was theretofore exercisable, divided by the
Average Price (as hereinafter defined). The exercise price of the Substitute
Option per share of the Substitute Common Stock (the "Substitute Purchase
Price") shall then be equal to the Purchase Price multiplied by a fraction in
which the numerator is the number of shares of the Issuer Common Stock for which
the Option was theretofore exercisable and the denominator is the number of
shares for which the Substitute Option is exercisable.
                                       B-4
<PAGE>   77
 
     (e) The following terms have the meanings indicated:
 
           (i) "Acquiring Corporation" shall mean (x) the continuing or
     surviving corporation of a consolidation or merger with Issuer (if other
     than Issuer), (y) Issuer in a merger in which Issuer is the continuing or
     surviving person, and (z) the transferee of all or any substantial part of
     the Issuer's assets (or the assets of its Subsidiaries).
 
           (ii) "Substitute Common Stock" shall mean the common stock issued by
     the Substitute Option Issuer upon exercise of the Substitute Option.
 
          (iii) "Assigned Value" shall mean the highest of (x) the price per
     share of the Issuer Common Stock at which a Tender Offer or Exchange Offer
     therefor has been made by any person (other than Grantee), (y) the price
     per share of the Issuer Common Stock to be paid by any person (other than
     the Grantee) pursuant to an agreement with Issuer, and (z) the highest last
     sale price per share of Issuer Common Stock quoted on the NYSE (or if
     Issuer Common Stock is not quoted on the NYSE, the highest bid price per
     share on any day as quoted on the principal trading market or securities
     exchange on which such shares are traded as reported by a recognized source
     chosen by Grantee) within the six-month period immediately preceding the
     agreement; provided, that in the event of a sale of less than all of
     Issuer's assets, the Assigned Value shall be the sum of the price paid in
     such sale for such assets and the current market value of the remaining
     assets of Issuer as determined by a nationally recognized investment
     banking firm selected by Grantee (or by a majority in interest of the
     Grantees if there shall be more than one Grantee (a "Grantee Majority"))
     and reasonably acceptable to Issuer, divided by the number of shares of the
     Issuer Common Stock outstanding at the time of such sale. In the event that
     an exchange offer is made for the Issuer Common Stock or an agreement is
     entered into for a merger or consolidation involving consideration other
     than cash, the value of the securities or other property issuable or
     deliverable in exchange for the Issuer Common Stock shall be determined by
     a nationally recognized investment banking firm selected by Grantee and
     reasonably acceptable to Issuer (or if applicable, Acquiring Corporation).
     If there shall be more than one Grantee, any such selection shall be made
     by a Grantee Majority.
 
           (iv) "Average Price" shall mean the average closing price of a share
     of the Substitute Common Stock for the one year immediately preceding the
     consolidation, merger or sale in question, but in no event higher than the
     last sale price of the shares of the Substitute Common Stock on the day
     preceding such consolidation, merger or sale; provided that if Issuer is
     the issuer of the Substitute Option, the Average Price shall be computed
     with respect to a share of common stock issued by Issuer, the person
     merging into Issuer or by any company which controls or is controlled by
     such merger person, as Grantee may elect.
 
     (f) In no event pursuant to any of the foregoing paragraphs shall the
Substitute Option be exercisable for more than 19.9% of the aggregate of the
shares of the Substitute Common Stock outstanding prior to exercise of the
Substitute Option. In the event that the Substitute Option would be exercisable
for more than 19.9% of the aggregate of the shares of Substitute Common Stock
but for this clause (f), the Substitute Option Issuer shall make a cash payment
to Grantee equal to the excess of (i) the value of the Substitute Option without
giving effect to the limitation in this clause (f) over (ii) the value of the
Substitute Option after giving effect to the limitation in this clause (f). This
difference in value shall be determined by a nationally recognized investment
banking firm selected by Grantee (or a Grantee Majority) and reasonably
acceptable to the Acquiring Corporation.
 
     (g) Issuer shall not enter into any transaction described in subsection (b)
of this Section 7 unless the Acquiring Corporation and any person that controls
the Acquiring Corporation assume in writing all the obligations of Issuer
hereunder and take all other actions that may be necessary so that the
provisions of this Section 7 are given full force and effect (including, without
limitation, any action that may be necessary so that the shares of Substitute
Common Stock are in no way distinguishable from or have lesser economic value
than other shares of common stock issued by the Substitute Option Issuer).
 
                                       B-5
<PAGE>   78
 
     (h) The provisions of Sections 8, 9, 10, and 11 shall apply, with
appropriate adjustments, to any securities for which the Option becomes
exercisable pursuant to this Section 7 and, as applicable, references in such
sections to "Issuer," "Option," "Purchase Price" and "Issuer Common Stock" shall
be deemed to be references to "Substitute Option Issuer," "Substitute Option,"
"Substitute Purchase Price" and "Substitute Common Stock," respectively.
 
     8.  REPURCHASE AT THE OPTION OF HOLDER.
 
     (a) Subject to the last sentence of Section 3(a), at the request of Holder
at any time commencing upon the first occurrence of a Purchase Event (as defined
in Section 3(b)) and ending 18 months immediately thereafter, all current and
former Holders shall sell to Issuer and Issuer shall repurchase from such
Holders the Option and all, but not less than all, shares of Issuer Common Stock
purchased by such Holders pursuant hereto whether or not such Holders then have
beneficial ownership of such shares. The date on which Holder exercises its
rights under this Section 8 is referred to as the "Request Date." Such
repurchase shall be at an aggregate price (the "Section 8 Repurchase
Consideration") equal to the sum of:
 
           (i) The aggregate Purchase Price paid by such Holders for any shares
     of Issuer Common Stock acquired by such Holders pursuant to the Option;
 
           (ii) $15 million; and
 
          (iii) Up to, but not in excess of $2.5 million of Holder's reasonable
     out-of-pocket expenses incurred in connection with the transactions
     contemplated by the Merger Agreement (including, without limitation, legal,
     accounting and investment banking fees and expenses).
 
     (b) If Holder exercises its rights under this Section 8, Issuer shall, on
the business day following the Request Date, pay the Section 8 Repurchase
Consideration to Holder in immediately available funds by wire transfer to an
account designated by Holder, and contemporaneously with such payment Holder
shall surrender to Issuer the Option and the certificates evidencing the shares
of Issuer Common Stock purchased thereunder with respect to which Holder then
has beneficial ownership, and Holder shall warrant that it has sole record and
beneficial ownership of such shares and that the same are then free and clear of
all liens, claims, charges and encumbrances of any kind whatsoever.
Notwithstanding the foregoing, to the extent that prior notification to or
Consent of any governmental or regulatory agency or authority is required in
connection with the payment of all or any portion of the Section 8 Repurchase
Consideration, Holder shall have the ongoing option to revoke its request for
repurchase pursuant to Section 8, in whole or in part, or to require that Issuer
deliver from time to time that portion of the Section 8 Repurchase Consideration
that it is not then so prohibited from paying and promptly file the required
notice or application for Consent and expeditiously process the same (and each
party shall cooperate with the other in the filing of any such notice or
application and the obtaining of any such Consent). If any governmental or
regulatory agency or authority disapproves of any part of Issuer's proposed
repurchase pursuant to this Section 8, Issuer shall promptly give notice of such
fact to Holder. If any governmental or regulatory agency or authority prohibits
the repurchase in part but not in whole, then Holder shall have the right (i) to
revoke the repurchase request or (ii) to the extent permitted by such agency or
authority, determine on a reasonable and proportionate basis whether the
repurchase should apply to the Option and/or Option Shares and to what extent to
each. Holder shall notify Issuer of its determination under the preceding
sentence within five business days of receipt of notice of disapproval of the
repurchase.
 
     Notwithstanding anything herein to the contrary, all of Holder's rights
under this Section 8 shall terminate on the date of termination of this Option
pursuant to Section 3(a).
 
     9.  REGISTRATION RIGHTS.
 
     (a) Issuer shall, subject to the conditions of subparagraph (c) below, if
requested by any Holder, including Grantee and any permitted transferee
("Selling Holder"), as expeditiously as possible prepare and file a registration
statement under the Securities Laws if necessary in order to permit the sale or
other disposition of any or all shares of Issuer Common Stock or other
securities that have been acquired by or are issuable to Selling Holder upon
exercise of the Option in accordance with the intended method of sale or other
 
                                       B-6
<PAGE>   79
 
disposition stated by Holder in such request (it being understood and agreed
that any such sale or other disposition shall be effected on a widely
distributed basis so that, upon consummation thereof, no purchaser or transferee
shall beneficially own more than 5% of the shares of Issuer Common Stock then
outstanding), including, without limitation, a "shelf" registration statement
under Rule 415 under the Securities Act or any successor provision, and Issuer
shall use its best efforts to qualify such shares or other securities for sale
under any applicable state securities laws. Each such Holder shall provide all
information reasonably requested by Issuer for inclusion in any registration
statement to be filed hereunder.
 
     (b) If Issuer at any time after the exercise of the Option, but prior to
the termination of the Option, proposes to register any shares of Issuer Common
Stock under the Securities Laws in connection with an underwritten public
offering of such Issuer Common Stock, Issuer will promptly give written notice
to Holder of its intention to do so and, upon the written request of Holder
given within 30 days after receipt of any such notice (which request shall
specify the number of shares of Issuer Common Stock intended to be included in
such underwritten public offering by Selling Holder), Issuer will use all
reasonable efforts to cause all such shares, the holders of which shall have
requested participation in such registration, to be so registered and included
in such underwritten public offering; provided, that Issuer may elect to not
cause any such shares to be so registered (i) if the underwriters in good faith
determine that the inclusion of such shares would interfere with the successful
marketing of the shares of Issuer Common Stock for the account of Issuer, or
(ii) in the case of a registration solely to implement a dividend reinvestment
or similar plan, an employee benefit plan or a registration filed on Form S-4 or
any successor form, or a registration filed on a form which does not permit
registrations of resales; provided, further, that such election pursuant to
clause (i) may only be made once. If some but not all the shares of Issuer
Common Stock, with respect to which Issuer shall have received requests for
registration pursuant to this subparagraph (b), shall be excluded from such
registration, Issuer shall make appropriate allocation of shares to be
registered among Selling Holders and any other person (other than Issuer or any
person exercising demand registration rights in connection with such
registration) who or which is permitted to register their shares of Issuer
Common Stock in connection with such registration pro rata in the proportion
that the number of shares requested to be registered by each Selling Holder
bears to the total number of shares requested to be registered by all persons
then desiring to have Issuer Common Stock registered for sale (other than Issuer
or any person exercising demand registration rights in connection with such
registration).
 
     (c) Issuer shall use all reasonable efforts to cause the registration
statement referred to in subparagraph (a) above to become effective and to
obtain all consents or waivers of other parties which are required therefor and
to keep such registration statement effective, provided, that Issuer may delay
any registration of Option Shares required pursuant to subparagraph (a) above
for a period not exceeding 90 days, provided Issuer shall in good faith
determine that any such registration would adversely affect an offering or
contemplated offering of other securities by Issuer or would require disclosure
by Issuer of any information (including, without limitation, financial
information) which is not reasonably available to Issuer. Notwithstanding
anything to the contrary contained herein, Issuer shall not be required to
register Option Shares under the Securities Laws pursuant to subparagraph (a)
above:
 
           (i) prior to the occurrence of a Purchase Event;
 
           (ii) more than twice;
 
          (iii) within 90 days after the effective date of a registration
     referred to in subparagraph (b) above pursuant to which the Selling Holders
     concerned were afforded the opportunity to register such shares under the
     Securities Laws and such shares were registered as requested; and
 
           (iv) unless a request therefor is made to Issuer by Selling Holders
     holding at least 15% or more of the aggregate number of Option Shares then
     outstanding or the right to acquire at least 15% of the Option Shares.
 
     In addition to the foregoing, Issuer shall not be required to maintain the
effectiveness of any registration statement after the expiration of 120 days
from the effective date of such registration statement. Issuer shall use all
reasonable efforts to make any filings, and take all steps, under all applicable
state securities laws to the
 
                                       B-7
<PAGE>   80
 
extent necessary to permit the sale or other disposition of the Option Shares so
registered in accordance with the intended method of distribution for such
shares, provided, that Issuer shall not be required to consent to general
jurisdiction or qualify to do business in any state where it is not otherwise
required to so consent to such jurisdiction or to so qualify to do business.
 
     (d) Except where applicable state law prohibits such payments, Issuer will
pay all expenses (including without limitation registration fees, qualification
fees, blue sky fees and expenses (including the fees and expenses of Issuer's
counsel), accounting expenses, printing expenses, expenses of underwriters,
excluding discounts and commissions but including liability insurance if Issuer
so desires or the underwriters so require, and the reasonable fees and expenses
of any necessary special experts) in connection with each registration pursuant
to subparagraph (a) or (b) above (including the related offerings and sales by
Selling Holders) and all other qualifications, notifications or exemptions
pursuant to subparagraph (a) or (b) above. Underwriting discounts and
commissions relating to Option Shares and any other expenses incurred by such
Selling Holders in connection with any such registration (including expenses of
Selling Holders' counsel) shall be borne by such Selling Holders.
 
     (e) In connection with any registration under subparagraph (a) or (b) above
Issuer hereby agrees to indemnify the Selling Holders, and each underwriter
thereof, including each person, if any, who controls such holder or underwriter
within the meaning of Section 15 of the Securities Act, against all expenses,
losses, claims, damages and liabilities caused by any untrue statement of a
material fact contained in any registration statement or prospectus (including
any amendments or supplements thereto) or any preliminary prospectus, or caused
by any omission to state therein a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, except insofar as such expenses, losses,
claims, damages or liabilities of such indemnified party are caused by any
untrue statement or alleged untrue statement or any omission or alleged omission
made in reliance upon and in conformity with, information furnished in writing
to Issuer by such indemnified party expressly for use therein, and Issuer and
each officer, director and controlling person of Issuer shall be indemnified by
such Selling Holder, or by such underwriter, as the case may be, for all such
expenses, losses, claims, damages and liabilities caused by any untrue, or
alleged untrue, statement or omission made in reliance upon, and in conformity
with, information furnished in writing to Issuer by such holder or such
underwriter, as the case may be, expressly for such use.
 
     Promptly upon receipt by a party indemnified under this subparagraph (e) of
notice of the commencement of any action against such indemnified party in
respect of which indemnity or reimbursement may be sought against any
indemnifying party under this subparagraph (e), such indemnified party shall
notify the indemnifying party in writing of the commencement of such action, but
the failure so to notify the indemnifying party shall not relieve it of any
liability which it may otherwise have to any indemnified party under this
subparagraph (e), except to the extent such failure to notify materially
prejudices the indemnifying party. In case notice of commencement of any such
action shall be given to the indemnifying party as above provided, the
indemnifying party shall be entitled to participate in and, to the extent it may
wish, jointly with any other indemnifying party similarly notified, to assume
the defense of such action at its own expense, with counsel chosen by it and
reasonably satisfactory to such indemnified party. The indemnified party shall
have the right to employ separate counsel in any such action and participate in
the defense thereof, but the fees and expenses of such counsel (other than
reasonable costs of investigation) shall be paid by the indemnified party unless
(i) the indemnifying party either agrees to pay the same, (ii) the indemnifying
party fails to assume the defense of such action with counsel satisfactory to
the indemnified party, or (iii) the indemnified party has been advised by
counsel that one or more legal defenses may be available to the indemnifying
party that may be contrary to the interest of the indemnified party, in which
case the indemnifying party shall be entitled to assume the defense of such
action notwithstanding its obligation to bear fees and expenses of such counsel;
provided, however, that the indemnifying party shall not be liable for the
expenses of more than one firm of counsel for all indemnified parties in any
jurisdiction. No indemnifying party shall be liable for any settlement entered
into without its consent, which consent may not be unreasonably withheld.
 
     If the indemnification provided for in this subparagraph (e) is unavailable
to a party otherwise entitled to be indemnified in respect of any expenses,
losses, claims, damages or liabilities referred to herein, then the
                                       B-8
<PAGE>   81
 
indemnifying party, in lieu of indemnifying such party otherwise entitled to be
indemnified, shall contribute to the amount paid or payable by such party to be
indemnified as a result of such expenses, losses, claims, damages or liabilities
in such proportion as is appropriate to reflect the relative benefits received
by Issuer, all Selling Holders and the underwriters from the offering of the
securities and also the relative fault of Issuer, all Selling Holders and the
underwriters in connection with the statements or omissions which resulted in
such expenses, losses, claims, damages or liabilities, as well as any other
relevant equitable considerations. The amount paid or payable by a party as a
result of the expenses, losses, claims, damages and liabilities referred to
above shall be deemed to include any legal or other fees or expenses reasonably
incurred by such party in connection with investigating or defending any action
or claim; provided, that in no case shall any Selling Holder be responsible, in
the aggregate, for any amount in excess of the net offering proceeds
attributable to its Option Shares included in the offering. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. Any obligation by any holder to
indemnify shall be several and not joint with other holders.
 
     In connection with any registration pursuant to subparagraph (a) or (b)
above, Issuer and each Selling Holder (other than Grantee) shall enter into an
agreement containing the indemnification provisions of this subparagraph (e).
 
     (f) Issuer shall use its best efforts to comply with all reporting
requirements and will do all such other things as may be necessary to permit the
expeditious sale at any time of any Option Shares by Holder in accordance with
and to the extent permitted by any rule or regulation promulgated by the SEC
from time to time, including, without limitation, Rules 144 and 144A.
 
     (g) Issuer will pay all stamp taxes in connection with the issuance and the
sale of the Option Shares and in connection with the exercise of the Option, and
will save Holder harmless, without limitation as to time, against any and all
liabilities, with respect to all such taxes.
 
     10.  QUOTATION; LISTING.  If Issuer Common Stock or any other securities to
be acquired upon exercise of the Option are then authorized for quotation or
trading or listing on the NYSE or any other securities exchange or any automated
quotations system maintained by a self-regulatory organization, Issuer, upon the
request of Holder, will promptly file an application, if required, to authorize
for quotation or trading or listing the shares of Issuer Common Stock or other
securities to be acquired upon exercise of the Option on the NYSE or any other
securities exchange or any automated quotations system maintained by a
self-regulatory organization and will use its best efforts to obtain approval,
if required, of such quotation or listing as soon as practicable.
 
     11.  DIVISION OF OPTION.  This Agreement (and the Option granted hereby)
are exchangeable, without expense, at the option of Holder, upon presentation
and surrender of this Agreement at the principal office of Issuer for other
Agreements providing for Options of different denominations entitling the holder
thereof to purchase in the aggregate the same number of shares of Issuer Common
Stock purchasable hereunder. The terms "Agreement" and "Option" as used herein
include any other Agreements and related Options for which this Agreement (and
the Option granted hereby) may be exchanged. Upon receipt by Issuer of evidence
reasonably satisfactory to it of the loss, theft, destruction or mutilation of
this Agreement, and (in the case of loss, theft or destruction) of reasonably
satisfactory indemnification, and upon surrender and cancellation of this
Agreement, if mutilated, Issuer will execute and deliver a new Agreement of like
tenor and date. Any such new Agreement executed and delivered shall constitute
an additional contractual obligation on the part of Issuer, whether or not the
Agreement so lost, stolen, destroyed or mutilated shall at any time be
enforceable by anyone.
 
     12.  MISCELLANEOUS.
 
     (a) EXPENSES.  Except as otherwise provided in Section 9, each of the
parties hereto shall bear and pay all costs and expenses incurred by it or on
its behalf in connection with the transactions contemplated hereunder, including
fees and expenses of its own financial consultants, investment bankers,
accountants and counsel.
                                       B-9
<PAGE>   82
       
     (b) WAIVER AND AMENDMENT.  Any provision of this Agreement may be waived at
any time by the party that is entitled to the benefits of such provision. This
Agreement may not be modified, amended, altered or supplemented except upon the
execution and delivery of a written agreement executed by the parties hereto.
       
     (c) ENTIRE AGREEMENT; NO THIRD-PARTY BENEFICIARY; SEVERABILITY.  This
Agreement, together with the Merger Agreement and the other documents and
instruments referred to herein and therein, between Grantee and Issuer (a)
constitutes the entire agreement and supersedes all prior agreements and
understandings, both written and oral, between the parties with respect to the
subject matter hereof and (b) is not intended to confer upon any person other
than the parties hereto (other than any transferees of the Option Shares or any
permitted transferee of this Agreement pursuant to Section 12(h) and other than
as provided in the Merger Agreement) any rights or remedies hereunder. If any
term, provision, covenant or restriction of this Agreement is held by a court of
competent jurisdiction or a federal or state governmental or regulatory agency
or authority to be invalid, void or unenforceable, the remainder of the terms,
provisions, covenants and restrictions of this Agreement shall remain in full
force and effect and shall in no way be affected, impaired or invalidated. If
for any reason such court or regulatory agency determines that the Option does
not permit Holder to acquire, or does not require Issuer to repurchase, the full
number of shares of Issuer Common Stock as provided in Sections 3 and 8 (as
adjusted pursuant to Section 7), it is the express intention of Issuer to allow
Holder to acquire or to require Issuer to repurchase such lesser number of
shares as may be permissible without any amendment or modification hereof.
       
     (d) GOVERNING LAW.  This Agreement shall be governed and construed in
accordance with the laws of the State of Delaware without regard to any
applicable conflicts of law rules.
       
     (e) DESCRIPTIVE HEADINGS.  The descriptive headings contained herein are
for convenience of reference only and shall not affect in any way the meaning or
interpretation of this Agreement.
       
     (f) NOTICES.  All notices and other communications hereunder shall be in
writing and shall be deemed given if delivered personally, telecopied (with
confirmation) or mailed by registered or certified mail (return receipt
requested) to the parties at the addresses set forth in the Merger Agreement (or
at such other address for a party as shall be specified by like notice).
       
     (g) COUNTERPARTS.  This Agreement and any amendments hereto may be executed
in two counterparts, each of which shall be considered one and the same
agreement and shall become effective when both counterparts have been signed, it
being understood that both parties need not sign the same counterpart.
       
     (h) ASSIGNMENT.  Neither this Agreement nor any of the rights, interests or
obligations hereunder or under the Option shall be assigned by any of the
parties hereto (whether by operation of law or otherwise) without the prior
written consent of the other party, except that Grantee may assign this
Agreement to a wholly owned Subsidiary of Grantee and Grantee may assign its
rights hereunder in whole or in part after the occurrence of a Purchase Event.
Subject to the preceding sentence, this Agreement shall be binding upon, inure
to the benefit of and be enforceable by the parties and their respective
successors and assigns.
       
     (i) FURTHER ASSURANCES.  In the event of any exercise of the Option by
Holder, Issuer and Holder shall execute and deliver all other documents and
instruments and take all other action that may be reasonably necessary in order
to consummate the transactions provided for by such exercise.
       
     (j) SPECIFIC PERFORMANCE.  The parties hereto agree that this Agreement may
be enforced by either party through specific performance, injunctive relief and
other equitable relief. Both parties further agree to waive any requirement for
the securing or posting of any bond in connection with the obtaining of any such
equitable relief and that this provision is without prejudice to any other
rights that the parties hereto may have for any failure to perform this
Agreement.
       
     (k) CONFIDENTIALITY AGREEMENTS.  The parties hereto agree that this
Agreement supersedes any provision of the Confidentiality Agreement that could
be interpreted to preclude the exercise of any rights or the fulfillment of any
obligations under this Agreement, and that none of the provisions included in
the Confidentiality Agreement will act to preclude Holder from exercising the
Option or exercising any other
 
                                      B-10
<PAGE>   83
 
rights under this Agreement or act to preclude Issuer from fulfilling any of its
obligations under this Agreement.
 
     IN WITNESS WHEREOF, Issuer and Grantee have caused this Stock Option
Agreement to be signed by their respective officers thereunto duly authorized,
all as of the day and year first written above.
 
                                          JOHN ALDEN FINANCIAL CORPORATION
 
                                          By: /s/ GLENDON E. JOHNSON
                                            ------------------------------------
                                            Name: Glendon E. Johnson
                                            Title: Chairman and Chief Executive
                                              Officer
 
                                          FORTIS, INC.
 
                                          By: /s/ J. KERRY CLAYTON
                                            ------------------------------------
                                            Name: J. Kerry Clayton
                                            Title: Executive Vice President
 
                                      B-11
<PAGE>   84
 
                                                                         ANNEX C
 
[CREDIT SUISSE FIRST BOSTON CORPORATION LETTERHEAD] 
 
July 29, 1998
 
Board of Directors
John Alden Financial Corporation
7300 Corporate Center Drive
Miami, FL 33126-1208
 
Dear Sirs and Madame:
 
You have asked us to advise you with respect to the fairness to the stockholders
of John Alden Financial Corporation (the "Company") from a financial point of
view of the consideration to be received by such stockholders pursuant to the
terms of the Agreement and Plan of Merger, dated as of March 9, 1998 (the
"Acquisition Agreement"), among the Company, Fortis, Inc. (the "Acquiror") and
JAFCO Acquisition Corp. (the "Sub"), which is attached as Annex A to the Proxy
Statement, dated July 29, 1998, of the Company (the "Proxy Statement"). The
Acquisition Agreement provides for the merger (the "Merger") of the Company with
the Sub pursuant to which the Company will become a wholly owned subsidiary of
the Acquiror and each outstanding share of common stock, par value $0.01 per
share, of the Company will be converted into and exchanged for the right to
receive $22.50 in cash.
 
In arriving at our opinion, we have reviewed certain publicly available business
and financial information relating to the Company, as well as the Acquisition
Agreement and Proxy Statement. We have also reviewed certain other information,
including financial forecasts, provided to us by the Company and have met with
the Company's management to discuss the business and prospects of the Company.
 
We have also considered certain financial and stock market data of the Company,
and we have compared those data with similar data for other publicly held
companies in businesses similar to that of the Company and we have considered
the financial terms of certain other business combinations and other
transactions which have recently been effected. We also considered such other
information, financial studies, analyses and investigations and financial,
economic and market criteria which we deemed relevant.
 
In connection with our review, we have not assumed any responsibility for
independent verification of any of the foregoing information and have relied on
its being complete and accurate in all material respects. With respect to the
financial forecasts, we have assumed that they have been reasonably prepared on
bases reflecting the best currently available estimates and judgments of the
Company's management as to the future financial performance of the Company. In
addition, we have not been requested to make, and have not made, an independent
evaluation or appraisal of the assets or liabilities (contingent or otherwise)
of the Company, nor have we been furnished with any such evaluation or
appraisal. Our opinion is necessarily based upon financial, economic, market and
other conditions as they exist and can be evaluated on the date hereof. In
connection with our engagement, we approached third parties to solicit
indications of interest in a possible acquisition of the Company and held
preliminary discussions with certain of these parties prior to the date hereof.
 
                                       C-1
<PAGE>   85
Board of Directors
John Alden Financial Corporation
July 29, 1998 -- Page  2
 
We have acted as financial advisor to the Company in connection with the Merger
and will receive a fee for our services, a significant portion of which is
contingent upon the consummation of the Merger.
 
In the past, we have performed certain investment banking services for the
Company and have received customary fees for such services.
 
In the ordinary course of our business, we and our affiliates may actively trade
the debt and equity securities of both the Company and the Acquiror for our and
such affiliates' own accounts and for the accounts of customers and,
accordingly, may at any time hold a long or short position in such securities.
 
It is understood that this letter is for the information of the Board of
Directors of the Company in connection with its consideration of the Merger,
does not constitute a recommendation to any stockholder as to how such
stockholder should vote on the proposed Merger and is not to be quoted or
referred to, in whole or in part, in any registration statement, prospectus or
proxy statement, or in any other document used in connection with the offering
or sale of securities, nor shall this letter be used for any other purposes,
without our prior written consent.
 
Based upon and subject to the foregoing, it is our opinion that, as of the date
hereof, the consideration to be received by the stockholders of the Company in
the Merger is fair to such stockholders from a financial point of view.
 
Very truly yours,
 
CREDIT SUISSE FIRST BOSTON CORPORATION
 
                                       C-2
<PAGE>   86
 
                                                                         ANNEX D
 
                     APPRAISAL RIGHTS PROVISIONS UNDER THE
                        DELAWARE GENERAL CORPORATION LAW
 
     Set forth below is the text of the statutory appraisal rights provisions
under Section 262 of the Delaware General Corporation Law.
 
     262 APPRAISAL RIGHTS.-- (a) Any stockholder of a corporation of this State
who holds shares of stock on the date of the making of a demand pursuant to
subsection (d) of this section with respect to such shares, who continuously
holds such shares through the effective date of the merger or consolidation, who
has otherwise complied with subsection (d) of this section and who has neither
voted in favor of the merger or consolidation nor consented thereto in writing
pursuant to Section 228 of this title shall be entitled to an appraisal by the
Court of Chancery of the fair value of the stockholder's shares of stock under
the circumstances described in subsections (b) and (c) of this section. As used
in this section, the word "stockholder" means a holder of record of stock in a
stock corporation and also a member of record of a nonstock corporation; the
words "stock" and "share" mean and include what is ordinarily meant by those
words and also membership or membership interest of a member of a nonstock
corporation; and the words "depository receipt" mean a receipt or other
instrument issued by a depository representing an interest in one or more
shares, or fractions thereof, solely of stock of a corporation, which stock is
deposited with the depository.
 
     (b) Appraisal rights shall be available for the shares of any class or
series of stock of a constituent corporation in a merger or consolidation to be
effected pursuant to Section 251 (other than a merger effected pursuant to
Section 251(g) of this title), Section 252, Section 254, Section 257, Section
258, Section 263 or Section 264 of this title:
 
          (1) Provided, however, that no appraisal rights under this section
     shall be available for the shares of any class or series of stock, which
     stock, or depository receipts in respect thereof, at the record date fixed
     to determine the stockholders entitled to receive notice of and to vote at
     the meeting of stockholders to act upon the agreement of merger or
     consolidation, were either (i) listed on a national securities exchange or
     designated as a national market system security on an interdealer quotation
     system by the National Association of Securities Dealers, Inc. or (ii) held
     of record by more than 2,000 holders; and further provided that no
     appraisal rights shall be available for any shares of stock of the
     constituent corporation surviving a merger if the merger did not require
     for its approval the vote of the stockholders of the surviving corporation
     as provided in subsection (f) of Section 251 of this title.
 
          (2) Notwithstanding paragraph (1) of this subsection, appraisal rights
     under this section shall be available for the shares of any class or series
     of stock of a constituent corporation if the holders thereof are required
     by the terms of an agreement of merger or consolidation pursuant to Section
     251, 252, 254, 257, 258, 263 and 264 of this title to accept for such stock
     anything except:
 
             a. Shares of stock of the corporation surviving or resulting from
        such merger or consolidation, or depository receipts in respect thereof;
 
             b. Shares of stock of any other corporation, or depository receipts
        in respect thereof, which shares of stock (OR DEPOSITORY RECEIPTS IN
        RESPECT THEREOF) or depository receipts at the effective date of the
        merger or consolidation will be either listed on a national securities
        exchange or designated as a national market system security or an
        interdealer quotation system by the National Association of Securities
        Dealers, Inc. or held of record by more than 2,000 holders;
 
             c. Cash in lieu of fractional shares or fractional depository
        receipts described in the foregoing subparagraphs a. and b. of this
        paragraph; or
 
                                       D-1
<PAGE>   87
 
             d. Any combination of the shares of stock, depository receipts and
        cash in lieu of fractional shares or fractional depository receipts
        described in the foregoing subparagraphs a., b. and c. of this
        paragraph.
 
          (3) In the event all of the stock of a subsidiary Delaware corporation
     party to a merger effected under Section 253 of this title is not owned by
     the parent corporation immediately prior to the merger, appraisal rights
     shall be available for the shares of the subsidiary Delaware corporation.
 
     (c) Any corporation may provide in its certificate of incorporation that
appraisal rights under this section shall be available for the shares of any
class or series of its stock as a result of an amendment to its certificate of
incorporation, any merger or consolidation in which the corporation is a
constituent corporation or the sale of all or substantially all of the assets of
the corporation. If the certificate of incorporation contains such a provision,
the procedures of this section, including those set forth in subsections (d) and
(e) of this section, shall apply as nearly as is practicable.
 
     (d) Appraisal rights shall be perfected as follows:
 
          (1) If a proposed merger or consolidation for which appraisal rights
     are provided under this section is to be submitted for approval at a
     meeting of stockholders, the corporation, not less than 20 days prior to
     the meeting, shall notify each of its stockholders who was such on the
     record date for such meeting with respect to shares for which appraisal
     rights are available pursuant to subsections (b) or (c) hereof that
     appraisal rights are available for any or all of the shares of the
     constituent corporations, and shall include in such notice a copy of this
     section. Each stockholder electing to demand the appraisal of his shares
     shall deliver to the corporation, before the taking of the vote on the
     merger or consolidation, a written demand for appraisal of his shares. Such
     demand will be sufficient if it reasonably informs the corporation of the
     identity of the stockholder and that the stockholder intends thereby to
     demand the appraisal of his shares. A proxy or vote against the merger or
     consolidation shall not constitute such a demand. A stockholder electing to
     take such action must do so by a separate written demand as herein
     provided.
 
          Within 10 days after the effective date of such merger or
     consolidation, the surviving or resulting corporation shall notify each
     stockholder of each constituent corporation who has complied with this
     subsection and has not voted in favor of or consented to the merger or
     consolidation of the date that the merger or consolidation has become
     effective; or
 
          (2) If the merger or consolidation was approved pursuant to Section
     228 or Section 253 of this title, each constituent corporation, either
     before the effective date of the merger or consolidation or within ten days
     thereafter, shall notify each of the holders of any class or series of
     stock of such constituent corporation who are entitled to appraisal rights
     of the approval of the merger or consolidation and that appraisal rights
     are available for any or all shares of such class or series of stock of
     such constituent corporation, and shall include in such notice a copy of
     this section; provided that, if the notice is given on or after the
     effective date of the merger or consolidation, such notice shall be given
     by the surviving or resulting corporation to all such holders of any class
     or series of stock of a constituent corporation that are entitled to
     appraisal rights. Such notice may, and, if given on or after the effective
     date of the merger or consolidation, shall, also notify such stockholders
     of the effective date of the merger or consolidation. Any stockholder
     entitled to appraisal rights may, within 20 days after the date of the
     mailing of such notice, demand in writing from the surviving or resulting
     corporation the appraisal of such holder's shares. Such demand will be
     sufficient if it reasonably informs the corporation of the identity of the
     stockholder and that the stockholder intends thereby to demand the
     appraisal of such holder's shares. If such notice did not notify
     stockholders of the effective date of the merger or consolidation, either
     (i) each such constituent corporation shall send a second notice before the
     effective date of the merger or consolidation notifying each of the holders
     of any class or series of stock of such constituent corporation that are
     entitled to appraisal rights of the effective date of the merger or
     consolidation or (ii) the surviving or resulting corporation shall send
     such a second notice to all such holders on or within 10 days after such
     effective date; provided, however, that if such second notice is sent more
     than 20 days following the sending of the first notice, such second notice
     need only be sent to each stockholder who is entitled to appraisal rights
     and who has demanded appraisal of such holder's shares in accordance with
     this
                                       D-2
<PAGE>   88
 
     subsection. An affidavit of the secretary or assistant secretary or of the
     transfer agent of the corporation that is required to give either notice
     that such notice has been given shall, in the absence of fraud, be prima
     facie evidence of the facts stated therein. For purposes of determining the
     stockholders entitled to receive either notice, each constituent
     corporation may fix, in advance, a record date that shall be not more than
     10 days prior to the date the notice is given, provided, that if the notice
     is given on or after the effective date of the merger or consolidation, the
     record date shall be such effective date. If no record date is fixed and
     the notice is given prior to the effective date, the record date shall be
     the close of business on the day next preceding the day on which the notice
     is given.
 
     (e) Within 120 days after the effective date of the merger or
consolidation, the surviving or resulting corporation or any stockholder who has
complied with subsections (a) and (d) hereof and who is otherwise entitled to
appraisal rights, may file a petition in the Court of Chancery demanding a
determination of the value of the stock of all such stockholders.
Notwithstanding the foregoing, at any time within 60 days after the effective
date of the merger or consolidation, any stockholder shall have the right to
withdraw his demand for appraisal and to accept the terms offered upon the
merger or consolidation. Within 120 days after the effective date of the merger
or consolidation, any stockholder who has complied with the requirements of
subsections (a) and (d) hereof, upon written request, shall be entitled to
receive from the corporation surviving the merger or resulting from the
consolidation a statement setting forth the aggregate number of shares not voted
in favor of the merger or consolidation and with respect to which demands for
appraisal have been received and the aggregate number of holders of such shares.
Such written statement shall be mailed to the stockholder within 10 days after
his written request for such a statement is received by the surviving or
resulting corporation or within 10 days after expiration of the period for
delivery of demands for appraisal under subsection (d) hereof, whichever is
later.
 
     (f) Upon the filing of any such petition by a stockholder, service of a
copy thereof shall be made upon the surviving or resulting corporation, which
shall within 20 days after such service file in the office of the Register in
Chancery in which the petition was filed a duly verified list containing the
names and addresses of all stockholders who have demanded payment for their
shares and with whom agreements as to the value of their shares have not been
reached by the surviving or resulting corporation. If the petition shall be
filed by the surviving or resulting corporation, the petition shall be
accompanied by such a duly verified list. The Register in Chancery, if so
ordered by the Court, shall give notice of the time and place fixed for the
hearing of such petition by registered or certified mail to the surviving or
resulting corporation and to the stockholders shown on the list at the addresses
therein stated. Such notice shall also be given by 1 or more publications at
least 1 week before the day of the hearing, in a newspaper of general
circulation published in the City of Wilmington, Delaware or such publication as
the Court deems advisable. The forms of the notices by mail and by publication
shall be approved by the Court, and the costs thereof shall be borne by the
surviving or resulting corporation.
 
     (g) At the hearing on such petition, the Court shall determine the
stockholders who have complied with this section and who have become entitled to
appraisal rights. The Court may require the stockholders who have demanded an
appraisal for their shares and who hold stock represented by certificates to
submit their certificates of stock to the Register in Chancery for notation
thereon of the pendency of the appraisal proceedings; and if any stockholder
fails to comply with such direction, the Court may dismiss the proceedings as to
such stockholder.
 
     (h) After determining the stockholders entitled to an appraisal, the Court
shall appraise the shares, determining their fair value exclusive of any element
of value arising from the accomplishment or expectation of the merger or
consolidation, together with a fair rate of interest, if any, to be paid upon
the amount determined to be the fair value. In determining such fair value, the
Court shall take into account all relevant factors. In determining the fair rate
of interest, the Court may consider all relevant factors, including the rate of
interest which the surviving or resulting corporation would have had to pay to
borrow money during the pendency of the proceeding. Upon application by the
surviving or resulting corporation or by any stockholder entitled to participate
in the appraisal proceeding, the Court may, in its discretion, permit discovery
or other pretrial proceedings and may proceed to trial upon the appraisal prior
to the final determination of the stockholder entitled to an appraisal. Any
stockholder whose name appears on the list filed by the surviving or
                                       D-3
<PAGE>   89
 
resulting corporation pursuant to subsection (f) of this section and who has
submitted his certificates of stock to the Register in Chancery, if such is
required, may participate fully in all proceedings until it is finally
determined that he is not entitled to appraisal rights under this section.
 
     (i) The Court shall direct the payment of the fair value of the shares,
together with interest, if any, by the surviving or resulting corporation to the
stockholders entitled thereto. Interest may be simple or compound, as the Court
may direct. Payment shall be so made to each such stockholder, in the case of
holders of uncertificated stock forthwith, and the case of holders of shares
represented by certificates upon the surrender to the corporation of the
certificates representing such stock. The Court's decree may be enforced as
other decrees in the Court of Chancery may be enforced, whether such surviving
or resulting corporation be a corporation of this State or of any state.
 
     (j) The costs of the proceeding may be determined by the Court and taxed
upon the parties as the Court deems equitable in the circumstances. Upon
application of a stockholder, the Court may order all or a portion of the
expenses incurred by any stockholder in connection with the appraisal
proceeding, including, without limitation, reasonable attorney's fees and the
fees and expenses of experts, to be charged pro rata against the value of all
the shares entitled to an appraisal.
 
     (k) From and after the effective date of the merger or consolidation, no
stockholder who has demanded his appraisal rights as provided in subsection (d)
of this section shall be entitled to vote such stock for any purpose or to
receive payment of dividends or other distributions on the stock (except
dividends or other distributions payable to stockholders of record at a date
which is prior to the effective date of the merger or consolidation); provided,
however, that if no petition for an appraisal shall be filed within the time
provided in subsection (e) of this section, or if such stockholder shall deliver
to the surviving or resulting corporation a written withdrawal of his demand for
an appraisal and an acceptance of the merger or consolidation, either within 60
days after the effective date of the merger or consolidation as provided in
subsection (e) of this section or thereafter with the written approval of the
corporation, then the right of such stockholder to an appraisal shall cease.
Notwithstanding the foregoing, no appraisal proceeding in the Court of Chancery
shall be dismissed as to any stockholder without the approval of the Court, and
such approval may be conditioned upon such terms as the Court deems just.
 
     (l) The shares of the surviving or resulting corporation to which the
shares of such objecting stockholders would have been converted had they
assented to the merger or consolidation shall have the status of authorized and
unissued shares of the surviving or resulting corporation. (Last amended by Ch.
120, L. '97, eff. 7-1-97.)
 
                                       D-4
<PAGE>   90
                        JOHN ALDEN FINANCIAL CORPORATION
                           7300 CORPORATE CENTER DRIVE
                            MIAMI, FLORIDA 33126-1223

              VOTING INSTRUCTIONS TO THE TRUSTEE OF THE JOHN ALDEN
                         EMPLOYEE SAVINGS INCENTIVE PLAN

               THIS PROXY SOLICITED BY THE BOARD OF DIRECTORS FOR
        THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 28, 1998

The undersigned participant in the Employee Savings Incentive Plan of JOHN ALDEN
FINANCIAL CORPORATION, a Delaware corporation (the "Company"), hereby instructs
Bankers Trust Company, as Trustee, to vote all shares of the Company's Common
Stock held for me by the Trustee at the Special Meeting of Stockholders of the
Company to be held at the Miami Airport Marriott, 1201 N.W. LeJeune Road, Miami,
Florida 33126 on August 28, 1998, at 10:00 a.m. (Eastern Time), and at any and
all adjournments or postponements thereof, as follows:


Notes:

(1)    This voting instruction must be executed by the participant or his
       attorney authorized in writing. If undated, this voting instruction is
       deemed to bear the date it was mailed to the participant.
(2)    The shares represented hereby will be voted as directed by the
       participant. If the participant fails to mark or sign and return this
       voting instruction, the Trustees will vote such shares in the same
       proportion as they vote the shares held for other participants for which
       the Trustees receive instructions.

PLEASE MARK, SIGN, DATE AND RETURN THIS VOTING INSTRUCTION CARD PROMPTLY, USING
THE ENCLOSED ENVELOPE.

                            - FOLD AND DETACH HERE -

<PAGE>   91
                                                  Please mark 
                                                  your votes as      [X]
                                                  indicated in  
                                                  this example

                                        





<TABLE>
<S>                                                                        <C>                                            
1.  Approval and adoption of the Agreement and Plan of Merger,             FOR            AGAINST             ABSTAIN  
    dated as of March 9, 1998 (the "Merger Agreement"), by and                                                         
    among Fortis, Inc., a Nevada corporation, JAFCO Acquisition            [ ]              [ ]                  [ ]   
    Corp., a Delaware corporation, and the Company, pursuant to            
    which, among other things, each issued and outstanding share of Company common stock, par value $.01 per share, 
    will be converted into the right to receive from Fortis, Inc. $22.50 in cash, without interest.

2.  OTHER MATTERS: Discretionary authority is hereby granted with respect to such other business as may properly come
    before the meeting or any adjournment or postponement thereof.
</TABLE>

THE COMPANY'S BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR THE APPROVAL
AND ADOPTION OF THE MERGER AGREEMENT



The undersigned hereby acknowledges receipt of the Notice of Special Meeting of
Stockholders and the related Proxy Statement furnished herewith.

Dated:                   , 1998
       ------------------
Signature:                                  
           ----------------------------------
Signature(s) (if held jointly): 
                                -------------------
                                                        
- ------------------------------------------

Title or Authority:
                    ----------------------------

IMPORTANT: Please sign your name exactly as it appears hereon. When signing as
attorney, agent, executor, administrator, trustee, guardian or corporate
officer, please give your full title as such. Each joint owner should sign the
instruction card. If executed by a partnership, this instruction card should be
signed by an authorized partner.


                           - FOLD AND DETACH HERE -


<PAGE>   92

                        JOHN ALDEN FINANCIAL CORPORATION
                           7300 CORPORATE CENTER DRIVE
                            MIAMI, FLORIDA 33126-1223

PROXY

               THIS PROXY SOLICITED BY THE BOARD OF DIRECTORS FOR
                THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON
                               AUGUST 28, 1998



The undersigned hereby appoints Glendon E. Johnson, Scott L. Stanton and Michael
P. Anderson, and each of them with full power to act alone, the true and lawful
attorneys in fact and proxies of the undersigned to vote all shares of Common
Stock of JOHN ALDEN FINANCIAL CORPORATION, a Delaware corporation (the
"Company"), held by the undersigned, with full power of substitution, with the
same force and effect as the undersigned would be entitled to vote if personally
present, at the Special Meeting of Stockholders of the Company to be held at the
Miami Airport Marriott, 1201 N.W. LeJeune Road, Miami, Florida 33126 on August
28, 1998, at 10:00 a.m. (Eastern Time), and at any and all adjournments or
postponements thereof, as follows:

PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY, USING THE ENCLOSED
ENVELOPE.




                           - FOLD AND DETACH HERE -

<PAGE>   93

<TABLE>
<S>                                                                   <C>                <C>                 <C>              
THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN.               Please mark                 
IF THIS PROXY IS SUBMITTED, BUT NO DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED               your votes as               
            "FOR" THE APPROVAL AND ADOPTION OF THE MERGER AGREEMENT.                           indicated in       [X]      
                                                                                               this example                
                                                                                                                           
                                                                                               

1.  Approval and adoption of the Agreement and Plan of Merger,        FOR                AGAINST             ABSTAIN 
    dated as of March 9, 1998 (the "Merger Agreement"), by and                                                       
    among Fortis, Inc., a Nevada corporation, JAFCO Acquisition       [ ]                  [ ]                 [ ]   
    Corp., a Delaware corporation, and the Company, pursuant to       
    which, among other things, each issued and outstanding share
    of Company common stock, par value $.01 per share, will be
    converted into the right to receive from Fortis, Inc. $22.50
    in cash, without interest.
</TABLE>
  

2.  OTHER MATTERS: Discretionary authority is hereby granted with respect to
    such other business as may properly come before the meeting or any
    adjournment or postponement thereof.

THE COMPANY'S BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR THE APPROVAL
AND ADOPTION OF THE MERGER AGREEMENT

  
The undersigned hereby acknowledges receipt of the Notice of Special Meeting of
Stockholders and the related Proxy Statement furnished herewith.

Dated:                    , 1998
       ------------------
Signature:                                  
           ---------------------------------
Signature(s) (if held jointly):                    
                                -------------------

- -----------------------------------------                         

Title or Authority:
                    ----------------------------

IMPORTANT: Please sign your name exactly as it appears hereon. When signing as
attorney, agent, executor, administrator, trustee, guardian or corporate
officer, please give your full title as such. Each joint owner should sign the
proxy. If executed by a partnership, this proxy should be signed by an
authorized partner. 



                           - FOLD AND DETACH HERE -



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission